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Deoxynivalenol: toxicological profile and potential for reducing cereal grain 
contamination using bacterial additives in fermented animal feed. 
William F. Vevers, Richard Billington, Jane Beal 
Abstract 
Deoxynivalenol (DON) contamination of grain destined for animal feeds is a major 
toxicological risk to monogastrics and is suspected of restricting productivity in ruminants.  
Whereas bacterial additives have been developed that can detoxify DON in the rumen 
and lower intestine, there are currently no commercial inoculants able to perform this 
task in crimped grain (CG) silage, a regionally important method of moist grain 
preservation based on homo- and heterofermentative lactic acid bacteria or chemical 
additives. Determining whether this ensiling process alongside the action of detoxifying 
bacteria has the potential to remove DON in CG prior to ingestion, was explored in mini-
silo ensiling experiments.  CG was heat treated (100 °C, 60 min) or ensiled fresh in 
triplicate 50 g silos, spiked with 5 mg/kg DON and inoculated with lactic acid bacteria 
derived from wild birds, natural epiphytic inoculants and commercially sourced silage 
additives (21 d).  DON recovery was only significantly reduced (31.2 ± 14.4% recovery, 
p<0.001, n= 30) by heat treatment, as determined by IAC-RP-HPLC-UV.  Bacterial 
assemblage analysis by 16S rRNA PCR-DGGE-SEQ identified Weissella cibaria, Pantoea 
agglomerans, Bacillus subtilis, B. licheniformis and Hafnia alvei as candidate detoxification 
agents, of which W. cibaria and H. alvei decreased DON recovery in vitro (11.3 and 6.2% 
recovery respectively, p<0.05, n = 18), which translated to inoculated W. cibaria yielding a 
decrease in DON recovery (67.2± 14.4%, 28 d) in naturally contaminated crimped wheat 
(13.5 ± 1.0 mg/kg, 35-40% moisture, p<0.05, n =15).  As W. cibaria is a lactic acid bacteria 
already associated with fermented CG by default it has promise as a novel DON 
detoxification agent in CG silage.  DON is however just one of many hepatotoxic co-
contaminants.  Retrorsine, a DNA-crosslinking pyrrolizidine alkaloid derived from Ragwort 
(Senecio sp.) was investigated for interactive toxicity with DON in an in vitro co-exposure 
experiment. HepG2 cells were exposed to Log10 multifactorial binary exposures for 48 h 
followed by a suite of assays to elucidate mechanisms of interactive cytotoxicity, 
genotoxicity and modulation of the proteome.  Retrorsine was tentatively confirmed to 
form DNA/protein crosslinks in the comet, micronucleus and crosslinking assays, whilst 
DON was found to potently induce cytotoxicity and apoptosis.  Co-exposure yielded a 
complex toxicity response, with low doses yielding antagonistic effects and high doses 
trending towards additive effects, although DON dose was generally the principle 
component.  The difficulties associated with undertaking an interactive toxicity study 
where both toxins have multiple metabolic and cellular targets are highlighted. 
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CFU; Colony forming units MRS; De Man, Rogosa and Sharpe
CG; Crimped grain MS; Mass spectrometry
CODA; Chloramphenicol/oxytetracyline dextrose agar MSM; Minimal salts media
Cyto-B: Cytochalasin-B MT; Mycotoxins
D3G; Deoxynivalenol-3-β-d-glucoside MTT; 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyl tetrazolium bromide
Da; Daltons NADH/NAD+; Nicotinamide adenine dinucleotide
DAS; Diacetylscirpenol NDI; Nucleoplasmic division index
DGGE; Denaturant gradient gel electrophoresis PA; pyrrolizidine alkaloids
DHP; Dehydopyrrolizidine pyrrole derivative PAT; Patulin
DM; Dry matter RCA; Reinforced clostridial agar
DMSO; Dimethylsulfoxide RET; Retrorsine
DNA; Deoxyribose nucleic acid RIPA; Radioimmunoprecipitation assay
DOM-1; De-epoxide-deoxynivalenol RNA; Ribose nucleic acid
DON; Deoxynivalenol ROS; Reactive Oxygen Species
DPBS; Dulbecco’s A phosphate buffered saline RP-HPLC; Reverse phase high performance liquid chromatography
EC50; Effective concentration 50% Sodlac; Sodium lactate (media)
EDTA; Ethylene diamine tetraacetic acid SPE; Solid phase extraction
ELISA; Enzyme linked immunosorbent assay TFAA; Trifluoroacetic acid
EtOH; Ethanol TMR; Total mixed ration
FD; Fluorescent detection TSB/TSA; Tryptone soya broth/agar
FHB; Fusarium Head Blight U-HPLC; Ultra high pressure liquid chromatography
FITC; Fluorescein isothiocyanate UV; Ultraviolet
F. ; Fusarium UVD; Ultraviolet detection
GC; Gas chromatography VOD; Veno-occlusive disease
GI; Gastro-Intestinal WCS; Whole crop silage
GLM; General linear model Wks; Weeks
HPLC; High-performance liquid chromatography ZEA; Zearalenone
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1 Deoxynivalenol: toxicological profile and potential for 
reducing cereal grain contamination using bacterial additives 
in fermented animal feed. 
1.1 Introduction 
Fermented animal feeds including crimped (CG) grain silage make up an important 
proportion of animal feeds globally with a significant area of agricultural land dedicated 
to its production.  As with all agricultural commodities CG silage can be susceptible to 
toxin producing pathogens in the field and spoilage organisms in storage (Borling Welin et 
al., 2015, Driehuis et al., 2008).  Beneficial microorganisms, such as lactic acid bacteria 
(LAB) minimise the latter during the ensiling process, with the production of organic acids 
which efficiently preserve the nutritive properties of the feed by lowering the pH and 
inhibiting the growth of undesirable organisms (Dunière et al., 2013).  However, this 
study will examine the additional possibility of such bacteria having the ability to increase 
feed safety by reducing the amount of pre-harvest toxins such as the ubiquitous 
mycotoxin (MT); deoxynivalenol (DON), the main subject of this investigation.    
1.2 DON: primary role, distribution and molecular structure 
Deoxynivalenol (DON) is a sesquiterpenoid mycotoxin (MT) and part of the type B 
trichothecene group (C15H20O6, 296.32 g/mol).  All trichothecenes are characterised by a 
12, 13-epoxide group with type B trichothecenes such as DON (Figure 1.1) having a 
carbonyl group bonded to the C-8 position (Pestka, 2007).  
DON is one of thousands of MTs found in a range of harvested staple commodities across 
the globe (D'Mello and Macdonald, 1997, Hussein and Brasel, 2001, Binder et al., 2007).  
MTs are toxic secondary metabolites produced by fungi and whilst the majority have yet 
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Figure 1.1 Structure of DON (Sigma-Aldrich). 
to be conclusively associated to any defined ecological function (Adam et al., 2015),  the 
toxic effects of these compounds to humans and production animals has attracted 
significant research effort  (Hussein and Brasel, 2001).  The role of DON in plant-pathogen 
interactions is a little more understood.  Correlational evidence suggests DON serves as a 
virulence factor in the colonisation of cereal crops (Ilgen et al., 2008), with Jansen and co-
workers proposing the inhibition of protein synthesis by DON allows the egress of hyphae  
between the interstitial space of the grain, and consequently the colonisation of the 
whole plant head.  Although DON is not strictly essential for mould growth, trichothecene 
gene knockouts did not yield the same degree of egress (Jansen et al., 2005).  Also, the 
mechanism of DON synthesis by the mould has been revealed to be fairly complex 
involving a large suite of enzymes fulfilling very little other purpose, adding support to the 
virulence factor hypothesis (Desjardins et al., 1993).  However, it must be noted that 
although the virulence hypothesis is conceivably valid, there is currently a paucity of 
evidence to support it conclusively (Adam et al., 2015).  
The impact of DON contamination on temperate food supply chains due to DON’s toxicity 
profile, ubiquitous distribution and resistant chemical structure has triggered extensive 
4 
 
 
research into methods of contamination prevention, robust detection and remediation 
(Jouany, 2007, Speijers, 2003, Binder, 2007, Bhat et al., 2010). 
DON is produced by plant pathogenic moulds including; Fusarium graminearum and F. 
culmorum, the main causative agents in Fusarium Head Blight (FHB) in grain crops and 
Gibberella ear rot in maize.  The wide geographical distribution of both F. graminearum 
and F. culmorum across temperate agricultural climates means DON contamination is a 
constant threat for all grain producers, food/feed manufacturers and consumers (D'Mello 
et al., 1999).  Contamination levels are found to be strongly related to prevailing climatic 
conditions during crop anthesis (Langseth and Elen, 1997, Wagacha and Muthomi, 2007), 
although other factors such as land stewardship, use of fungicides and crop resistance all 
play a part in modulating the final contamination level from year to year (Edwards, 2004, 
Beyer et al., 2006).  
1.3 Detection of DON 
Prior to the advent of liquid chromatography which allowed detection of MTs down to µg 
levels, the presence of deleterious MTs in agricultural commodities was difficult to 
determine.  Indeed, only the historical reoccurring mycotoxicosis episodes in both 
humans (St Antony’s Fire, (Matossian, 1984)) and production animals (Turkey X disease, 
100,000 turkeys succumbed to AFB1), yielded a suggestion of toxigenic mould 
involvement, with the causative agents only identified and named “mycotoxins” in the 
early 1960’s (Richard, 2007).  It must be noted that in many countries, especially in rural 
sub-Saharan Africa, the provision of adequate MT detection and quantification methods 
are still scarce leading to human fatalities and severe health risks (Turner et al., 2007).   In 
modern agricultural practices within the EU, the provision of strict MT testing of 
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commodities to set maximum permitted levels (Table 1.1) has meant that human 
mycotoxicotic outbreaks are now rare in the developed world with effects on animal 
productivity the current priority concern, although current guidance for animal feeds is 
based on commodities at 12% moisture only (see Table 1.2 for guidance maximum levels 
in the EU (European-Commision, 2006)).  A suggestion by Eckard et al. (2011) to carry out 
a Europe-wide analytical survey of whole-crop maize silage, an untraded on-farm 
commodity outside the realm of MT testing, was supported by the fact that 100% of the 
maize tested in Switzerland was DON contaminated between 780-2990 µg/kg. Since 
ensiled maize and cereals form a large proportion of cattle forage in modern agriculture 
(Driehuis, 2013), it is imperative that robust methods of silage analysis are developed to 
determine risk and instigate amelioration strategies. 
Additionally, guidance values have been recommended for a further five mycotoxins in 
animal feeds under Commission Recommendation 2006/576/EC: deoxynivalenol, 
zearalenone, ochratoxin A and fumonisins B1 and B2. These mycotoxins pose a risk to 
animal health and can affect livestock production for several species, but the risk to public 
health is considered low; in all cases, food of animal origin only contributes marginally to 
the total human exposure to these toxins.  
Adequate detection and quantification of MTs is reliant on efficient extraction from the 
commodity matrix, the suitability of the separation protocol and the sensitivity of chosen 
mode of detection.  Reverse Phase High Performance Liquid Chromatography (RP-HPLC) is 
broadly the industrial standard for separation followed by gas chromatography, although 
immunoaffinity methods have recently been shown to yield comparable results in the 
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form of ELISA assays, or used solely for the initial sample clean-up stage for 
chromatography (Turner et al., 2009).   
Table 1. 1.  The maximal permitted limits of DON in human food in the European Union (EC No 
1881/2006 (Amended by 1126/2007, 105/2010, 165/2010, 594/2012, 1058/2012). 
Consumer Food type 
Maximum permitted 
DON content (mg/kg 
final product) 
Note/exceptions 
Human; adult 
Unprocessed cereals 
other than maize, oats 
and durum wheat 
1.25  
 
Unprocessed durum 
wheat, maize and oats 
1.75 
(exception of maize for wet 
milling) 
 
Semi-processed grain 
products such as barley / 
wheat / maize flour and 
flakes 
1 (increased from 0.75, 
28
th
 Nov. 2013) 
A maximum tolerated daily 
intake of 1 µg/kg body weight is 
recommended by the EU for 
consumption of DON in humans. 
 
Processed foods 
including bread, biscuits, 
cereal snacks and 
breakfast cereals 
0.5  
 Pasta (dry) 0.75  
Human; infants 
Baby food (dry matter 
basis) 
0.2 (reduced from 0.5, 
28
th
 Nov. 2013) 
Thought to be at the most at risk 
from DON 
 
Table 1. 2.  The guidance limits of DON in animal feeds in the European Union (data extracted from the 
Commission Recommendation (European-Commission, 2006a)) 
Feed type Feed 
Ingredients 
Maximum permitted 
DON content at 12% 
moisture (mg/kg) 
Note/exceptions 
Part ingredient in 
animal feed  
Barley/wheat 
 
8 Level in complete feed or 
complementary feed must not exceed 
5 mg/kg, or levels stated as follows: Maize 12 
Complete feeding 
material/ 
complimentary 
inclusion 
Barley/wheat 5 for pigs the maximum level is 0.9 
mg/kg
 
, for calves <4months, lambs 
and kids the maximum level is 2 mg/kg
 
Maize 5 
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In the current investigation, microbial MT biotransformation will be evaluated in 
fermented animal feeds and growth media.  The extraction and detection protocol needs 
to be robust against any cross-contaminating agents stemming from the components of 
bacterial growth, inherent media acidity, the low concentrations of DON used, the 
additional requirement of detecting DON-metabolites and the sequestering potential of 
the feed component matrix.  Such complex media requires extensive sample clean-up and 
sensitive detection capacity, as illustrated in Table 1.3.  There are relatively few 
publications describing the extraction of DON from fermented feeds or bacterial media 
(Driehuis et al., 2008), although this will likely increase along with the expanding interest 
in this research area (WMF, 2014).  
Seeling and co-workers (2006) used a conventional method of DON determination using 
immunoaffinity clean-up and RP-HPLC with DAD detection (viz. UV absorbance).  This is a 
method typically supplied by the commodity testing suppliers and is therefore well 
validated for many matrices and gives high sensitivity, although the immunoaffinity 
columns (IAC) are expensive and are specific for DON, so validation is required for other 
trichothecenes homologues and metabolites within the sample.   
Driehuis et al. (2008) undertook an analytical survey of MT in Dutch silage using LC-
MS/MS, the gold standard in MT detection due to the capability for high sensitivity multi-
residue analysis without excessive clean-up steps.  A combination of these approaches  
was employed successfully by Döll and colleagues (2009) to achieve the sensitivity 
required for DON-conjugate analysis in cell culture media, although gas chromatography 
can also be used in equally complex matrices such as simulated gastrointestinal fluid 
(Avantaggiato et al., 2004).  
8 
 
 
Table 1.3. Examples of DON detection and quantification protocols in animal fluids, feed components and 
bacterial liquid media. 
Matrix and extraction details 
including % recovery 
Separation method Mode of detection 
and sensitivity  
Reference 
Fusarium-contaminated wheat and 
maize.  Samples oven dried, extracted 
with 88:12 H2O/ACN, immune-affinity 
clean-up with DONprep columns (R-
Biopharm).  74% recovery  
RP-HPLC (reverse phase 
high pressure liquid 
chromatography), C18, 250 
mm x 3 mm, 4 µm, 40 °C, 
0.5 ml / min isocratic 12% 
ACN v/v, 50 µl injection   
Diode array 
detection (DAD), 
LOD; 30 µg/kg DM 
Seeling et al. 
(2006) 
Maize and whole crop wheat silage.  
Sample oven dried, powdered, mixed 
with 80% ACN, diluted and filtered.  
73-111% recovery. 
RP-HPLC, C18 150 mm x 
3.2 mm, 5 µm, binary 
gradient of 0.1% formic 
acid in H2O/ACN, 0.3 
ml/min, 20 µl injection 
Tandem mass 
spectrometry 
(MS/MS), triple 
quadrupole, LOQ; 
250 µg/kg DM 
Driehuis et al. 
(2008) 
Dialysate fluid from dynamic GI 
absorption model extracted with 
ACN, dried under N2, cleaned up in a 
Mycosep® column, derivatised using 
Tri-Sil TBT, partitioned with hexane 
and dried with Na2SO4 
Gas chromatography,  RTX-
5 capillary column, 30 m x 
0.32 mm, 0.25 mm film 
thickness, detector 
temperature; 310 °C 
Electron capture 
detection (ECD). 
No LOQ given as all 
relative peak areas. 
Avantaggiato 
et al. (2004)  
Cellular and tissue growth media 
extracted twice with ethyl acetate, 
then passed through disposable 
chem. Elute columns and DON test 
immunoaffinity columns.  88% 
recovery of which 54% was found 
conjugated with glucuronic acid and 
released following a 24 h 37 °C pH 5.5 
incubation with β-glucuronidase prior 
to extracting. 
Liquid chromatography- 
HPLC C18 column; 100 
mmx2.1 mm, 3 µm, binary 
gradient with 0.31 mM 
ammonium acetate in H2O 
(pH 7.4) and ACN. 
Electron spray 
ionization tandem 
mass spectrometry 
with external 
calibration, LOD; 
1.6 µg/l 
Döll et al. 
(2009)  
Pig’s urine and maize extracted with 
multifunctional MycoSep column.  64-
102% recovery for all compounds in 
both matrices.   
HPLC column; Polar-RP C18 
column.  H2O:ACN:MeOH 
isocratic with 1 ml/min 
flow rate. 
Atmospheric 
pressure chemical 
ionisation mass 
spectrometry. LOD; 
25-150 ng/g 
Razzazi-Fazeli 
et al. (2003)  
1.4 Preventative measures and post-harvest treatment strategies for 
reduction of DON levels in cereal crops 
Levels of MTs for both plant pathogenic and spoilage moulds are directly linked to the 
amount of toxigenic mould present which is related to whether optimal conditions 
conducive to spore germination, mycelial growth and reproduction are present and 
whether plant, microbial and climatic antagonistic stimuli induce MT production.  The 
effect of climate change on mould ecophysiology and MT production has also been 
brought to the fore (Magan et al., 2011).  
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Toxigenic plant pathogens such as Fusarium spp. can be kept in check with topical 
application of fungicides, employing good farming practices such as crop rotation, tilling 
of the soil and growing of resistant cultivars (may include future use of genetic 
manipulation technology) (Beyer et al., 2006, Edwards, 2004).  However, wet weather 
during certain stages of grain growth is a greater correlational factor concerning DON-
contamination (Langseth and Elen, 1997).   
Daliè and co-workers (2010) found significant inhibition of Fusarium sp. growth by 
Pediococcus pentosaceus, a lactic acid bacteria (LAB) isolated from the maize, therefore 
illustrating that an innovative prevention strategy may be to use LAB in place of 
fungicides (and illustrating that by employing the inhibitive properties of bacteria already 
in competition with Fusarium sp. it may be possible to reduce MT levels).  Use of LAB as 
bio-control agents (BCAs) has been also studied in the context of bread spoilage by Gerez 
et al. (2009) who found lactic, acetic and phenyl-lactic acid to play a vital role in inhibiting 
both mycelia and conidia spore germination.  The results of this study relate well to the 
need for inhibition of toxigenic spoilage moulds during grain storage, such as Aspergillus 
sp. and the production of ochratoxin A (Böhm et al., 2000).  This can be extended to LAB 
in fermented feeds where de novo production of DON post-harvest needs to be 
prevented in addition to inhibition of other toxigenic mould species.   
Bacteria are a particularly diverse group of organisms in terms of substrate metabolism, 
and it is theoretically plausible that any of a wide range of natural and xenobiotic 
pollutants could be targeted with the use of a metabolically capable bacterial strain.  
Ideally the metabolism of toxin yields simple, innocuous precursors or at the very least, a 
toxin with lowered toxicity produced by irreversible biotransformation.  LAB have already 
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been shown to reduce the toxicity of dietary heterocyclic aromatic amines (Orrhage et al., 
1994), benzo[a]pyrene and heavy metals with dietary inclusion of LAB in humans 
correlating with reduced incidences of colon cancer by a range of suggested mechanisms 
(Rafter, 2002, Bolognani et al., 1997).  The two main detoxification mechanisms focused 
on in the literature concerning LAB are toxin binding and enzymatic biotransformation.   
1.4.1 The binding of mycotoxins 
The binding of MTs to clay, activated charcoal and microbial polysaccharide membrane 
including LAB has been very effective for the so called “absorbable” MTs that includes 
AFB1 (Hernandez-Mendoza et al., 2009).  DON has been shown to bind in vitro to certain 
LAB strains (El-Nezami et al., 1998) and Bacillus sp. (Cheng et al., 2010), yet the tenacity 
of the interaction following GI transit is contested by Avantaggiato and co-workers (2004), 
who found many DON binding agents to be grossly inadequate when tested in an in vitro 
gastrointestinal model, with the majority of any binding being reversed.  Importantly, in 
vivo binding studies are notorious for showing huge variation in zootechnical parameters.  
Binders are often non-specific and whilst they are possibly functional, they bind essential 
micronutrients such as vitamins; thus reducing animal productivity but also quenching the 
binding sites of the binder and consequently reducing the capacity for MT removal 
(Tomašević-Čanović et al., 2000).  Binders can be very matrix/animal specific suggesting 
innate binding or diet effects may be confounding factors in vivo.  It must be noted that 
many of the in vitro binding studies so far attempted have shown a degree of binding 
takes place with most materials, yet few have compared such activity to that of 
indigestible dietary elements such as insoluble fibre, or even the likely contaminated 
matrix used as feeds; i.e. maize (Lemke et al., 2001).   
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1.4.2 Bacterial biotransformation of DON 
The first suggestion of the possibility of trichothecene degradation was elucidated as far 
back as the 1960’s by Horváth and Varga (1961) whilst investigating such toxins as 
possible antibiotics, however the treatment and mechanism was not indicated.  The first 
known metabolite of DON biodegradation, deepoxy-DON (DOM-1), was initially 
characterised by Yoshikawa and co-workers (1983) in rat urine and later found to be 
produced following an in vitro rumen incubation, in cow’s milk (Cote et al., 1986, 
Yoshizawa et al., 1986) and pigs urine (Razzazi-Fazeli et al., 2003).  This forged the 
concept that bacterial biotransformation was indeed possible and this was further 
confirmed by work with chicken and pig intestinal contents viz. microflora (He et al., 1992, 
Sundstøl Eriksen et al., 2004) .   
 
Figure 1. 2 The structure of DON (right) and DOM-1 (left) with the epoxide moiety highlighted (Sigma-
Aldrich) 
The epoxide structure is intrinsically linked to the toxicity of DON, and exchanging it for a 
double bonded CH2 dramatically reduces its toxicity (DOM-1 was 500X less toxic in 
exposed mouse fibroblast 3T3 cells, (Sundstøl Eriksen et al., 2004)).  This is now known to 
be possible using bacterial epoxidases derived from two commercially developed 
detoxifying bacteria that are sold to perform this task in vivo.  These strains are DSM-
11798 (Coriobacteriaceae sp., previously Eubacterium sp.) and DSM-11799 (Enterococcus 
casseliflavus) which are patented by Biomin® as BBSH-797 and isolated from cow rumen 
12 
 
 
(Fuchs et al., 2002).  Such anaerobic strains are better incorporated into the diet for 
biotransformation in the rumen or GI tract where anaerobic conditions and optimal 
temperature allow such processes to occur (Awad et al., 2006).  These strict requirements 
for growth preclude the use of these detoxifying agents to treat contaminated grain in a 
fermented feed detoxification strategy, although finding one suitable to these conditions 
would be very valuable indeed, as the chief danger of using additives that only function 
during digestion is at times there may be variations in gut transit time limiting effective 
detoxification.  A more recently isolated soil borne bacteria, Citrobacter freudii, with de-
epoxidase capacity under both aerobic and anaerobic conditions across a wide range of 
temperatures shows increased potential as a true postharvest amelioration additive as it 
can hypothetically be applied and reduce DON at the feed formulation stage rather than 
following ingestion.  C. freudii is a facultative anaerobe and opportunistic human 
pathogen found in a wide range of environments from the soil to the lower intestine 
where it converts nitrite to nitrate during respiration (Wang et al., 2000).  It is therefore a 
surprising candidate for such an application, although as the researcher suggests the 
genes responsible could be inserted in planta for maximum effect (Islam et al., 2012).   
Whilst de-epoxidase has been found to be effectual for modification of the epoxide 
moiety, other research has found other modes of biotransformation that could be 
employed for a similar effect.  Theison and Berger (2005) screened a bank of epoxide 
hydrolase organisms for the biotransformation of DON and found that the mould; 
Alternaria alternata f. sp. lycopersici AS27-3, converted around 50% of DON into a 
metabolite dissimilar to DOM-1 and more polar to DON (identified with TLC), following 
incubation for 6 d with the model epoxide hydrolase substrate; trans-stilbene oxide, as 
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the main carbon source and inducer.  The transformation of epoxides by microbes is 
relatively complex compared to in mammals, but the provision of epoxide hydrolase 
enzymes is broadly the same (even though the enzyme structures are very 
different)(Swaving and de Bont, 1998).  If an epoxide hydrolase enzyme were responsible 
for the biotransformation of DON, then it would be prudent to screen any potential 
microbial detoxification candidates for the ability to produce such an enzyme.  It is worth 
also considering that the phenomenon of co-metabolism could come into play.  Enzymes 
produced by the bacteria to metabolise one substrate may be partially effective at 
metabolising a slightly different one, hence the use of sole carbon source enrichment 
strain selection.  Such an interaction may have little benefit for the bacteria, yet in the 
context of mycotoxin degradation, it could be fortuitous.  Since DON contains an epoxide 
group, it is possible that epoxide hydrolase will be an important enzyme worthy of further 
investigation.  Epoxide hydrolases are found in most organisms and function in preventing 
toxicity from dietary epoxides such as limonene-1,2-epoxide (LIMOX) (Hammock and 
Morisseau, 2005).   LIMOX was incidentally chosen as the co-metabolism substrate in the 
current screening schedule. 
Another biotransformation pathway elicited by Shima and co-workers (1997) using a soil 
bacterium of the Agrobacterium-rhizobium group, produced a different product to DOM-
1, namely 3-keto-4-DON by a suggested enzymatic mechanism, which was one tenth as 
immunosuppressive as DON using a lymphocyte proliferation assay.  The strain was 
isolated using enrichment medium where a group of bacteria is incubated long term with 
DON and the strain able to withstand and proliferate following fourteen serial 
inoculations into fresh enrichment medium (200 µg/ml DON) is identified.  This end-
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product was also found in a mixed culture by Völki and co-workers (2004) when screening 
1285 farmyard-isolated strains.  The hypothesis behind testing so many farmyard-isolated 
strains was the notion that even though DON is prevalent, there is no accumulation in the 
soil and therefore some biological process must be responsible, with bacteria the most 
likely entity. 
One practical aspect of these biological solutions to DON contamination is that these 
species are unlikely to function in low pH, LAB-based fermented feeds, the main subject 
of investigation in the current thesis, and therefore a different approach is perhaps 
required to find a biotransforming bacterium which fulfils these criteria.  The acid 
conditions generated in ensiled crimped grain (CG) or liquid feeds (LF) by production of 
lactic, acetic and propionic acid work well at preventing the growth of undesirable 
organisms such as spoilage moulds, yet the indirect role of these bacterial metabolites on 
the degradation of DON has not been explored in animal feeds.  A study by Méndez-
Albores et al. (2007) working with AFB1 found a 1 N citric acid treatment reduced levels by 
up to 86% in extruded maize beckoning the question of why other acids have not been 
given similar attention.  Non-enzymatic hydrolysis or degradation of MT due to acidic 
conditions is a relatively unknown area of research, but one of especial relevance when 
concerning ensiled feeds.  Dänicke and co-workers found DON-contaminated grain 
treated with sodium bisulphite and propionic acid concurrently was more effective at 
DON-degradation than sodium bisulphite in isolation (Dänicke et al., 2009, Beyer et al., 
2010).  This transformation required strongly acidic aqueous conditions, however, the 
provision of a suitable enzyme eliminates this requirement (He et al., 2010a).  This was 
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found to occur with an Aspergillus sp. which was able to increase the molecular weight of 
94.4% of DON by 18.1, viz. hydration of the C=C (He et al., 2008).   
An important final point is that the EU commission currently prohibits the use of 
remediation agents where the level of grain contamination exceeds set limits for animal 
feed (Table 1.2).   
“The use of such products may not result in an increase of the existing maximum or 
guidance levels established in the context of Directive 2002/32/EC of the European 
Parliament and of the Council (2), but should improve the quality of the feed for animal 
nutrition which is lawfully on the market, providing additional guarantees for the 
protection of animal and public health.” EU regulation 386/2009, (European-Commission, 
2009) 
This regulation prevents the use of any agent to rectify grain which would not be 
permitted to feed to cattle for example, nevertheless since a large proportion of forage 
grain is presumably ensiled without undertaking any on-farm MT testing and there is not 
yet an enforcement of these regulations in silage, the justification for applying a 
detoxification agent to fermented feed would be for preventative purposes or following 
anecdotal risk awareness.  The response of many feed additive companies would be that 
any level of contamination affects growth and therefore any reduction in levels is 
advantageous.  On a similar theme, the biotechnology companies supplying silage 
additives work hard to find evidence of MT detoxification in existing fermented feed 
inoculants as this would be a one size fits all solution, an avenue explored in Chapter 2.  
Undertaking detoxification processes within a fermented feed silo can also be seen to 
complement detoxification capability within the animal; in fact the silo could be seen as 
an extension to the rumen in some respects.     
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1.5 Sources of potential detoxifying bacteria  
Many organisms are exposed to MTs, which can be traced to the offensive/defensive 
efforts of potential pathogens, hosts or competitors.  Evidence suggests that the most 
MT-susceptible organisms are not always the host fungus, an interesting example of this 
being that Rainbow trout are the most sensitive organisms to the carcinogenic effect of 
AFB1 (Bailey et al., 1988).  One hypothesis is that the least susceptible organism is the one 
which habitually comes into contact with the toxigenic mould, or even consumes it 
directly for sustenance.  In this case the organisms survival depends on a suite of 
biotransformation enzymes encompassing conjugative, oxidative, reductive and 
hydrolytic mechanisms (Shen and Dowd, 1991), or the instrumental involvement of 
symbiotic and commensal gut bacteria.  The properties of such bacteria can potentially be 
exploited for MT remediation and the quest for the most efficacious strains is progressing 
quickly (Karlovsky, 2011).  Some potential sources of such bacteria are explored below. 
1.5.1 Production animals: monogastrics, ruminants and chickens 
Monogastric organisms include pigs, horses and humans.  Plant based MTs are absorbed 
into the bloodstream in the small intestine for metabolism and excretion by the liver. The 
large intestine is where the majority of bacterial interactions occur, including the 
metabolism of MT (Pestka, 2007).  Pigs have been found to have a small quantity of the 
far less toxic DON metabolite; deepoxylated-DON (DOM-1), presumably accomplished by 
such lower intestinal bacteria (Kollarczik et al., 1994).  The low susceptibility of ruminants 
to DON was found to be largely due to bacterial biotransformation in the rumen of DON 
to DOM-1 (Yoshizawa et al., 1986, Yoshizawa et al., 1983), hence this is a good place to 
source degradation bacteria.  However, the strongly anaerobic conditions in the rumen 
mean that such fastidious bacteria are difficult to use in fermented animal feeds where 
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microaerophillic bacteria are more suited.  Young et al. (2007) found the contents of 
chicken digesta to have the potential for biotransformation of DON to 1-DOM, with the 
two strains testing positive for this ability (LS100, 5S3) found to also transform other 
trichothecenes as well, albeit not producing the same species of product.  The non-
acetylated trichothecenes such as DON, nivalenol and verrucarol were transformed to 
their de-epoxy metabolites and the acetylated trichothecenes such as 3-acetyl DON, 15-
acetyl DON and fusarenon X transformed to their deacetylated products. Yunus and co-
workers (2010) found low de-epoxidase ability in acutely DON exposed chickens, but 
overall found only 0.04% of the fed DON was found in the plasma after 1h suggesting 
such a metabolism may be insignificant due to the very low uptake in the gut, however 
with a chronic exposure it was found that regions of the gut such as the crop had 
progressively more DOM-1 with acclimation time, suggesting physiological or microbial 
assemblage changes were induced (Yunus et al., 2012) 
1.5.2 Wild birds 
The effect of MTs on wild birds is a completely unexplored area and there is a general 
paucity of data regarding wild birds as a source of LAB in general.  The current 
investigation will attempt to isolate LAB from granivorous birds obtained from the wild 
(both wild reared and birds reared in captivity and released) through shooting or natural 
deaths.  The significance of them being wild sourced stems from them firstly habitually 
feeding on grain that could be contaminated with toxins (viz. MTs and seed 
antifeedant/digestion compounds) and secondly having a crop-sac where such grain is 
stored and is known to host significant amounts of LAB which could play a role in toxin 
resistance.  Wild mallard ducks in the grain-producing belt of Canada obtain 90% of their 
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energy needs from grain during the harvest season (Clark and Sugden, 1990), although 
they showed no sign of toxicity or feed refusal when fed highly contaminated wheat 
(naturally 5-8 µg/g) in a 2 wk experimental study (Boston et al., 1996).  One advantage of 
isolating LAB from birds is that they would be immediately compatible with poultry in 
terms of temperature and may have probiotic or gut assemblage shaping potential. 
1.5.3 Grain-silo insects 
There is generally a strong link between insect infestation of growing cereals and stored 
commodities and toxigenic mould incidence leading to presence of MT.  Insects damage 
the grains whilst feeding leaving a favourable situation for moulds to colonise and in 
some cases actually act as spreading vectors for mould by carrying the spores and 
sporangiospores on the integument or as contents of the gut, for some insects seek 
mould as primary forage.  An example of mould consumers are the Psorcids, which feed 
on a range of moulds which include Aspergillus flavus and Fusarium spp. (Kalinovic et al., 
2006) and have therefore been implicated in the increased presence of MT.  Since 
Psorcids consume on toxigenic moulds, it is conceivable that they possess mechanisms for 
detoxification, which could include a microflora element.  Since they also feed on 
bacterial biofilms there is potential for picking up candidate detoxifying bacteria.  Dowd 
(1992) proposed that dried fruit beetle (Carpophilus hemipterus) which feeds primarily on 
mould was able to hydrolyse a model trichothecene, although it was not found that a 
microbial enzyme was responsible.  The author states that such a mechanism is likely 
derived from the insect’s need for resistance against plant allelochemicals and secondary 
metabolites. 
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1.5.4 Soil, cereal phyllosphere, silage and moulds 
Volki and co-authors (2004) hypothesised that since DON is widespread in arable 
agriculture and does not seem to accumulate in the soils, the most potential source of 
bacterial isolates capable of toxin metabolism theoretically lies within the soil, grains or 
insects.  However, the only bacterial strain that seemed to degrade DON to 3-keto-DON 
was isolated from pond water.  More recent farm platform work presented by Wettstein 
et al. (WMF, 2014) has confirmed that DON does not accumulate but actually leaches 
from the soil into neighbouring water courses; hence this pond-isolate is still fairly 
relevant.   Shima et al. (1997) did however find a soil bacterium able to metabolise DON 
to the same metabolite following enrichment culture using DON as a sole source of 
carbon over an extended anaerobic incubation period. 
Plants have innate mechanisms to combat the effects of DON, such as  glucosidic 
conjugation and phenolic acid production (Engelharclt et al., 2002, Poppenberger et al., 
2003).  The role of epiphytic commensal bacteria on the ecological interaction between 
Fusarium sp. and the plant and whether these bacteria aid in MT removal is an exciting 
avenue of research starting to yield interesting results.  Daliè et al. (2010) for example, 
isolated a Pediococcus pentosaceus (L006) from a maize leaf with novel antifungal 
properties that could be used as a bio-control agent (BCA) against toxigenic Fusarium sp. 
in growing crops, therefore reducing MTs prophylactically.  It can be envisaged that such 
bacteria, whilst commensal in growing plants, are opportunistic decomposers of damaged 
plant tissue and the pioneering inocula for silage fermentation, hence would be exposed 
to DON in this capacity (chapters 3, 4, 5).  Commercially available silage inoculants were 
all presumably isolated from naturally fermented material (and therefore would have 
existed in the living plant) and screened for the ability to effectively preserve ensiled 
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material from deleterious organisms.  The possibility of these commonly used strains also 
having the capacity for DON removal in fermented feeds forms the basis for chapters 2 
and 3.      
The concept of reducing DON in naturally contaminated grain using a DON-degrading 
bacterium derived from the phyllosphere of the wheat or barley itself has been recently 
explored by Ito and co-workers who isolated a Marmoricola sp. from the heads of wheat 
and applied it to DON-contaminated material, yielding a 66% decrease in DON (2012).  
This illustrates how naturally occurring microbial MT biodegradation pathways could be 
employed both for reduction of FHB effects in planta and in harvested commodities (Ito 
et al., 2013).  Whilst this is extremely encouraging, the current study would require that 
an epiphytic isolate not only has the DON-degradation ability but also has the potential 
for growth and amelioration of DON within a fermented feed scenario.  
As a side point, the fact that DON does not affect the mould producing the toxin is 
evidence that non-activation and possibly deactivation is possible with specific enzymes 
present.  Morisseau et al. (1999) found high levels of epoxide hydrolase in Alternaria sp. 
concomitant with levels of AAL toxin production (sphingoline homologue) indicating a 
molecular synthesis application that could be used for exogenous compounds too.  This 
avenue is beyond the scope of the present study. 
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1.6 Fermented animal feeds: an opportunity to remove mycotoxins and 
increase feed value and safety 
1.7 Screening for mycotoxin bioremediation properties, including 
evaluation of biotransformation and binding efficacy in a variety of 
conditions    
1.7.1 Screening techniques  
The main techniques for screening for a specific metabolic trait range from; using the 
pure form of the specific compound in question and measuring transformation 
spectrophotometrically, using chromatography or immunodetection; to using the 
compound as an sole carbon source enrichment component where bacteria able to 
metabolise the compound/structure are able to reproduce and be detected as growing 
colonies in minimal media (Teniola et al., 2005).  Such an approach is also used for 
structural homologues of the compound/toxin in question, where due to cost, availability 
or toxicity, the MT is replaced by a compound sharing structural moieties that if 
metabolically modified may indicate the ability to metabolise the MT by proxy, and as 
such is a valid first screen approach.   
Whereas Theison and Berger (2005) used DON surrogate homologues such as styrene 
oxide as a sole carbon source to screen for epoxide metabolism properties in a range of 
microbes, other workers have used the same molecule when screening for epoxide 
hydrolase activity in marine bacteria (Hwang et al., 2008).  Such an epoxide hydrolase 
enzyme is also responsible for transforming limonene-1,2-epoxide into limonene-1,2-diol, 
and since this is a commercially available flavouring with low toxicity, (Arand et al., 2003)   
it is chosen as the sole carbon source in the current investigation. 
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1.7.2 Procedures for evaluating remediation efficacy 
Obviously the best way to determine if DON has been degraded would be to analyse the 
spiked media/grain matrix prior to and after LAB inoculation.  ELISA or HPLC methods can 
be utilised for such a purpose, however since the derivatives or metabolites of DON may 
share a degree of toxicity with the parent molecule it is important to verify the safety of 
the fermented product (Sundstøl Eriksen et al., 2004).  Past studies have utilised cell lines 
and sterile filtered MT growth medium to evaluate cytotoxic, genotoxic or carcinogenic 
responses, and in doing so have highlighted the need to characterise not only the efficacy 
of MT removal but also toxicity of the finished product (Kollarczik et al., 1994, Mokoena 
et al., 2006).  This should be extended to the cell membrane MT-binding phenomenon 
frequently found in the literature, see tables 1.4 and 1.5 (Jin et al., 2015).  Should the 
supernatant of the medium be extracted, then it would be conceivable that the 
concentration of MT may have reduced from time zero, however if we were able to fully 
extract the pellet/ matrix then the MT may be shown to concentrate in to this fraction.  
The adsorption properties between the cell membrane/ matrix and MT dictate the 
efficiency of extraction and recovery leading to an underestimation in terms of 
concentration, but could be a valuable mechanism worthy of investigation.  Furthermore 
and more crucially, should the MT be bound and toxicologically innocuous during animal 
feed digestion and GI transit, without affecting the nutritive content of the liquid animal 
feed, then a beneficial trait is present (this binding phenomenon forms the basis of 
physical and biological remediation methods discussed in section 1.4).  Should the 
efficacy of binding be reduced following changes in pH, ionic strength (bile salts) or 
presence of extracellular enzymes in the stomach, then it is conceivable that toxicological 
status of the feed may resort back to previous levels and thus removing the remediation 
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potential of the binder/microbe (Avantaggiato et al., 2004).  In order to verify whether 
binding is a possible characteristic to utilise it is necessary to carry out not only 
simulations of gut conditions following binding, but also evaluate the strength of 
interaction by extracting with a range of solvents/heat and determining if both viable and 
non-viable cell fractions share the beneficial characteristic (Haskard et al., 2000, El-
Nezami et al., 2002).     
Table 1.4.  Examples of different methods of determining the efficacy of AFB1 inactivation in a range of 
bacteria-inoculated liquid media/feeds 
Media, MT and treatment Proposed 
mechanism of 
MT inactivation 
Evaluation of remediation value  Reference 
Maize meal (58.3% H2O), 
AFB1, Streptococcus lactis, 
Lactobacillus delbrueckii 
incubation 
Not established Cytotoxicity of LF extracts 
evaluated in human esophageal 
cell line using the MTT assay.  
Shown that LAB reduced toxicity of 
extract.   
Mokoena et al. 
(2006)  
MRS broth, AFB1, strains of 
Lactobacillus casei 
incubation 
Binding  Washing steps and exposure to bile 
salts to simulate digestion showed 
a 0.6-9.2% release was possible. 
Hernandez-
Mendoza et al. 
(2009)  
Dry AFB1 contaminated 
maize, heat and 1 N citric 
acid treatment (3 ml per g 
of maize) 
Chemical 
inactivation 
End product shown to have 
reduced genotoxicity in the Ames 
test and was innocuous as duckling 
feed. 
Méndez-Albores, 
Del Río-García et 
al (2009)  
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Table 1. 5 Examples of different methods of determining the efficacy of DON inactivation in a range of 
treatments and media 
Media and 
treatment 
Proposed mechanism of 
MT inactivation 
Evaluation of remediation value  Reference 
PBS for in vitro 
activated charcoal 
binding experiments 
and dry wheat (with 
activated charcoal) 
for GI absorption 
model  
Binding The binding affinity was analysed by 
determining the percentage of bound 
DON after in vitro incubation, then by 
determining the percentage of DON 
absorbed in the simulated small 
intestine (Jejunal/Ileum) following 
addition of activated charcoal.  With a 
2% inclusion rate, the absorption of 
DON was almost halved   
Avantaggiato 
et al. (2004)  
Viable and non-
viable bacterial cells 
assessed for binding 
of trichothecenes 
including DON at 20 
µg/ml in PBS for 1 h 
at 37 °C 
Binding to cell membrane 
(no degradation products 
found with GC-MS) 
4 out of 7 trichothecenes were bound 
in vitro (incl. DON) with binding of 18-
93% found for L. rhamnosus GG, L. 
rhamnosus LC-705 and 
Propionibacterium freudenreichi ssp. 
Shermanii.  In vitro results need to be 
supported by in vivo data, as the 
binding complex may not be strong 
enough to pass through the GI tract. 
El-Nezami et 
al. (2002)  
Detoxification of 
DON in wheat or 
maize served as a 
realistic model for 
use in contaminated 
animal feeds for two 
strains of Bacillus sp. 
59 probiotic strains 
incubated with 1000 mg/L 
DON and degree of 
degradation measured 
using indirect competitive 
ELISA.  Parallel study 
looked at the interference 
of MRS medium, with 
neutralisation and 32-fold 
dilution yielding better 
results. 
 
Due to the measurement being by 
ELISA, confirmation that the change is 
non-reversible is speculation.  Had 
the metabolites been measured with 
chromatography, more information 
would be available about the de-
toxification mechanism, although the 
spent cell supernatant held the 
important element responsible which 
was heat labile, hence was likely to be 
an enzyme, however the authors 
mention that another agent may be 
also important in DON interaction. 
(This paper states B. subtilis and B. 
licheniformis as decreasing DON by 80 
and 14-44% respectively, yet a study 
by Dänicke et al. (2010) found the 
addition of these strains in vivo to 
have no effect.)  
Cheng et al. 
(2010)  
1.8 The role of D3G when considering fermented feeds 
As previously mentioned DON is a disease virulence factor enabling swift colonisation of 
crops; however some cultivars are able to reduce this impact by conjugating DON to a 
glucoside residue and locking it out of toxic contention as DON-3-glucoside (D3G).  This 
phenomenon actually makes consuming the grain potentially more risky as D3G is 
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converted back to its toxic precursor during gastro-intestinal (GI) enzymatic transit and 
this form of DON may not be factored in a grain analysis strategy (Nagl et al., 2012). 
D3G or “masked” DON is a relatively recent discovery that has sent shockwaves through 
the food and feed testing industries as it was thought levels of DON could be accurately 
determined by well validated testing methods in a wide range of commodities and 
products allowing risk assessments to be written and maximum contamination levels to 
be set (Klötzel et al., 2005, EFSA, 2013).  These maximum contamination levels in a range 
of cereal products are calculated to prevent acute and chronic toxicity and associated 
drops in productivity in production animals.  Although they have a margin of safety, if a 
proportion of DON was masked from the analysis in D3G form, the actual level of DON 
exposure in the animals gut may be significantly higher following cleaving of the glucoside 
residue (Rasmussen et al., 2012).  It is therefore crucial that it is included in any future 
DON determination in cereal based animal feeds and consideration must also be made to 
D3G stability in fermented feeds such as CG silage and LF, especially in feed for 
monogastrics.  It would also be interesting to determine whether D3G is biotransformed 
by LAB in vitro or within the silo environment to DON or even whether the presence of 
the glucoside residue facilitates further DON degradation.  It would also be prudent to 
determine whether the process of ensiling and microbial growth plays a role in increasing 
the unlocking of compartmentalised DON/D3G into a more readily detectable and 
therefore bioavailable form in terms of animal exposure and toxicity.  Simsek and co-
workers (2012) investigated the fate of DON and D3G In wheat during the processing 
from whole grain to flour, fermentation, dough and baked bread and discovered that a 
large proportion of both toxins were locked up in the husk material, or attached to 
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kernel-borne proteins and only measurable following protease treatment.  Interestingly, 
When determining the levels of measurable DON/D3G during the production of beer, 
Lancova et al. (2008) found levels of DON and D3G to increase during the malting phase 
and levels of D3G to increase further during the brewing phase.  This further illustrates 
how levels of DON/D3G may fluctuate in fermented feeds as microbial metabolism takes 
place and should be investigated. 
Although the D3G form may pass further through the gut than DON before being 
toxicologically active the exact timing and efficiency of this digestion is not currently 
known, although in rats it was shown that in equimolar exposures a larger proportion of 
DON was found in the faeces for those exposed with D3G indicating that absorption was 
reduced when a glucoside was present (Nagl et al., 2012) and concentrations of 
glucuronidised DON for urinary excretion in pigs was reduced 2 fold when exposed as 
D3G suggesting bioavailability was also reduced (Nagl et al., 2014).  D3G has been shown 
to possess different biochemical properties to DON including; a difference in solubility 
and chromatographic separation (Berthiller et al., 2005).  
1.9 Toxicity of DON in monogastrics 
Even though the primary role of DON is to act as a virulence factor in plants, the most 
sensitive organisms to this toxin are mammals, specifically the monogastrics such as 
humans and pigs (Table 1.6).  In pigs, symptoms of acute DON ingestion range from 
emesis and abdominal stress to intestinal haemorrhage, liver damage and anorexia 
(Pestka, 2007).  Such effects, although not life-threatening when considering the highest 
likely dose as an acute exposure, do cause a severe impact on animal productivity and 
welfare during chronic exposure (Dänicke et al., 2006).  This is a major consideration  
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Table 1.6 The in vitro and in vivo toxicity profile of DON in monogastrics  
Organism/Cell 
type 
DON concentration and experimental 
detail 
Principle symptoms and effects Reference 
Primary isolated 
pig hepatocytes 
and Kupffer 
macrophages 
 
0.5-16000 nM exposed to tissue 
cultures with LPS (lipopolysaccharide) 
co-exposure.  Disruption of protein 
synthesis determined by H
3
-leucine 
incorporation and albumin secretion.  
Disruption of metabolism determined 
by MTT assay.  Cellular membrane 
integrity determined by neutral red 
uptake assay.  Determination of 
glucuronidation (hepatocyte 
conjugation) factor by use of 
DON/Deepoxy DON detection before 
and after incubation with β-
glucuronidase. 
A 2-4 µM DON exposure resulted 
in a significant decrease in 
neutral red uptake, but 
metabolism was unaffected up 
to 16 µM.  Reduced albumin 
secretion by both cell types (39-
47% of normal) with LPS 
decreasing the effect on 
secretion, but increasing the 
effect on cellular protein 
synthesis. Glucuronidation rate 
decreased with increasing levels 
of DON. 
Döll et al. 
(2009)  
Caco-2 (human 
colon cancer cell 
line) 
Degree of protein synthesis inhibition 
determined by H
3
 leucine 
incorporation and scintillation.  Trans-
well membranes seeded with cells 
were exposed on one side to DON (50-
5000 ng/ml) and H
3
-mannitol diffusion 
measured by scintillation.  Tight 
junction gene synthesis activity also 
measured. 
DON inhibits the expression of 
key regulatory and cell 
maintenance proteins (tight 
junctions etc.) leading to an 
increase in membrane 
permeability 
De Walle 
et al. 
(2010)  
Swiss mouse 
fibroblasts (3T3) 
Cytotoxicity of de-epoxidated DON 
measured using the BrdU 
incorporation assay.  De-epoxidation 
accomplished using pig microflora and 
purified fractions collected using 
HPLC. 
De-epoxy DON (DOM-1) found to 
be 52 times less toxic than DON 
in terms of concentration 
needed for 50% inhibition of 
DNA synthesis 
Sundstøl 
Eriksen et 
al. (2004) 
Pigs Pigs fed chronically with DON-spiked 
feed for chronic experiment and 
injected with acute DON levels using 
an in situ catheter.  This catheter for 
chronic and acute exposures was also 
utilised for administering/ flooding 
the body with 
3
H6-phenylalanine, 
which allowed protein synthesis 
inhibition in each tissue following 
sacrifice to be determined using GC-
MS. 
Protein synthesis was 
significantly reduced in the 
kidneys, spleen and ileum of 
exposed pigs, with the 
chronically exposed (4 weeks) 
showing greater effects, due 
perhaps to the differing degree 
of glucuronidation between the 
two treatments. 
Dänicke et 
al. (2006) 
Pigs Pigs fed DON-contaminated feed (3.5-
4.4 mg/kg) Monocyte derived 
dendritic cells were isolated and 
either tested once more with DON, or 
left untreated.   
Dietary exposure of DON led to a 
reduced endocytosis of FITC-
dextran in the presence of DON 
and LPS/TNFα by monocyte 
derived dendritic cells, but did 
not stimulate a T-cell response.  
Flow cytometry indicated 
maturation and vitality of 
monocyte derived dendritic cells 
was reduced with in vitro DON 
dosing of control diet.   
Bimczok et 
al. (2007) 
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when formulating compound and LF for pigs, and the strict EU limits (Table 1.1) aid in 
reducing DON toxicity (in addition, once incorporated into LF there is a further possibility 
of reducing toxicity to even lower levels by inoculating with DON-detoxifying LAB (Shetty 
and Jespersen, 2006), Chapter 2).  
The mechanism of DON-toxicity is inhibition of protein synthesis by interacting with the 
60S ribosomal subunit within eukaryotic cells and preventing initiation and elongation of 
polypeptides (Carter and Cannon, 1977).  This response can also materialise as 
immunosuppressive and neuro-endocrine effects contributing to the burden associated 
with DON contaminated feed (Pestka et al., 2004, Goyarts et al., 2006, Bimczok et al., 
2007).  In pigs DON is rapidly absorbed in the small intestine and ideally conjugated to 
glucuronides in the liver permitting swift excretion (  8̴  h) (Pestka, 2007, Maul et al., 
2014).  The evidence suggests there is no bioaccumulation of DON; therefore, this 
transitory period is key to the liver/intestinal toxicity.  Chronic exposure to DON has been 
shown to inhibit intestinal cell proliferation, therefore disrupting intestinal permeability 
which cascades to increase DON being absorbed (De Walle et al., 2010, Sergent et al., 
2006).  Dänicke et al. (2006) found another result of chronic exposure (this occasion using 
pigs in vivo) was the depletion of glucuronides over time, which resulted in greater 
damage than those acutely dosed which were able to excrete DON more effectively.  
Interestingly, any detoxification of DON by biotransformation, occurs in the large 
intestine by resident micro flora; too late to prevent hepatotoxicity in pigs, but it does 
illustrate the huge difference in DON sensitivity when compared with ruminants which 
have ruminal microflora capable of converting DON to DOM-1, a less toxic homologue, 
prior to absorption (Yoshizawa et al., 1986). 
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1.10 Toxicity and performance effects of DON in ruminants 
A large proportion of the total mixed ration (TMR) for dairy and beef cattle globally is 
made up of fermented whole crop maize and CG, of which a large proportion is 
contaminated with DON (Driehuis et al., 2008, Adesogan et al., 2003).  Fortunately the 
ruminants are the least susceptible production animal to the effects of DON due to 
microbial interactions in the rumen, though this detoxification capacity may be 
overwhelmed or disrupted by rumen acidosis; leading to subtle yet significant decreases 
in animal productivity, compromised immune function and altered rumen fermentation 
(Table 1.7, (Seeling et al., 2006, Korosteleva et al., 2009, Keese et al., 2008)).  By 
evaluating these biomarkers of effect and exposure the No Observed Adverse Effect Level 
(NOAEL) can challenge the guidance contamination limits outlined in the EU regulations, 
which are currently 5 mg/kg (12% moisture) in barley/wheat fed as principle ration.  
Intervention strategies should be considered should the DON content of the pre/post-
harvest grain surpass the NOAEL, especially concerning pre-ruminant or transition calves 
which do not possess full ability to metabolise DON within the rumen (Fink-Gremmels, 
2008).    
Winkler and co-workers (2014) found a significant correlation between ingestion of DON-
contaminated maize and concentration of DOM-1 in the plasma of 13 week-treated dairy 
cows with up to 10% measured as DON, suggesting ruminal de-epoxidation is not 
definitive and a degree of liver exposure is possible before glucuronidation-based 
excretion occurs.  However, the Holstein cows in this study showed no change in milk 
production or weight gain.  The effect of a mixture of DON and Zearalenone (ZEA) on 
ruminant acidosis was studied by Keese et al. (2008) who found the inclusion of infected 
triticale (wheat/rye hybrid) in the TMR resulted in a shift in rumen fermentation products 
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caused by either a modification in the microbial community and/or a physico-chemical 
change in the grain itself.  The problem exists when such studies work with binary 
exposures rather than individual MTs, as it can be difficult to make firm conclusions on 
either component.  However, MTs naturally co-occur in grain and silage (Eckard et al., 
2011), therefore realistic mixture exposures are justified (Grenier and Oswald, 2011) (see 
Chapter 6).  A combination of DON and ZEA was actually implemented in the deaths of 
several dairy cattle in Poland following confirmation of these MTs in the serum of 
similarly fed cows and post-mortem analyses (Marczuk et al., 2012).  This is more an 
aetiological approach following a catastrophic mycotoxicotic incident, hence the 
experimental design is somewhat departed from other studies, although the researchers 
found indirect evidence of immunosuppression when analysing blood cell morphology 
and biochemical parameters.     
Table 1.7   The effects on ruminant performance and health following DON exposure. 
Ruminant 
details  
DON concentration and 
experimental detail 
Biomarkers of exposure and effect Reference 
Holstein 
dairy cows  
Up to a max of 5.2 mg DON / kg 
DM in mixed ration made with 
Fusarium infected maize (i.e. the 
EU guidance value).  Cows 
treated for 13 wk.  
Levels of DON and DOM-1 in the blood 
plasma were closely correlated to DON in 
feed of which 90% was DOM-1.  No adverse 
effects on animal growth, milk production 
or milk composition. 
Winkler et 
al. (2014) 
Holstein 
Dairy 
cows 
Cows fed TMR with 5 mg DON 
and 113 mg ZEA / kg DM for 1 
period of 11 wk, then 4.6 mg 
DON and 73 mg ZEA /kg for 
another 18 wk.  The DON/ZEA 
content was from Fusarium 
contaminated Triticale.  
Ruminal fermentation patterns and acidosis 
severity measured in ruminal fluid.  
Increase in acidosis with triticale inclusion, 
due to either MT effects on rumen 
microbes or matrix modification effects of 
Fusarium on the triticale concentrate. 
Keese et 
al. (2008) 
Dairy 
cows 
TMR consisting of maize silage, 
cereal grains and haylage fed ad 
libitum.  No MT analysis.  
Experimental grouping 
undertaken (x3) on the basis of 
serum DON/ZEA content 
following mortalities.   
Aetiological study links serum levels of DON 
and ZEA to immunosuppression, acute 
immune response and death.  
Haematological and biochemical 
parameters measured in all cows and 
interrogated for correlation with DON/ZEA- 
positive groups.    
Marczuk et 
al. (2012) 
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1.11 Toxicity profile of DON in combination with other mycotoxins and 
potentially with plant derived toxins such as retrorsine. 
DON is an extremely effective cytotoxin that resides in many harvested cereal crops at 
levels that induce deleterious effects.  However, DON is one of many microbial and plant 
toxins that could be present in harvested grain, both pre- and post-harvest.  The 
interaction between these toxins on a tissue and cellular level in humans and production 
animals needs to be considered as part of commodity risk assessment and management 
(Verstraete, 2013).   
To date there has been a small number in research articles on the co-exposure of 
different MTs (Speijers and Speijers, 2004, Alassane-Kpembi et al., 2013, Kouadio et al., 
2007, Lei et al., 2013, Prosperini et al., 2014, Tammer et al., 2007, Wan et al., 2013) and a 
complete lack of papers associated with MTs and plant toxins, even though modern 
analytical methods now permit multi-toxin identification in a range of harvested materials 
(Berthiller et al., 2007). 
Assessing toxicological interaction between toxins is not a straightforward task, as it 
quickly becomes a highly logistical exercise as the multitude of toxin combinations and 
range of doses required leads to large scale experiments and synthesis of complex data 
that requires robust statistical interrogation (Table 1.7).  Kouadio and co-workers (2007) 
investigated the interaction of the Fusarium produced MTs; DON, zearalenone (ZEA) and 
Fumonisin using a select range of doses aimed to simulate that likely encompassed by 
intestinal cells in vivo by consumption of contaminated grain (Table 1.8).  Human-derived 
Caco-2 intestinal cells were exposed to binary and tertiary combinations of MTs and a 
suite of assays were employed to diagnose the interactive toxicological relationships 
between co-occurring MTs, especially those of a synergistic, potentiating or antagonistic 
32 
 
 
nature.  Synergistic impacts were seen regarding lipid peroxidation and additive effects 
with cell viability measured using lysosomal membrane integrity, both endpoints linked to 
oxidative damage.  Antagonistic responses were found when considering inhibition of 
DNA synthesis and DNA fragmentation when binary and tertiary exposures were 
evaluated illustrating the complexity of multifactorial analyses. 
Table 1.8. Examples of studies where the interactive cellular toxicity of DON with other Fusarium-
mycotoxins is investigated in vitro. 
Mixtures tested and 
concentrations used 
Toxicity assays 
 Employed 
Method of deriving  
interaction and result 
Reference 
DON (4, 10, 20 µM), 
zearalenone (5, 10, 20 
µM) and fumonisin B1 
(10 µM).  These doses 
chosen to reflect the 
likely in vivo intestinal 
cell exposure levels 
following ingestion of 2-
4 mg/kg contaminated 
grain. 
Neutral red 
uptake/retention, DNA 
fragmentation and 
methylation, protein and 
DNA synthesis, 
malonedialdehyde 
production (ROS) in 
human derived Caco-2 
cells (intestinal epithelial 
colon adenocarcinoma).  
Binary exposure combinations of 
listed concentrations and tertiary 
exposures all at 10 µM.  
Comparison with control and 
between treatments using 
percentage of control data and 
non-parametric statistics.  Below 
additive effects seen with DNA 
synthesis, synergistic with lipid 
peroxidation and cellular viability 
decreasing with DON concentration 
most influential.   
Kouadio et 
al. (2007) 
DON (0.5, 2 µM), 
nivalenol (0.5, 2 µM), 
zearalenone (10, 40 
µM) and Fumonisin B1 
(20, 40 µM) exposed as 
combinations of 
cytotoxic and non-
cytotoxic doses (from 
independent dose 
response data) 
An inscribed central 
composite design of 
exposure combinations 
was employed to reduce 
the combinations from 
256 to 16 and 
cytotoxicity measured 
using the MTT assay 
(mitochondrial 
metabolism) following a 
48 h exposure to primary 
swine intestinal cells. 
Non parametric statistical 
comparison with the control 
indicated at non-cytotoxic doses 
only those combinations where 
DON was tested showed significant 
reductions with the mix of all four 
MTs having the greatest effect on 
viability.  At cytotoxic doses, all 
interactive exposures gave reduced 
viability.  All data was percentage 
of control. 
Wan et al. 
(2013) 
Independent, binary 
and ternary mixtures of 
the type-B 
trichothecenes DON, 
3AcDON, 15AcDON, 
nivalenol (all 0.2-6.7 
µM) and fusarenon 
(0.007-0.12 µM). 
Caco-2 exposed to MT 
dissolved in DMSO for 48 
h after which the MTT 
(mitochondrial vitality) 
and neutral red 
retention assays 
(lysosomal integrity) 
employed to derive 
cytotoxicity.  Note. the 
cell culture medium 
contained the antibiotics 
Penicillin and 
streptomycin, toxic 
secondary metabolites in 
their own right.   
Two methods used: the 
isobologram method where the 
IC10, IC20 and IC50 (inhibitory 
concentration yielding X% 
cytotoxicity) values are plotted 
together, and an additive 
relationship is a straight line, and a 
deviation above is antagonistic, 
below is synergistic.  Combination 
index takes the dose required of 
each individual toxin to achieve X% 
inhibition and divides it by the 
interactive response at these 
doses. 0.9-1.1 (additivity), <0.9 
(synergism) and >1.1 (antagonism)    
Alassane-
Kpembi et 
al. (2013) 
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Wan and co-workers (2013) also investigated mixtures of Fusarium MTs in an intestinal 
primary cell line, this time derived from swine, and focussed on only one cytotoxic dose 
and one non-cytotoxic dose of each in a selective multifactorial approach employing the 
MTT assay to derive mitochondrial vitality and cellular viability.  Preliminary dose 
response curves were constructed using the individual toxins to determine which 
concentrations illicit cytotoxic/non-cytotoxic responses for use in interaction experiments.  
DON was found to be the instrumental component when in combination at non-cytotoxic 
doses and all combinations at cytotoxic doses yielded reduced viability over the control 
and antagonistic responses were absent in both dose types.  Due to the lack of a 
multifactorial dosing strategy, there is no interaction measured between both cytotoxic 
and non-cytotoxic doses which does reduce the amount of treatments considerably (from 
256 to 16), but at the expense of interpreting a true interactive dose response. 
Alassane-Kpembi et al. (2013) recently used an isobologram approach where cytotoxicity 
responses of intestinal cells exposed in vitro were plotted as unary and binary exposures 
and the interaction term was calculated.  This is perhaps the most effective approach to 
the problem of mixtures, however it only works when the toxins tested target the same 
cellular components to yield a linear dose-response. 
What is apparent with these studies is that toxin mixtures have the potential to induce 
highly deleterious effects in vivo, often by complex interactions, and consequently more 
work is necessary to deduce risk factors associated with multiple-toxin contaminated 
food and feed.  There is a lack of research in this particularly relevant area of feed and 
food safety (Grenier and Oswald, 2011), with the consensus seemingly being that the 
research community has a sufficient grasp of the toxins individually but does not wish to 
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commit to the challenge of toxin mixtures, unless epidemiological data already alludes to 
a valid interactive toxicity hypothesis, i.e. the apparent relationship between chronic 
levels of AFB1 and Fumonisin B1 in mouldy maize in China and the incidences of human 
oesophageal cancer (Chu and Li, 1994), with a strong synergistic relationship between 
these co-occurring MTs confirmed in rats (Gelderblom et al., 2002a).  
The current academic focus is on mixtures of MTs, however there are a plethora of 
potential field-borne natural toxins associated with weed infested cereal crops that can 
be a significant source of human and livestock toxicosis that should be considered as part 
of the general hazard assessment of toxin mixtures in cereal crops.  Of particular interest 
is the group of 200 toxins belonging to the pyrrolizidine alkaloid group (PA) that are 
produced by around 300 plants worldwide including plants of Senecioneae spp. 
(Asteraceae family) such as Senecio jacobea; the common European Ragwort, or one of 
the more potent tropical relatives including S. inaequidens which was responsible for the 
acute deaths of several cows in South Africa (Dimande et al., 2007).  Both of these plants 
have several PAs present acting as anti-feedants, although one particularly potent PA 
common to both species is retrorsine (RET) and is chosen as representative of hepatotoxic 
Senecioneae PAs in general.  Due to both DON and RET exerting significant toxicity in the 
liver and having the potential for co-harvest, they form the subject of a preliminary 
interactive toxicity study in Chapter 6.   
Following consumption, PAs are metabolised in the liver by the same activation enzymes 
instrumental to AFB1  genotoxicity, the cytochrome P450 monooxygenases, specifically 
CYP3A which yield an especially DNA and protein reactive pyrrole intermediate (DHP) 
(Kolars et al., 1994).  This manifests as DNA/protein adducts and DNA-DNA/DNA-protein 
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crosslinks that lead to genotoxicity and tumorigenecity, mitotic arrest and hepatic veno-
occlusive disease (VOD) where megalocytosis causes a constriction of the hepatic veins 
leading to cirrhosis, failure and death (Figure 1.3).   
 
Figure 1.3  Metabolism of RET in mammals illustrating the enzymes involved in activation leading to 
DNA/protein-DHP adducts with the downstream possibility of mutations, mitotic arrest, veno-occlusive 
disease and cancer.  The enzymes responsible for effective excretion are also shown.  Diagram based on 
work published by Fu et al. (2002), He et al. (2010b) and Wang et al. (2005) and drawn with 
ACD/Chemsketch 12.01 (Advanced Chemistry Development Inc.) 
Ingestion by humans and production animals is often due to co-harvesting with cereals, 
and poor sorting prior to processing or converting to silage (Prakash et al., 1999b).  
Several episodes involving Senecio consumption are documented in Table 1.9, including 
the well documented study in South Africa by Dimande and co-workers (2007) which 
confirmed S. inaequidens was responsible for lethal toxicity or Seneciosis in grazing cows 
by administering the relevant plant extract to rats and sheep.  The resulting characteristic 
histopathological lesions in the liver and metabolised RET measured in the liver, lungs and 
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urine strongly linked S. inaequidens to the cattle deaths.  In southern Brazil Seneciosis is 
actually the main cause of cattle mortality, with S. madagascariensis and S. brasiliensis 
the species responsible (Bandarra et al., 2012), both of which contain high levels of PAs 
that include RET.  In Australia S. lautus (later identified as S. madagascariensis) was the 
significant weed responsible for 226 cattle deaths between 1988-1992, with pyrroles 
identified in the blood samples during necropsy and RET the main PA likely responsible.   
Another diagnostic study from S. Africa based on hospital records and necropsy evidence 
from 1931-41, highlights the potential for human toxicosis and lethal VOD following 
ingestion of bread made with PA-contaminated flour (Selzer and Parker, 1951), a theme 
that re-occurs in Western Afghanistan with wheat and goats milk contaminated with 
another PA containing plant; Heliotropium popovii (Boraginaceae). 
Table 1.9. Summary of toxicity episodes attributed to pyrrolizidine alkaloid contamination of 
food/feed/fodder. 
Pyrrollizidine alkaloid 
and plant species  
Episode location and health 
effects 
Source and cause of 
contamination 
Reference 
S. inaequidens 
(retrorsine, 
Senecionine, 2 
unidentified) 
South Africa.  Several cattle 
mortalities with associated severe 
hepatic necrosis and multiple 
haemorrhages 
Cattle grazing  Dimande et 
al. (2007) 
S. madagascariensis 
(retrorsine, 
mucronatinine, 
florosenine, 
seneciverinine)  
NE Australia.  226 cattle mortalities 
in 4 years.  Deaths occurred some 
months after ingestion during 
which the cattle lost condition, had 
persistent diarrhoea and had 
dramatic changes in behaviour.  
Liver necropsy yielded significant 
lesions in common with Seneciosis 
and blood/liver sample extractions 
showed pyrroles were present 
Cattle grazing  Noble et al. 
(1994) 
Senecio spp. (unknown) South Africa.  12 human cases with 
severe acute VOD of which 6 died 
(and 12 mules locally) 
In all cases bread was 
made from locally milled 
wheat flour where the 
wheat was imperfectly 
winnowed 
(Selzer and 
Parker, 
1951) 
Heliotropium popovii 
(heliotrine, 
lasiocarpine, jacobine) 
Afghanistan. 400 human cases with 
100 deaths caused by VOD and 
liver necrosis. 
Contaminated wheat 
flour made into bread 
and to a lesser extent 
goat milk.  
(Kakar et al., 
2010) 
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Whilst it would appear that these records are from a growing environment very much 
departed from European cereal cultivation, there is growing evidence that with climate 
change and with the spread of non-native Senecio spp. rife throughout the globe there 
could be an incident where FHB affected and PA producing plants could be co-harvested, 
or at least incorporated into the total mixed ration (TMR) of cattle as silage supplemented 
with cereal grain.  For example where wheat and barley is grown in dry countries 
inundated with Senecio spp. such as South Africa, where large-scale irrigation is necessary, 
it has been recently shown that FHB caused by F. graminearum and F. culmorum is 
becoming more common, along with DON (Boutigny et al., 2011).  DON producing F. 
culmorum has been recently conformed in 40% of harvested maize kernels in one study in 
Southern India (Venkataramana et al., 2013), an area where the PA-producing Crotalaria 
spp. have caused numerous cases of human mortality (Prakash et al., 1999a)  It will also 
always be the case that in areas where rural subsistence farming is common, inadequate 
quality control and winnowing may occur, and climatic anomalies may both encourage 
the growth of FHB/Senecio spp. and necessitate the use of contaminated grain for 
consumption or as animal feeds.  Furthermore, it has been shown that chronic, low levels 
of DON in feed over an extended period of time can disrupt the normal process of 
xenobiotic metabolism in mice (Gouze et al., 2006), leading to a potential increased 
susceptibility to toxins such as RET.  This will be investigated using an established human 
liver cell line in vitro in Chapter 6. 
1.12 Research questions to be addressed in the current investigation 
Despite the vast research interest in reducing FHB and DON production in the field, there 
is currently no method of preventing DON from entering the feed and food chains 
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completely; hence strict grain testing and risk assessment regimes are necessary to 
reduce downstream toxicological effects in a range of consumers with differential 
susceptibility (Table 1.1).  Grain that is either DON-positive or not tested at all due to the 
“farm produced feed” nature of the crop comprises significant risks to the farmer in terms 
of animal productivity and welfare.  This warrants the development of an effective 
biological method of post-harvest DON detoxification within the fermented feed 
environment.  In addition, DON rarely exists as a single contaminant in crops and many 
co-occurring toxins have been shown to induce toxicosis in humans and production 
animals, therefore to put the DON detoxification element in perspective; the toxicological 
impact of DON with a co-exposed crop weed derived liver toxin is explored.   The main 
research questions to be addressed in the current investigation: 
 Do LAB play a role in reducing levels of DON in fermented animal feeds? 
 Do commensal LAB in wild birds have DON detoxification potential? 
 Are there other bacteria associated with fermented grain feeds which could be 
developed for DON biodegradation, specifically in CG feeds? 
 Does DON exhibit a degree of interactive toxicity following with co-exposure with 
other co-occurring plant derived liver toxins, and what mechanisms are 
responsible? 
1.12.1 Crimped grain silage, fermented liquid feeds and biofuel co-product 
utilisation 
Forage crops such as maize, barley and wheat make up a large proportion of animal feed 
globally of which the majority is ensiled in on-farm silos utilising naturally occurring or 
artificially inoculated fermentative LAB as a safe and effective method of preserving the 
nutritive value of the feed, whilst preventing the growth undesirable microorganisms 
(Elferink et al., 2000).  Since these crops are likely to be contaminated to varying degrees 
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with a range of MTs including DON, it would be valuable to know the fate and behaviour 
of DON within these fermented feed silos, especially if the microbial community or 
individual bacterial species could be aligned to any decrease in DON leading to an 
associated increase in feed safety and performance.     
The ensiling process is divided into 4 biological phases post-harvesting.  The aerobic phase 
involves the rapid drop in oxygen within the silo due to physical compression, the 
presence of facultative aerobic microorganisms and the residual respiration capacity of 
the plant material.  Providing the pH remains high the plant material has a degree of 
enzymatic competency leading to autolysis of protein and carbohydrates.  As anaerobic 
conditions advance, the main fermentation phase begins where homo- and 
heterofermentative LAB (Figure 1.4, 1.5) metabolise water soluble carbohydrates (WSC) 
to form predominantly lactic acid (plus acetic acid, ethanol) and dropping the pH 
dramatically from around pH 6  to 4 leading to the inhibition of carbohydrases/proteases 
and undesirable biodegradation microorganisms.  At this pH only a few obligate 
heterofermentative LAB, such as L. buchneri, are still metabolically active and produce 
further amounts of acetic acid from the metabolism of lactic acid to reduce the pH further 
to around 3.8 and underpinning this stable phase.  It is the presence of this acetic acid 
which minimises aerobic instability following silo opening by inhibiting aerobic 
microorganisms and preventing dry matter (DM) loss in the aerobic spoilage phase 
(McDonald et al., 1991, Dunière et al., 2013, Elferink et al., 2000). 
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Figure 1.4. Fermentation of glucose and fructose by homofermentative LAB such as Pediococcus 
acidilactici, L. plantarum* and Streptococcus faecium forming lactic acid.  Figure redrawn from McDonald 
and Henderson (1991) 
 
1,2-propanediol Propionate 
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Figure 1.5. Fermentation of fructose and glucose by obligate heterofermentative LAB such as L. buchneri, 
L. plantarum*, L. fermentum, Weissella cibaria and Leuconostoc mesenteroides forming lactic and acetic 
acid in addition to ethanol and CO2.  Figure redrawn from McDonald and Henderson (1991) with putative 
catabolism of lactate to acetate, 1,2-propanediol and propionic acid included with dashed lines (Lindgren 
et al., 1990, Oude Elferink et al., 2001, Krooneman et al., 2002).  * L. plantarum is facultative 
heterofermentative. 
One type of fermented feedstock with particular relevance to grain-borne DON is crimped 
grain (CG).   The crimping of moist grain prior to ensiling is a relatively recent agricultural 
phenomenon championed in Finland and used extensively in northern Europe for 
ruminants (Olstorpe et al., 2010b) with the potential for swine and poultry production 
(Siljander-Rasi et al., 2000, Borling Welin et al., 2015).  It forms a valuable source of locally 
produced, and hence fully traceable, high quality animal feeds from a starting material 
that does not need to be necessarily ripe or mature.  Pressed (crimped) grains are ensiled 
until use in airtight clamps following inoculation with LAB, buffered organic acids or 
chemical preservatives.  Commercially available LAB inoculants such as Lactobacillus 
buchneri and L. fermentum have been shown to give consistently high product stability 
comparable with chemical preservatives (Adesogan et al., 2003).  However, variations in 
initial grain moisture, crimping, consolidation and preservation effectiveness can on 
occasions yield the localised growth of potentially toxigenic moulds, hence sourcing LAB 
inoculants able to inhibit mould germination and growth under such conditions would be 
well received (Borling Welin et al., 2015).      
The lack of the energetically costly drying step found in conventionally harvested grain 
and the potential for in-house production, especially during short or disrupted growing 
seasons, means CG will likely play a significant role sustainable feed production in the 
future (Jokiniemi et al., 2014).  The possibility that grain affected by prevailing climatic 
conditions may not reach peak maturity within a growing season and would then be 
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channelled into the crimping process could mean that such material is more likely to be 
contaminated with MT, for there is an observed strong correlation between wet summers 
and high DON levels (Langseth and Elen, 1997), and deleterious levels of DON in ensiled 
wheat and maize has been reported in the Netherlands (Driehuis et al., 2008).  Likewise, 
harvesting earlier could reduce the amount of accumulated DON in the final feed and the 
moisture content would be such that potential bacterial biotransformation could 
continue within the silo, compared with dried grain where DON levels are essentially fixed 
(Figure 1.6).   
It is therefore apparent that a research opportunity exists for the development of an 
inoculating strain of ensiling bacteria, ideally a LAB, which can fulfil the vital role of DON 
biodegradation within the silo environment and storage timeframe (this research avenue 
is explored in chapters 3-5).  Following development, the bacteria could be inoculated in a 
precautionary or intervention strategy in the production of CG feeds from DON-
susceptible crops.  Such a candidate bacteria would need to have proven 
biotransformation ability with the metabolites formed being of much lower toxicity.  It 
would also be beneficial that the presence of such a strain would also inhibit the growth 
and virulence of undesirable fungi and bacteria, remain viable across different aerobic 
conditions and not significantly affect the palatability or nutritive value of the feed.  There 
is a distinct possibility that a bacteria species exists which can be used to remove DON, 
yet does not share the properties associated with desired LAB metabolism, in which case 
a degree of co-inoculation with a proven inoculant may be prescribed such as the 
functional consortium approach to CG fermentation explored by Borling et al. (2015).   
Another type of fermented feed is liquid feed (LF) and is commonly used in swine 
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Figure 1. 6 Diagram illustrating crimped grain feedstock as a strategy of reducing DON contamination.  
The original growth-stage diagram was modified from “the barley growth guide”, HGCA, winter 05/06.                          
 
 
 
 
The main advantages of fermented crimped barley grain as a feedstock: 
 Grain is most nutritious at 35-45% moisture (growth stage 75) and ensiled crimped 
feed is palatable, shown to increase productivity and low in dust.  
 No energy input required for drying grain in damp harvest years. 
 Harvesting earlier enables the next crop to be sown and get established 3-4 weeks 
earlier, especially important in northern Europe where growing seasons are shorter. 
 Climatic factors may encourage Fusarium spp. growth/colonisation leading to ever-
increasing DON levels (kg
 -1
 dry weight), which could be reduced in severity by 
harvesting 3-4 weeks earlier than conventional grain (may be ad hoc intervention 
following risk assessment of crop for that year or FHB prevalence) 
 Ensiling provides the potential opportunity to reduce the levels of DON through 
interaction with bacteria within the silo. 
 
 
   
 
 
 
 
 
 
 
 
3-4 weeks early 
HGCA©
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production.  Grain-based Ingredients, including food industry co-products are mixed and 
spiked with LAB inoculants in common with CG, to help preserve the nutritive quality 
whilst reducing undesirable bacterial growth, e.g. Salmonella sp. (Brooks, 2008, Beal et al., 
2002).  Additionally, such a controlled fermentation has been suggested to reduce anti-
nutritional factors, including MTs such as AFB1 (Shetty and Jespersen, 2006).  Some batch 
ingredients are naturally more contaminated with DON than others, especially where 
poor quality grain is channelled into lower category use (Whitlow, 2007).  Co-product 
from the bioethanol industry is currently increasing in volume at such a rate that 
incorporation into animal feeds is inevitable and is already driving LF research (European-
Commission, 2006b, Gallagher, 2008, Lyberg et al., 2008).  The major issue with 
incorporating such material is that MTs are conceivably up to 3 times more concentrated 
than the starting material due to the process of ethanol/glycerol removal and the husk 
being the location of initial mould activity (Wu and Munkvold, 2008). 
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2 Isolation of lactic acid bacteria from wild birds for use as 
fermented animal feed inoculants with potential DON-
detoxification capability 
 
2.1 Aims and objectives 
To isolate a range of LAB from wild birds and evaluate their DON-bioremediation 
properties and potential as fermented feed inoculants in terms of preventing the growth 
of spoilage mould. 
2.2 Introduction 
Fermented animal feeds have been an integral part of livestock production systems from 
ancient Greece through to the present day.  It is however only in the past 60 years that 
this agricultural area, which includes: crimped grain (CG), whole crop silage (WCS), total 
mixed ration (TMR) and liquid feeds (LF), has been focused on for scientific evaluation and 
improvement; resulting in a consistently high quality and safe method of forage storage 
and nutrition delivery (McDonald et al., 1991). 
One aspect of primary concern is the effectiveness of the lactic acid bacteria to produce 
carboxylic acids and impart a chemical environment where the growth of spoilage 
organisms is inhibited (i.e. MT-producing moulds (Cheli et al., 2013a)), the nutritional 
value of the forage is retained and the palatability of the feed is favourable (Dunière et al., 
2013).  A great number of studies have focussed on the isolation and screening of LAB for 
this purpose in different cereal-based and whole-crop silage (Doi et al., 2013, Santos et al., 
2013, Pang et al., 2011), yet none have managed to find a LAB capable of fulfilling the task 
of yielding effective fermentation characteristics in addition to DON biodegradation 
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ability, and naturally fermented feed does not usually result in a drop in DON levels from 
the starting material (Garon et al., 2006).   
The source of bacterial inoculum for fermented whole crop/grain feeds is often the 
phyllosphere of the forage used (thus producing a naturally fermented product), although 
freeze dried commercially available LAB applied at optimal rates during processing 
increase the likelihood of the fermentation being undertaken swiftly by the desired LAB 
assemblage with the finished feed possessing high aerobic stability and consistency 
(Adesogan et al., 2003, Filya et al., 2006).  These commercial strains were originally 
isolated from a range of environments and screened for efficient feed fermentative 
properties.  Some strains were actually isolated from production animals such as swine in 
order to impart beneficial probiotic effects during GI transit (Missotten et al., 2009). 
The current work aims to investigate the feed fermenting potential of LAB isolated from 
wild granivorous (viz. grain-eating) birds whilst also exploring the hypothesis that a 
microbial detoxification element exists in granivorous birds which aids in the 
detoxification of toxins such as DON, and could be employed for that purpose in 
fermented feeds.  Wild birds which habitually feed on cereal grains have two regions of 
the fore-gut dedicated to food processing where LAB are likely to be found.  The pre-
gastric crop-sac consists of an expansion of the oesophagus where food is stored for 
extended periods prior to peristaltically passing it to the gizzard via the proventriculus 
where mucus, HCl and pepsinogen are secreted.  The gizzard then homogenises the food 
prior to further digestion in the small and large intestines.  The crop-sac of birds is known 
to harbour appreciative counts of LAB (Baele et al., 2001), especially in the wood pigeon 
(Columba palumbus) which is noted for producing “pigeon milk”, a protein, cytokine and 
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probiotic-laden sustenance secreted for newly hatched progeny (Gillespie et al., 2012).  
This LAB-rich environment is also where the birds will be first exposed to surface bound 
MT such as DON (a large proportion of which is found on the grain surface) (Kushiro, 
2008).   It is envisaged that the crop-sac is therefore the first organ to be exposed to MT, 
and it is possible that a commensal LAB assemblage is present which may possess the 
ability to detoxify DON therefore inadvertently counteracting DON exposure in the bird.  
Bacteria have already been found in the lower intestine of chickens which can detoxify 
DON by enzymatically biotransforming it to DOM-1 (Young et al 2007).  This illustrates 
one detoxification mechanism that could be developed by the agri-biotechnology industry 
as a feed inoculant, although the strict anaerobic conditions required precludes them 
from use as conventional silage inoculants, whereas LAB isolated from the pre-gastric 
region of the gut may be more amenable to growing in fermented feeds as well as in vivo 
where they may act as probiotics.  Desirable isolate properties in order of importance 
include: the ability to irreversibly biotransform DON into lesser toxic elements, the ability 
to irreversibly bind DON allowing it to pass through the digestive system intact and being 
an instrumental factor in producing metabolites which create an environment where DON 
is more prone to degradation and less likely to be absorbed in vivo.  Further desired traits 
in addition to these are: the LAB is amenable to laboratory culture with swift growth in 
fermented feeds at a range of temperatures and matrix pH, with effective production of 
anti-mould metabolites such as carboxylic acids; in addition to being non-pathogenic and 
generally recognised as safe (GRAS, (Schultz, 1997)) with the potential for probiotic status. 
An initial screening for limonene-1,2-epoxide (LIMOX) metabolising activity is proposed to 
be a way of finding potential epoxide moiety degradation strains of LAB.  The low cost of 
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the material compared with purified DON and the low toxicity (used as a human food 
flavouring) enables a sole carbon source screening experiment to take place where LAB 
able to metabolise LIMOX are present as growing colonies that can be tested for DON 
degradation in further experiments.  This is not the first study to utilise the structural 
homologue approach with the biodegradation of MT the goal. Theison and Berger (2005) 
explored the potential for finding microorganisms capable of degrading DON by screening 
for epoxide-hydrolase activity using epoxide-based sole carbon sources, and studies 
employing coumarin as a surrogate to aflatoxin B1 (AFB1) have proved fruitful in the sole 
carbon source screening for AFB1-degrading bacteria (Guan et al., 2008).  The epoxide 
residue in DON is intrinsically linked to its functional toxicity and the removal of which to 
form de-epoxide-DON (DOM-1), dramatically reduces its toxicity in swine kidney cells 
(Kollarczik et al., 1994).    
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2.3 Materials and methods 
The steps involved in the screening process for DON degradation by LAB are shown in 
Figure 2.1.  
 
Figure 2.1.  Schematic plan of LAB screening experiments. 
2.3.1 Isolation of lactic acid bacteria 
The wild birds used in this study were Columba palumbus (Wood Pigeon), Alectoris rufa 
(Red Legged Partridge), Phasianus colchicus (Pheasant) and Prunella modularis (Dunnock) 
and were processed in November 2008.  The Dunnock was found freshly dead due to 
natural causes (flying into a window) and the game birds were purchased from a local 
butcher as duplicates, sourcing locally in Devon, UK (long legged in the feather, i.e. not 
gutted).  Birds were stored at 4 °C during the period between death and processing.  
Dissection was undertaken with sterile equipment that included clamps enabling the 
sectioning of the gut into crop and gizzard regions to prevent cross contamination.  An 
Lactic acid bacteria isolated from birds 
using MRS agar 
Ability to form colonies on LIMOX agar/broth 
Characterisation of strain according to growth curve properties in MRS broth 
Characterisation of strain according to glucose utilisation and metabolites produced 
evaluated using HPLC 
Determination of anti-fungal properties of bacterial medium supernatant using the 
mould spore inhibition assay and mycelial growth inhibition assay  
Determination of deoxynivalenol metabolism in liquid medium using ELISA and HPLC 
Various silage inoculants and probiotic 
strains held by our research group 
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incision was made in the side of each organ region and the whole contents were 
squeezed into a petridish to record the contents description and estimated proportions, 
then mixed into a pre-weighed bottle of 100 ml autoclaved PBS and homogenised using a 
Waring (USA) laboratory blender.  This was serially diluted 10-fold in PBS and enumerated 
using MRS agar (de man, Rogosa, Sharpe medium, pH 5.4; Oxoid, Basingstoke, England) 
for LAB (37 °C, 5% CO2, 48 h).  The total counts were additionally counted using 
fluorescent microscopy with DAPI stained material on a haemocytometer.  A 
representative selection of colonies were selected from each bird species (crop-sac and 
gizzard) according to morphological characteristics (size, colour, colony shape and texture 
and incubated to stationary phase in MRS broth (50 ml centrifuge tubes incubated 
statically with zero head space, 37 °C, 5% CO2, 48 h) prior to harvesting by centrifugation 
(2000g, 20 min) and storage in cryopreservation medium (sterile 30% glycerol in MRS 
broth) at -80 °C (Table 2.1). 
Table 2.1.  Isolates and commercially available additives used in the current study. 
Strain Origin/application Reference/Source 
L. fermentum (NCIMB 6991) Silage additive UoP collection, Oregon 
State Collection 
L. buchneri (DSM 40788) Silage additive Biotal, UK 
P. acidilactii (PD-962) Silage additive Medipharm, Chr. 
Hansen, Denmark 
L. plantarum (DSM 16568) Silage additive Medipharm, Chr. 
Hansen, Denmark 
P. acidilactii (CNCM MA 18/5M) Probiotic feed additive Lallemand, France 
5a (L. plantarum) Chicken isolate Josef Nissimov, Israel 
5b (Leucobacter albus)
 
 Chicken isolate Josef Nissimov, Israel 
L. sakei Small intestine scrape, 
chicken 
Savvidou (2009)  
#9 (L. plantarum) Small intestine scrape, 
chicken 
Savvidou (2009) 
Phy2c1 Pheasant crop This study 
Phy2c2 Pheasant crop This study 
PayC6 Partridge crop This study 
Payg5 Partridge gizzard This study 
Pi6(3) Pigeon crop This study 
PiyG7 Pigeon gizzard This study 
Dun1 Dunnock crop This study 
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2.3.2 Selection for growth using LIMOX agar 
The gradient plate technique was chosen for the initial screening of all strains.  LIMOX 
medium was formulated as 1 L of minimal salts medium (MSM) agar (12.8 g 
Na2HPO4
.7H2O, 3.1 g KH2PO4, 0.5 g NaCl, 1.0 g NH4Cl, 10 g agar and 1 ml sterile MgSO4 
added post autoclaving) with 1% 0.2 µm filter sterilised Limonene-1,2-epoxide (v/v) and 
0.05% Tween-80 added at 47 °C before pouring into glass plates (to prevent chemical 
interaction of polystyrene with LIMOX).  10 ml of LIMOX medium was added to plates 
positioned on a bench sloped with an angle of 25° and left to set before adding 10 ml of 
MSM agar (no carbon source) on a flat bench to give a double layer (Figure 2.2).  
Confluent culture grown in MRS (20 µl) was spread onto each plate and incubated for 7 d 
(37 °C, 5% CO2).  Those strains exhibiting growth by forming colonies were inoculated into 
fresh MRS broth and stored for the next screening stage.  Positive controls for LIMOX or 
DON metabolism were not included as they were not commercially available. The 
theoretical solubility of DON and LIMOX is also shown for comparison (Figure 2.3).  
 
  
 
 
 
 
 
Figure 2. 2.  Method of isolating LAB able to utilise LIMOX as a source of carbon.  The thickness of the 
over-riding minimal medium agar regulates the amount of compound available by diffusion. 
MSM 
agar LIMOX agar 
Colonies utilising 
LIMOX as a sole 
carbon source 
Continuous concentration gradient 
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 Limonene-1,2-epoxide Deoxynivalenol 
Formula and mass C10H16O, 152.23 Da C15H20O6, 296.32 Da 
Water solubility at 25 °C, 
estimated using US Environmental 
Protection Agency’s EPISuite™ 
0.14 g/L 51.75 g/L 
Figure 2.3. Comparison of molecular structure and estimated water solubility between limonene-1,2-
epoxide and DON showing epoxide moiety (a).  Estimation Program Interface (EPI) Suite was accessed 
through Chemspider (www.chemspider.com)  
2.3.3 LIMOX broth turbidimetric analysis 
LIMOX broth was formulated as above, but without agar.  Confluent culture (50 µl) was 
added to 50 ml of LIMOX broth in glass Schott bottles and incubated at 30 °C with lids 
sealed.  Suspended culture (50 µl) was removed at 1 h intervals and analysed at 600 nm 
for increases in turbidity.   
2.3.4 Detection of DON metabolising ability 
LAB able to produce colonies on LIMOX agar were further tested with genuine DON.  DON 
was purchased from Sigma-Aldrich as a freeze dried powder (5 mg) and re-suspended in 
HPLC-grade ACN to a concentration of 5 mg/ml.  This was verified spectrophotoscopically 
by diluting 1000-fold and using the Beer/Lambert equation:  
Absorbance = ε x concentration (mol) x pathlength (cm). Absorbance = 0.134, Molar 
extinction coefficient (ε) = 6805 L/cm/mol at 217nm (Krska et al., 2007), Pathlength of far 
UV grade cuvette = 1cm,       0.134/6727 x 1  = 1.97 x 10-5 =19.69 µM in a 1000-fold 
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dilution in ACN=19.69 mM in initial stock.  0.01969 M x 296.32 = 5.83 mg/ml (16.70% 
more than stated on label). 
This 5.83 mg/ml stock was spiked into 20 ml of MRS broth at a concentration of 5000 µg/L 
(16.8 µl, 5000 ppb) with the same volume of ACN added to negative control MRS.  These 
treatments were put on 48 well plates (0.5 ml) and inoculated with 10 µl of each specific 
strain in 24 h growth phase.  The plates were incubated in a plate reader (Infinity-200, 
Tecan, Austria) to enable differences in growth rates to be monitored.  The entire 
contents of each well were then collected at 48 h in pre-weighed 0.5 ml tubes prior to 
centrifugation at 10000g.  Supernatant (400 µl) was removed and stored leaving the 
pellet fraction, which was weighed to determine the proportion of DON in each fraction, 
hence resolving the degree of DON binding in the pellet if present.  The experiment was 
undertaken in triplicate and the determination of DON undertaken using a RIdascreen 
DON™ competitive ELISA (Rhône-Biopharm, Glasgow, UK) following the procedure 
outlined in the kit (Figure 2.4).  A minimum R2 value of 0.99 was required for the standard 
curve.  Following the spiking of MRS with DON it was very difficult to use the cell-free 
supernatant (CFS) directly with the ELISA.  A very high false positive was found in this 
competitive ELISA indicating that a cross-contaminating or denaturing agent was present.  
Presumably, this agent will have a similar effect on the immunoaffinity columns needed 
for HPLC verification of DON and D3G.  To remedy these effects a greater DON 
concentration was used in the LAB incubation (5000 µg/L instead of 50 µg/L) to allow for 
a 100 fold dilution prior to adding to the ELISA.  This prevented any contaminating effects 
attributed to the acidity, ionic strength, detergent or protein content of the MRS broth.  
In addition, the effect on DON recovery by the low inherent pH of CFS was confirmed by 
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using a neutralising step with differing amounts of 1N NaOH and measuring the ELISA 
recovery before and after as well as the pH (micro-pH electrode, Fisher). 
 
Figure 2.4.  DON Standard curve for competitive ELISA.  Standards used were 0, 3.7, 11.1, 33.3, 100 µg 
DON/l in water.  Absorbance values are given as a percentage of 0 µg/L DON absorbance.  The non-linear 
regression fit is Y = 76.288+14.581(lnX - 1.673) with an R2 of 99.6%.  The dotted line indicates where the 
control DON level should appear following a 100x dilution of the 5000 µg/L treatment medium.      
2.3.5 Evaluation of LAB growth and metabolism characteristics 
On the basis of population growth curve properties and evaluation of simple sugar 
metabolism allows the rapid determination of co-occurring strains and enables the 
selection of bacteria likely to be of use in fermented liquid animal feeds.  Overnight 
cultures (37 °C, 5% CO2, 48 h) were diluted to a uniform turbidity of 0.2 in micro-cuvettes 
(600 nm) and 10 µl was added in replicate to 240 µl MRS broth in 96 well plates, flushed 
with 5% CO2 and read at 600 nm every 30 min for 48 h (Infinity-200, Tecan, Austria).  The 
data was analysed using the Magellan 6.5 software for the following parameters; curve 
slope, OD peak.  After 48 h, the incubated MRS medium was centrifuged (10000g, 20 min) 
and filtered to 0.22 µm before storage at -80 °C.  HPLC analysis was performed using a 
Phenomenex organic acids column (7 mm x 300 mm) with nitrogen degassed 2.5 mM 
H2SO4 as the mobile phase in isocratic mode (0.5 ml/min).  The sample (500 µl) was 
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spiked with 20 µl of 7% H2SO4 (v/v) to protonate the acids and stabilise the column and 10 
µl of sample was injected with the aid of a Gynotek autosampler and run for 30.5 min.  
Peak analysis was undertaken using Chromeleon-6™ software (Figure 2.5). 
Figure 2.5. A representative HPLC chromatogram of mixed monosaccharide and metabolite standards at 
25, 50 and 100 µM measured using refractive index detection.   
For the organic acid samples, it was necessary to both dilute the sample down and 
remove proteins that produced an irresolvable hump preventing the identification of acid 
peaks.  Samples were diluted 1:10 with distilled water prior to protein precipitation.  
Addition of perchloric acid is a standard protein precipitation technique.  The sample to 
be treated was added to an equal volume of 0.5 M perchlorate and then neutralised with 
twice the sample volume of dipotassium carbonate (1 M) and centrifuged at 10000g to 
leave a purified supernatant (noting the additional dilutions).  
2HClO4+K2CO3 → 2KClO4 + CO2 + H2O 
2.3.6 Determination of mould conidia spore inhibition by bacterial 
metabolites 
Inhibition of growth was determined using the turbidimetric approach in common with 
the bacterial growth assays with a method adapted from Lavermicocca et al. (2003).  
Aspergillus niger was employed as a surrogate toxigenic spoilage mould for its ease of 
56 
 
 
laboratory culture and sporulation (CABI 393094).  Fusarium was not used for this initial 
study due to inconsistent sporulation and this assay was developed for spoilage mould 
rather than phytopathogenic species.  A. niger was grown on potato dextrose (PD) agar 
(Oxoid) following spore inoculation.  The generation of spores is apparent as black 
structures in localised areas on the mycelia.  These are washed off using 7% NaCl/0.05% 
TWEEN-80 to facilitate spore removal and separation, and then counted with a 
haemocytometer before diluting to 104 spores/ml in distilled water.  The spore solution 
for each experiment was enumerated on PD agar and viable counts of 4000 CFU ± 
1000/ml were found across all experiments. 
Serial dilutions of 0.2 µm filter sterilised LAB supernatant (48 h culture in sealed 50 ml 
centrifuge tube at 37 °C and centrifuged at 10000g) were added to a 96 well plate (190 µl).  
Spore suspension (10 µl) was added to each treatment well and the plate was incubated 
at 30 °C for 48 h prior to an absorbance reading (600 nm) where each individual well is 
scanned in 16 separate positions and an average taken (mycelia growth is less 
homogenous than bacterial growth).  Positive controls for germination inhibition were 
made in pure MRS with 10-fold serially diluted concentrations of acetic, propionic, butyric, 
lactic from 1 M in MRS and phenyllactic acid from 250 mM (>99% purity, Sigma)   
Due to the spent medium being inherently low in nutrients following bacterial utilisation, 
glucose (20 g/L) and lab-lemco (8 g/L) was later added to the medium before adding the 
spores.  A 1:1 mix of cell free supernatant (CFS) and MRS was used which provided the 
nutrients required for germination and the inhibiting compounds produced by the LAB, 
albeit 50% diluted.  A heat inactivated CFS (1 h at 95°C in water bath) diluted by 50% with 
MRS enables the elucidation of a heat labile based inhibition agent. 
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2.3.7 Statistics 
Growth curve data was first characterised in terms of; gradients, maximum OD, time to 
reach specific OD, using the Magellan v6.1 software integral to the plate reader.  Data 
was then compared using Minitab (version 16) and correlations made with other 
endpoint parameters if available.  Depending on normality and homogeneity of variance, 
a 1-way ANOVA with Tukey’s pairwise comparison was carried out.   
2.4 Results 
2.4.1 Isolation of LAB from birds  
The total cell counts recorded microscopically for the three main bird species (the 
Dunnock crop-sac was immersed in broth for 24 h prior to plating due to the initial 
dilution not yielding colonies and absolute counts were therefore unavailable) varied 
between 3.50 x 105 and 2.28 x 107 cells/g dry matter in the crop-sac of which the 
proportion that were able to form colonies on MRS and were therefore likely to be LAB 
was a large proportion when considering the pheasant and less in the other species (Table 
2.2).  In the gizzard total counts ranged between 1.29 x 104 and 5.91 x 105 of which few 
were viable when plated out illustrating the transit of LAB from the crop-sac to the lower 
intestine is prevented on the whole by the harsh chemical conditions in the gizzard.  It 
could be hypothesised that the LAB able to be isolated from the gizzard are more likely to 
have a probiotic role to play in any fermented feed scenario.  The crop-sac contents were 
cereal based for the Pheasants and Dunnock, grass and cereals for the Partridge and ivy 
berry/foliage based for the wood pigeons.  This is possibly an indication of seasonal 
availability and human provision, yet the bacteria isolated may well be omnipresent as a 
commensal assemblage within the birds GI tract in all seasons. 
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Table 2.2.  Description of wild bird crop and gizzard contents given as means of triplicate measurements.  The total bacterial count was undertaken using fluorescent 
microscopy of diluted samples and the viable LAB plated on MRS agar with the percentage viable of the total cell count in shown in brackets. 
Bird Species 
Total bacterial cells/g dry 
matter 
Viable LAB CFU/g dry matter (MRS agar,  
37 °C, 5% CO2) 
Description of crop sac contents (estimated) 
Crop sac Gizzard Crop sac Gizzard Crop sac Gizzard 
Male 
Pheasant 
6.00 x 105 6.02 x 104 4.21 x 104 (6.83%) ND 
90% whole wheat, 
10% grit 
80% ground wheat, 20% 
grit 
Female 
Pheasant 
3.50 x 105 2.49 x 105 1.06 x 104 (3.03%) ND 
90% whole wheat, 
10% grit 
80% ground wheat, 10% 
grass, 10% grit 
Partridge A 1.51 x 105 1.34 x 104 7.77 x 103 (5.15%) ND 
70% whole wheat, 
30% grass 
60% ground wheat, 30% 
grass, 10% grit 
Partridge B 2.28 x 107 1.29 x 105 ND ND 100% grass 90% grit, 10% grass 
Wood pigeon 
A 
2.94 x 106 3.51 x 104 2.94 x 103 (0.10%) 8.85 x 10-1 (0.25%) 100% ivy berries 
80% ground ivy berries, 
20% grit 
Wood pigeon 
B 
8.17 x 106 5.91 x 105 ND 1.83 x 100 (0.00%) 
100% unidentified 
brown  
Leaf material 
90% grit, 10% wheat 
Dunnock - - - - 100% Wheat  - 
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2.4.2 Screening for limonene-1,2-epoxide metabolism ability. 
In an initial experiment with 4 representative LAB strains inoculated into LIMOX broth it 
was apparent that all exhibited an initial rise in population followed by a decline after 24 
h indicating that the 1% (v/v) LIMOX was not initially toxic enough to halt growth but was 
equally not able to support further proliferation as a source of carbon, as the curves were 
similar to that found in M9 medium where no carbon source was present (Figure 2.6).  A 
second experiment using glass Petri dishes to avoid the action of this volatile 
monoterpene oil on polystyrene (as indicated in a pilot experiment) and increasing the 
concentration of limonene-1,2,-epoxide to 2% with and without Tween-80 to aid 
substrate solubility for bacterial utilisation over 7 d (37 °C, 5% CO2) yielded a better 
response than the previous experiment.  Colonies formed around the droplets of 
substrate held within the agar matrix confirming utilisation of hydrophobic compounds is 
possible by this mechanism.  The viability of colonies was confirmed microscopically and 
by transferring a portion of underlying agar to a tube of MRS broth.  The fact that several 
strains are able to exhibit a form of growth on LIMOX agar is not proof that any of these 
positive strains interact with the epoxide moiety in order to derive energy from the 
LIMOX compound (Table 2.3).  It is conceivable that an oxidation is occurring to form a 
more soluble entity that can be utilised more readily and does not share any of the 
desired DON-like structural properties.  Some strains not showing LIMOX activity, but 
having favourable growth characteristics were used in the DON metabolism experiment 
for discovering whether such a sole carbon source LIMOX technique is worthwhile.  
Differences in growth between liquid and solid LIMOX medium may be explained by 
differences in oxygen levels, although this was not explored further.  Use of coumarin and 
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umbelliferone as surrogate AFB1 homologues proved to be difficult due to their very low 
solubility, and were abandoned (data not shown). 
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Figure 2.6.  Effects on bacterial growth of using Limonene- 1,2,-epoxide (LIMOX) as a sole carbon source 
in minimal medium broth (MSM, pH 6.2, 30 °C).  The population was determined by serially diluted plate 
counts on MRS agar (CFU).  The four representative strains used in this enrichment culture were 
randomly chosen for this pilot experiment. Right; colony formation on LIMOX agar by L. plantarum (in 
glass Petri dish, image taken using fluorescent illumination.) 
Table 2.3.  Summary of LAB colony formation on LIMOX agar over 7 d.  Plates given a visual score of 
response in comparison with un-inoculated equivalent plates (++ = presence of several large and small 
colonies, + = sparse growth, absent growth left blank). (a) signifies that LAB was isolated from this plate 
for the DON experiment whereas (b) signifies that the isolate was taken from the original stock culture.  
Strain LIMOX LIMOX + TWEEN-80 
L. fermentum (UoP) + + 
(a)
 
L. buchneri (Biotal) + + 
(a)
 
P. acidilactii (Medipharm) + + 
(a)
 
L. plantarum (Medipharm) ++ ++ 
(a)
 
 P. acidilactii (Lallemand) + + 
(a)
 
5a (Chicken) + + 
(a)
 
5b (Chicken)
 (b)
   
L. sake (Chicken) + + 
(a)
 
#9 (Chicken)
 (b)
   
Phy2c1 (Pheasant crop)  + 
(a)
 
Phy2c2 (Pheasant crop) +  
PayC6(1) (Partridge crop) +  
Payg5 (Partridge gizzard) + + 
(a)
 
Pi6(3) (Pigeon crop)
 (b)
   
PiyG7 (Pigeon gizzard)
 (b)
   
Dun1 (Dunnock crop) + + 
(a)
 
 
 
. 
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2.4.3 Determination of DON removal by lactic acid bacteria in vitro 
 
Figure 2.7.  Percentage DON recovery following incubation with different LAB for 48 h in MRS broth at 
37 °C.  Mean of triplicate experiments of duplicated ELISA wells shown with SE. 
All the strains were found to have insignificant DON biotransformation and binding 
activity, with mean recoveries similar to that of the starting level (Figure 2.7).  There were 
no significant differences in activity between the strains (ANOVA: F= 0.81, P= 0.662, n = 
16).  As these measurements were made using the supernatant of each exposure and the 
DON concentration had not changed, it can be assumed that the proportion of DON in the 
bacterial pellet is equal in terms of medium volume and no binding of DON has occurred.  
Furthermore, the presence of DON in the medium at the concentration used did not 
influence the growth parameters of the LAB (data not shown).  It is worth remembering, 
that the ELISA kit used is subject to cross-contamination by differing DON derivatives such 
as 3-Acetyl-DON and 15-Acetyl DON, so it is important to double check the suite of 
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metabolites produced using HPLC, although the almost 100% recovery in the current 
experiment suggests DON is not being metabolised to a derivative dissimilar to DON. 
Figure 2.8.  The effect of lactic acid treatment on DON recovery (48 h at 37 °C).  The mean percentage of 
control DON recovery (pH 6.2) measured by ELISA is shown with SE of 8 replicates per treatment.   The 
regression fit: % reduction in DON = -5.35ln[lactic acid] + 65.27, accounts for 89.3% of the variance of the 
data.  The pH of each treatment is given beneath each data point with the asterisks denoting a significant 
(P<0.05) reduction in DON recovery compared to the control.  
A one-way ANOVA indicated lactic acid reduced the recovery of DON significantly (F = 
42.2, p<0.001, n = 48), although without confirmation of the mechanism by HPLC analysis 
and identification of degradation products, it is not clear if the structure of DON was 
irreversibly modified.  The use of a positive control DON-metabolism strain would have 
greatly benefitted this part of the study, although presently the only commercially 
available bacterium able to perform this task does so under strict anaerobic conditions in 
vivo (Binder et al., 1997).   
Any influence the pH of the sample may have on the functioning of the ELISA was 
evaluated by utilisation of a pH increasing step, yielding a spread of pH values that 
showed no significant increase on recovery (Figure 2.7, p =0.619, n = 24 (12 treatments in 
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duplicate), suggesting elevated concentrations of lactic acid does effect the levels of 
measurable DON using ELISA.   
 
Figure 2.9.  Percentage of control (pH 6.2) recovery of DON using ELISA following treatment with lactic 
acid and then adjusting the pH to different levels using NaOH.   
2.4.4 Evaluation of mould inhibition potential and carboxylic acid 
production 
The validation results of the Aspergillus niger conidia germination assay illustrated that it 
is a sensitive assay for determining conidia germination and growth inhibition by different 
compounds and growth was not limited by the use of MRS broth.  Propionic acid was the 
most potent inhibitor of germination with EC50 values 100 fold lower than lactic acid 
(Figure 2.10, Table 2.4).  Much higher concentrations were required for complete 
inhibition however, perhaps a measure of the tenacity of the mould which was able to 
grow albeit at a reduced rate.  The influence of pH was found at higher concentrations, 
although the presence of Cl- ions could be the dominant factor rather than H+ in the HCl 
treatment. 
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Figure 2.10.  The effect of different carboxylic acids and ethanol on the germination and growth of 
Aspergillus niger conidia in MRS.  Mean of triplicate experiments shown without error bars for clarity. 
Table 2.4.  The concentration of carboxylic acids and ethanol required to reduce mould germination and 
growth over 48 h (37 °C) by 50% compared with the MRS broth control. 
Treatment pKa EC50 
concentration 
mM  (mg/ml) 
Non- linear cubic regression fit 
R
2 
(%) 
Lactic acid 3.86 9.05 (0.82) 81.76 - 29.71x- 6.054x
2
 + 2.028x
3
 83.2 
Acetic acid 4.75 3.91 (0.23) 66.46 - 33.51x - 4.067x
2
 + 2.578x
3 
80.3 
Propionic acid 4.87 0.08 (0.01) 28.21 - 23.86x + 0.3130x
2
 + 1.560x
3
 59.7 
Butyric acid 4.82 0.50 (0.04) 44.06 - 36.05x - 1.209x
2
 + 2.891x
3
 69.0 
Phenyl-lactic acid 3.72 2.30 (0.38) 64.30 - 22.77x - 3.344x
2
 + 0.2353x
3 
68.9 
Ethanol 16.00 ̴1000 (  ̴46.07) 91.99 + 1.428x - 2.837x
2
 - 0.7603x
3 
65.7 
Hydrochloric acid <1.00 15.52 (0.57) 385.9 - 495.1x + 205.8x
2
 - 27.78x
3 
65.7 
 
The assay was found to be well suited to evaluating the inhibitory potential of LAB 
metabolites in CFS.  Strains producing enough carboxylic acids to reduce the pH to below 
4.4 were able to prevent germination outright in 1:1 diluted medium, with pH indicative 
of total carboxylic acid content largely responsible (Pearson correlation coefficient = -
0.890, P<0.001 for pH, -0.792, P<0.001 for total acids).  It is likely that strains not 
producing sufficient lactic acid for inhibition are also slow to exhaust nutrients as 
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indicated by the differential mean growth rates and the resulting CFS may be more 
favourable for conidia growth as is found with Phy2C1(2) and PiyG7 (Table 2.5).  
Supplementation of CFS with glucose and Lab-lemco (meat extract) did little to improve 
conidia growth in the inhibiting CFS treatments, yet diluting CFS 1:1 with MRS helped 
elucidate the strains with lower inhibition potential.  The most inhibiting strains were 
characterised as having a high mean growth rate (Pearson 0.558, P = 0.025), high 
maximum OD at 48 h (Pearson 0.504, 0.046) and high lactic acid content (Pearson 0.795, 
P<0.001) that was likely the main heat resistant inhibition agent with the other acids 
contributing to the effect (Figure 2.11). The unusual level of propionic acid production in L. 
plantarum PayG5 and DUN1 (Figure 2.12) can be explained by the anaerobic metabolism 
of lactic acid by these bacteria, a phenomenon recorded by Driehuis et al. (1999) and 
Lindgren et al. (1990) in L. buchneri and L. plantarum, where other electron acceptors 
such as shikimate or oxaloacetate enable lactate catabolism and reinforce the antifungal 
capacity of the CFS by production of acetic, 1,2-propanediol and propionic acid. 
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Figure 2.11.  Percentage of control (MRS broth) mould conidia germination and growth in cell free supernatants (CFS) of a selection of lactic acid bacteria isolated 
from wild birds, broiler chickens or commercially available silage inoculants.  Additional medium components and treatments enable identification of inhibitory 
elements in CFS.  The mean of duplicate experiments (with triplicate wells) is shown with the standard error. 
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Figure 2.12.  The concentration (mM) of lactic, acetic and propionic acids produced by each strain of bacteria in MRS broth incubated for 48 h at 37 °C (5% CO2). 
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Table 2.5.  Growth characteristics of each strain in MRS (48 h at 37 °C, triplicate wells). 
Strains 
Mean Slope 
(OD/min x 10
-4
) 
Max Slope 
(OD/min x    10
-3
) 
Time to max 
slope (min) 
Max 
OD 
Time to max OD 
(min) 
L. fermentum (UoP) 5.22 2.26 960 1.11 2010 
L. buchneri (Biotal) 5.09 2.56 1340 1.02 2240 
P. acidilactici (Medipharm) 4.36 3.09 940 1.04 1610 
L. plantarum (Medipharm) 4.99 3.06 1160 1.04 1850 
P. acidilactici (Lallemand) 4.76 2.93 1130 1.04 1750 
5A 3.22 3.19 580 0.88 2800 
5B 3.24 3.23 600 0.88 2770 
L. sake          4.95 2.76 1210 1.02 1780 
No. 9       3.92 2.91 840 0.97 1550 
Phy2c (1) 3.74 2.83 830 1.02 1370 
Phy2c (2) 3.24 3.23 600 0.88 2770 
PayC6 (1) 4.93 2.81 1170 1.02 1750 
Payg5 (2) 3.52 2.46 640 0.94 1730 
Pi6 (3) 4.04 2.14 790 0.92 2050 
Piyg7 (1) 1.28 7.07 860 0.33 2260 
Dun (1) 3.84 2.88 810 1.03 1350 
Mean 4.02 3.09 903.75 0.95 1977.50 
Standard Error 0.26 0.29 62.12 0.05 122.72 
Coefficient of variation (%) 0.25 0.36 0.27 0.19 0.24 
 
Figure 2. 13. Dendrogram of strain growth parameters in terms of similarity.  
Comparing the turbidimetric growth parameters of each strain in MRS broth aids in 
understanding which strains have shorter lag phases, delayed or shortened logarithmic 
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phases and elevated maximal OD, which allows strains to be putatively clustered into 
similar trait groups (Figure 2.13). 
2.5 Discussion 
DON is both renowned for its potent toxicity and resistance to metabolism and 
degradation; hence the identification of a method of biological removal would be well 
received by the cereal growing and livestock rearing industries.  The potential for finding 
a species of bacteria capable of deactivating DON in vitro that could be then developed to 
remediate contaminated cereal grains is explored in the current study using various 
screening techniques and a bank of LAB isolated from wild birds, chickens and 
commercially available ensiling strains. 
This proof of concept study has illustrated one approach to finding a strain of LAB capable 
of detoxifying DON in fermented animal feeds.  The use of LIMOX media to screen for a 
possible epoxide hydrolase or similar enzyme was ineffective and the use of DON itself is 
warranted for future initial screening tests (Völkl et al., 2004), unless a rapid assay for de-
epoxidase is developed.  So far no other research has been able to elucidate a microbe 
able to deactivate DON in fermented feeds, even though some groups have found some 
bacteria to eliminate DON under other conditions such as in vivo (Kollarczik et al., 1994) 
and in vitro incubations with aquatic isolates (Völkl et al., 2004, Ito et al., 2012).  In 
general, DON is highly resistant to modification by non-anaerobic strains, which may be 
linked to the main function of DON.  DON is stable under the conditions in planta where 
the plant is unable to degrade the toxin and simply conjugates it to a sugar as DON-3-
glucoside for safe storage using the UDP-glucosyltransferase enzyme (Poppenberger et al., 
2003).  Since DON does not affect LAB growth and is not removed from broth, there is 
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evidence to suggest that a DON detoxification mechanism is absent, perhaps due to the 
lack of niche overlap.   
LAB are present as symbionts in the GI tract of birds at levels that can influence the health 
of the individual (Fuller, 1973).  The LAB community develops following colonisation 
throughout the bird’s lifetime of LAB sourced from food and nesting material, water and 
parental carryover (Baele, Devriese et al. 2001).  Of the many LAB species likely to be 
found in such an environment, it is interesting that DUN1 and PAYG5 should have 
comparable growth characteristic to the commercially marketed fermented feed strains.  
This highlights the potential for further isolation of microbes from wild birds in the future. 
Even though none of the strains affected levels of DON in vitro, the fact that these strains 
produced sufficient carboxylic acids to inhibit mould conidia germination by lowering silo 
and conidia cytoplasmic pH (Alakomi et al., 2000), means they could factor in a fermented 
feed preparation for poultry.  The benefits of producing high levels of carboxylic acid also 
include the acid hydrolysis of complex sugars and a potential interaction with DON.  With 
a greater source of sugars in fermented grain feeds, it is possible that a sufficient amount 
of lactic acid is produced to give the effects on DON recovery found in this study.  
Conversely to this last point, Mansfield et al. (2005a) found conditions in corn silage to 
have little effect on reducing the levels of DON found in the starting material, and a 
similar silo experiment is required to confirm the results presented here. 
This DON-lactic acid interaction is worthy of further investigation for two reasons.  Firstly, 
it is possible that a lactic acid-related modification is being made to DON, which 
depending on the type of transformation, may be a method of bioremediation in its own 
right.  Secondly, the fact that biopreserved feeds tend to have high levels of lactic acid 
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may mean that any DON testing procedure should bear in mind the mechanism of lactic 
acid interaction and neutralisation by NaOH may result in an underestimation of DON 
present.  It will be interesting to investigate whether the interaction is related to that 
between propionic acid and sodium metabisulphite (Dänicke et al., 2009). As a side point 
influence of binding agents on mycotoxin testing has already been evaluated in an EU 
report (Kolossova et al., 2009), a similar approach may be needed for fermented material, 
especially taking into account the increased interest in MT fate within fermented feeds 
(Pereyra et al., 2008, Keller et al., 2013)   
The lack of in vitro DON binding or metabolism by LAB isolated from the crop and gizzard 
does not equate to birds not having the ability to detoxify DON in vivo.  Young and co-
workers (2007) found chicken microbes in the large intestine to be responsible for 
converting DON to DOM-1 (de-epoxide form) and it is plausible that a different group of 
bacteria exist in wild birds performing a similar task.  Having the ability to undertake such 
a biotransformation is of little consequence to the bird’s health as absorption of DON and 
liver damage would occur before reaching the lower intestine.  According to Yunus et al. 
(2010), Chickens have a much-reduced absorption of DON compared with other animals 
with only 0.044% of ingested DON found in the plasma.  This amount is rapidly excreted 
and a degree of de-epoxidase activity also occurs in a minority of the birds suggesting 
uptake of the DOM-1 form in the lower intestine following microbial biotransformation.  
A similar phenomenon may occur in the birds studied here with any resistance to cereal-
borne MT a function of reduced absorption rather than microbial transformation.  Further 
work is required to understand the effect of MTs on wild bird populations, a completely 
unexplored research area.   The isolation of LAB from the fore-gut was aimed at finding a 
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more transferable isolate than from the very anaerobic condition in the lower intestine 
which would not yield isolates capable of growth and competition in fermented feeds. 
The current study focusses on LAB in part due to their omnipresence in fermented animal 
feeds, but also related to their GRAS (generally recognised as safe) status and ease of 
culture/isolation.  This does limit the search for a DON degrading bacterium somewhat, 
and had LIMOX media been used with bulk bacterial assemblage isolates from the GI tract 
of birds or soil for example, it may have selected for better candidates.  This approach has 
been explored by Ito and colleagues (2012) who were able to find DON-degrading 
bacteria employing in house produced and purified DON as the sole carbon source, which 
is always going to be the best option providing the safety concerns can be answered.   
This first experimental chapter entertains the idea that LAB may be able to both produce 
a quality fermented feed whilst being instrumental in DON degradation.  However, whilst 
LAB have been found to bind trichothecene MTs such as DON, ZEA and T2 toxin, there is a 
paucity of evidence suggesting anything more significant such as metabolising MTs into 
lesser toxic elements.  Probiotic strains of LAB have been shown in the past to be 
ineffectual bio-degraders of trichothecenes (including DON) in vitro, which is in 
agreement with the current data (Böhm et al., 2000).  The results here in a 48 h growth 
experiment show little evidence of binding, metabolism or both, but it must be 
considered that these are processes could occur over different timeframes.  Some 
workers have found that MT binding in LAB occurs most frequently during exponential 
growth phase and that the degree of binding is partially reversible with MT being released 
back into the medium over time (El-Nezami et al., 2004).  Since binding has been found to 
be a reversible process, employing this property to detoxify ensiled grains would be highly 
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questionable due to the likelihood of desorption on GI transit (i.e. no likely difference in 
toxicity).  Moreover, in a fermented feed scenario the presence of LAB producing LA/AA 
may actually inhibit the growth of co-occurring microbial assemblages with DON 
biotransformation capacity and thus relying on LAB alone may be counterproductive in 
terms of DON detoxification.  However, in terms of the inhibition of spoilage mould LAB 
have been shown, both in the current investigation and in the literature, as extremely 
effective and therefore when considering the safety and quality of fermented feeds as a 
whole they still have an important role to play.  Interestingly, DUN1 and PayG5 produced 
comparable inhibition to that of the commercially available silage additives linked to the 
suite of acidic secondary metabolites produced, especially acetic and propionic acids.   
The lack of DON metabolism also equates with the equivocal result found with the LIMOX 
sole carbon source experiment.  This could be due to a lack of enzyme present in LAB that 
catabolise or co-metabolise this type of molecule.  LAB thrive on media rich in water 
soluble carbohydrates, less so on carbon sources beyond the realm of homolactic and 
heterolactic fermentation of hexoses and pentoses.  They consequently have a low 
capacity for direct biotransformation, although co-metabolism via Mailliard reactions may 
occur where exuded proteins and sugars deactivate DON indirectly. An ability to 
biotranform DON by Aspergillus tubingensis was found by He and co-workers (2008) to be 
due to the addition of H2O (hydration) with the putatively described epoxide hydrolase 
responsible.  Epoxide hydrolase is the same enzyme responsible for the conversion of 
LIMOX to limonene and hence would be a useful enzyme to find in LAB, although gene-
sequence led research suggests that LAB lost their epoxide hydrolase genes during 
evolution, as bacteria have a bias towards deleting genes no longer needed (Van Loo et 
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al., 2006).  The only bacteria able to biotransform LIMOX to limonene-1,2-diol with 
soluble epoxide hydrolase was Corynebacterium sp. C12, a bacteria species originally 
isolated using an epoxide (the hazardous cyclohexene oxide) as a sole carbon source 
(Carter and Leak, 1995). 
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3 The effect of different bacterial inoculants, chemical 
preservatives and heat treatment on crimped grain silage 
fermentation and deoxynivalenol recovery 
3.1 Aims and objectives 
To evaluate the effect of different CG treatment strategies on the reduction of DON in 
experimental silos using a validated chromatographic detection method, determine 
important biochemical properties of the fermentation and verify if these metabolites 
have any effect on DON stability in vitro. 
3.2 Introduction  
Fusarium head blight (FHB) is a grain disease prevalent in temperate cereal growing 
regions with Fusarium culmorum and F. graminearum the main pathogenic moulds 
responsible.  During the process of infection several MTs including DON are produced by 
these moulds to aid colonisation of the plant (Poppenberger et al., 2003).  Levels of DON 
can reach toxic levels when prevailing weather conditions are wet during crop anthesis 
facilitating spore egress, a phenomenon not always preventable with topical application 
of fungicides or choice of resistant cultivars (Langseth and Elen, 1997, Mansfield et al., 
2005a).  Such episodes were observed in the 2008 UK harvest where levels in certain 
cereals precluded the incorporation into food and feed with associated financial losses 
(Day, 2009).  To minimise the effect on livestock a range of chemical and biological 
additives are being developed which have the potential to bind and degrade DON under 
specific conditions (Dänicke et al., 2009, Völkl et al., 2004).  In the current investigation, 
the process of ensiling is evaluated as having the potential for bioremediation of 
contaminated material.   
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CG silage feeds are an integral part of temperate agriculture where growing seasons can 
be disrupted by climate and a locally produced feedstock high in nutrients is desirable.  
Grain is harvested with a moisture content of around 40% and ensiled with biological or 
chemical preservatives prior to storage in airtight silos (Adesogan et al., 2003).  The main 
purpose of these additives is to reduce the pH to the critical 3-4 level where bio-
deterioration and microbial respiration are curtailed (Virtanen, 1945).   Whether DON 
levels are affected by the conditions of ensiling, in terms of microbial interaction and 
fermentation chemistry, forms the main basis of the current study.  In addition, the 
measurement of DON-3-glucoside (D3G) in crimped feed was investigated. 
Several different strains of lactic acid bacteria (LAB) are trialled as biological additives 
following crimping and compared with a combined chemical preservative (Crimpstore) 
and heat treatment strategy for the ability to assist in the production of an efficient 
fermented feed with the potential for reduction of DON.  The efficiency of the ensiling 
process is characterised by measuring several biochemical parameters such as organic 
acid and soluble sugar concentration, and related these to the viable counts of yeast and 
LAB. 
3.3 Materials and methods 
3.3.1 Spiking with DON and ensiling of crimped barley 
Barley (Westminster, 38.40±0.37% moisture) was harvested and crimped in July 2011 in 
the south west of the UK prior to treatment with the chemical preservative Crimpstore(R) 
2000 S (an additive containing a mixture of formic acid (43%), propionic acid (10%), 
ammonium formate (30%), and benzoic acid (2%) in water, Kelvin Cave Ltd., UK) at a rate 
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of 4 ml/kg or inoculated with different commercially available or in-house isolated lactic 
acid bacteria (identified with 16S rRNA identification: see Chapter 4) at a rate of (105 
CFU/g moist grain) in 50 ml polystyrene containers (Fisher, Loughborough, UK) containing 
approximately 50g of grain (exact weight of each sample taken for calculations).  This was 
followed by spiking with DON standard in H2O (Sigma Aldrich, Poole, UK) at 250 µg silo
-1 
(concentration of 5 µg/g CG), tightly closing the lid and incubating at 20 °C for 21 d in the 
dark.  Silos spiked with DON but without additives served as naturally fermented samples 
and spiked samples kept frozen for the same period served as unfermented controls 
allowing comparison for the treated samples.  In addition, samples heat treated prior to 
spiking (100°C for 1 h in hot air oven) served as semi-sterile incubations.  The nutritional 
proximate analysis results for the barley were as follows: lipid 0.92%, ash 1.36%, protein 
6.76%, carbohydrate 53.00% and moisture 38.40% (analysis undertaken by Liz Preston, 
Food and Nutrition, Plymouth University)  
3.3.2 Extraction and HPLC analysis 
Ninety five ml of DPBS (plus 5 ml H2O from pH determination, see below) was added to 
the entire silo contents and blended for 2 min on full speed (Waring Blender, USA) and 10 
ml of supernatant was passed through a Whatman 113 filter paper (according to sample 
preparation and chromatography guidelines provided by Rhōne-Biopharm Ltd).  This 
filtrate was then centrifuged at 5000g for 10 min and passed through a 0.22 µm syringe 
filter (Millipore).  Supernatant (2 ml) was then passed drop-wise through a DONprep(R) 
immunoaffinity column (Rhōne-Biopharm Ltd, Glasgow, UK) and the column rinsed with 5 
ml HPLC grade H2O, also dropwise (1 drop/s).  All H2O was expelled and 1.5 ml of HPLC 
grade methanol (MeOH) was passed drop-wise through the column with 1 backwash 
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included using the affixed syringe.  This eluent was collected in a glass test tube and 
blown down to dryness with compressed nitrogen and re-suspended for 30 s using a 
vortex mixer with 1 ml 5% (v/v) MeOH in water.  The extracts were passed through a 0.22 
µm syringe filter for HPLC (Dionex UltiMate® 3000, Thermo Scientific).  The HPLC gradient 
program was as follows; 0 min 5% MeOH, 20 min 5% MeOH 1% ACN, 21 min 50% MeOH 1% 
ACN, 25 min 50% MeOH 1% ACN, 26 min 5% MeOH 1% ACN to 30 min.  Fifty µl of sample 
was injected and the DON was eluted at 23 min.  The C18 column (Aquasil C18, 150 mm x 
4.6 mm, 3 µm, standard, Thermo) and C18 guard column was kept at 25 °C and a UV 
detector set at 220 nm (5 nm bandwidth).  The peak area was used to compare between 
DON levels in the treatments compared with the frozen time zero DON-spiked control.  
The crimped barley used in this study contained zero natural DON contamination.   
3.3.3 Validation of DON-specific IAC columns for use with D3G and 
crimped feeds including verification of optimum analyte loading 
concentration,  and effects of organic acid concentration and 
temperature on D3G/DON stability 
The capacity of the DONprep(R) immunoaffinity columns for both D3G and DON was 
determined by passing various concentrations of compound through the column and 
measuring the concentration before, in the initial eluate and in retained fraction using 
HPLC and following the manufacturer’s protocol as mentioned previously.  HPLC analysis 
of DON/D3G concentrations (in PBS) following the sequential addition of lactic acid or 
following heating enabled further characterisation of DON/D3G stability within the silo 
environment.  Additional HPLC studies were undertaken to determine the effect of 
increasing concentrations of lactic, acetic and propionic acid on in vitro DON and D3G 
stability (50 µg/ml H2O) by sequential 50 µl HPLC injections and replacement additions of 
79 
 
 
30, 300 and 3000 mM acid stocks and calculating the adjusted peak area according to the 
reduced DON concentration.  The effect of heating at 50, 75 and 100 °C was also 
determined. 
3.3.4 Determination of silage integrity 
On mini-silo opening 5 ml of H2O was mixed with 1 g fermented CG for determination of 
pH (Fisher Accumet) and added back to the silo contents.  Following addition of 95 ml PBS 
and blending, a 1 ml sample was serially diluted in PBS and plated on MRS (de Man, 
Rogosa and Sharpe), RCA (reinforced clostridial agar, samples heated to 70 °C for 5 min to 
confirm presence of resistant spores and incubated for 48 h anaerobically at 37 °C and 
CODA chloramphenicol/ oxytetracyline dextrose agar, 25 °C) agar for enumeration of 
lactic acid bacteria, clostridia and yeast/moulds respectively (moulds were distinguished 
from yeasts by their furry appearance).  In addition, a 250 µl sample was deproteinated 
with 250 µl 0.5 M perchloric acid and then neutralised with twice the sample volume of 
dipotassium carbonate (1 M), centrifuged at 10000g, spiked with 20 µl of 7% H2SO4 and 
20 µl was injected into an HPLC (Dionex) for the presence of lactic, acetic, propionic, 
butyric acids and maltose, fructose, glucose and ethanol (Agilent H+ column, 0.4 ml/min 5 
mM H2SO4 with Shodex (Japan) RI detector) based on the method published by Niven et al. 
(2004)  
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3.4 Results 
3.4.1 Validation of IAC columns for use with D3G and crimped feeds and 
effects of organic acid concentration and temperature on D3G/DON 
stability 
 
Figure 3.1.  The UV absorption spectra of DON and D3G (5 µg/ml).  Samples suspended in far-uv grade 
ACN. 
Using a wavelength of 220 nm for DON and D3G was found to be appropriate when using 
HPLC-UV following spectrophotometric analysis of standards suspended in far-UV grade 
ACN and analysed with a UV spectrophotometer (Helios Beta, Unicam, UK, Figure 3.1).  
Extracted samples processed with IAC could not be analysed with this technique due to 
the poor sensitivity attributed to cross-contaminants in the column matrix, hence the 
need for HPLC-UV.  The DONprep IAC tested did show an affinity for D3G, although the 
loading capacity of the column was slightly lower compared with DON (Figure 3.2).  The 
optimum loading of the column, where approx. 100 ±10% of the analyte loaded in 1ml 
was actually measured following the IAC manufacturers protocol, was between 0.5-2 
µg/ml for both DON and D3G.  Below this concentration range the proportion recovered 
was reduced, perhaps due to the analyte not eluting completely from the column.  
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Figure 3.2.  Comparison of immunoaffinity column capacities for DON and D3G.  1 ml of a range of 
concentrations were passed through different columns, eluted with methanol and re-analysed with HPLC.  
Mean of 2 replicates shown with SE. 
 
 
 
Figure 3.3.  D3G (black) and DON (grey) stability in DPBS following serial additions of lactic acid (mM).  
The mean of duplicate runs is shown with the SE.  The pH is shown for each concentration. 
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Figure 3.4.  The effect of heating on the stability of the glucosidic bond in D3G.  Data shown as percentage 
of initial concentration (25 °C) prior to heating for 10 min at 50, 75 and 100 °C.  The mean of duplicate 
treatments is shown with the SE.  
 
Figure 3.5.  The effect of lactic, acetic and propionic acid concentration on DON stability incubated in PBS 
at 25 °C.  Data shown as percentage of initial measured concentration in triplicate with SE.  
Treatment of D3G and DON with lactic acid or heat up to 100 °C did little to reduce the 
detection and thus amounts of DON or D3G (Figure 3.3, 3.4) and reaffirming the stable 
nature of these compounds.  Treatment of DON with propionic or acetic acid gave a 
similar response to lactic acid (Figure 3.5).  The drop in response between pH 7.2 and 6.35 
suggests a potential shift in the ionic status leading to a modulation in UV absorption or 
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modifying the interaction with the c18 matrix rather than any degradation of compound 
as the higher concentrations yielded close to 100% recovery.   The highest concentration 
tested of 500 mM equates to silo levels of 360, 240 and 296 mg/g CG of lactic, acetic and 
propionic acid respectively, which corresponds to 5, 14 and 28x that found naturally in 
the experimental silos (Figure 3.5).  This indicates that organic acids themselves are not 
likely to be instrumental in DON remediation and conversely may restrict growth of those 
organisms with potential DON metabolism capacity. 
3.4.2 Levels of DON following ensiling 
 
Figure 3.6.  Percentage recovery of crimped grain silos spiked with DON (5 µg/g) following a 21 d 
incubation at 20 °C either with the addition of lactic acid bacteria, the chemical preservative Crimpstore®, 
no addition of treatment or/and DON, frozen for duration control (5 µg/g) or heat treated prior to 
addition of DON.  Mean percentage of unfermented frozen control silos in triplicate shown with SE and 
significantly different treatments labelled with A (p≤0.001) 
A 21 d mini-silo CG spike and recovery experiment was carried out with DON in order to 
determine if any farm-relevant bacterial additives or chemical treatments were able to 
reduce DON and render the CG safer for animal consumption.  Interestingly, the levels of 
DON recovered from the spiked CG was not significantly affected by any of the lactic acid 
bacteria, chemical preservative or natural fermentation treatments, yet the heat treated 
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CG silos yielded a significant 68.8 ± 14.4% decrease (p<0.001, ANOVA) in DON recovery 
compared with the other treatments (Figure 3.6).  The grain was heat treated prior to 
ensiling and spiking with DON, therefore a biological or chemical component was likely 
responsible for this phenomenon.  Whilst it may be thought to be an oversight not to 
spike with DON and then heat the material, DON was shown to be resistant to heat and 
this treatment was initially designed to be a reduced inocula control rather than a realistic 
CG ensiling scenario.   None of the samples yielded any measurable amounts of D3G 
indicating de novo conjugation in planta did not occur in the period between spiking with 
DON and fermentation.  Recovery in the frozen control was 99.6 ± 20% when considering 
the total amount of DON spiked as 250 µg/silo (therefore bypassing the need for dry 
weight).  LOD was 0.01 µg/ml and 0.035 µg/ml for DON and D3G standards respectively. 
3.4.3 Fermentation characteristics 
Numbers of LAB and yeasts In the mini-silos following incubation for 21 d was similar 
between all LAB strain treatments with DUN1 (L. plantarum) producing the lowest yeast 
counts (Table 3.1), which corresponds to the highest measured lactic and acetic acid 
content.  There was also correlation between levels of lactic, acetic and ethanol (Figure 
3.7, Table 3.2) indicating the development of a bi-phasic fermentation dominated by 
homofermentative then heterofermentative LAB with acid tolerant yeasts possibly 
forming additional viable populations.  This demonstrates how fermented feeds have a 
degree of microbial and metabolic succession governed by nutrients, anaerobiosis, 
acidification and diversity of initial inocula and is supported by comparing with the time 
series data (2 and 4 weeks) presented in Chapter 5.  The measured pH was approximately 
4 in all cases, indicating water soluble carbohydrates (WSC) levels were initially 
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favourable for swift homolactic fermentation.  These measured properties suggest the 
fermentation is of high quality and a reasonable representation of actual CG silo 
processes, although this is related to a zero-decrease in the recovery of DON.   
Crimpstore® did not prevent biological fermentation outright at the concentration used, 
yet the yeast count was dramatically reduced.  The amount of LAB enumerated suggests 
that Crimpstore® may enable a stable population of LAB to develop over the 3 weeks, 
albeit to a lesser extent as supported by the reduced utilisation of WSC including maltose 
and fructose.  Given more time a greater colonisation by LAB may occur with the 
Crimpstore®, providing WSC levels are sufficient. 
The heat treated samples produced the largest counts on MRS agar with appreciative 
amounts of propionic acid present suggesting that the community deviates from the 
conventional LAB-based assemblage supported by the low level of lactic acid and high pH.  
In addition, the ability to withstand the heat treatment suggests the community 
assemblage is potentially made up of heat resistant species.  Levels of glucose and 
maltose were similar to the LAB fermentations yet fructose was absent from the silo 
extract, suggesting the bacteria were chiefly exploiting fructose for energy.  There were 
zero yeast counts on CODA illustrating how heat treating reduces the yeast population 
either directly by heat effects or indirectly by matrix modification, pH and inhibitory 
secondary metabolites secreted by colonising bacteria.  The presence of propionic acid 
was correlated to the only drop in DON levels (Table 3.2, Figure 3.8) which makes the 
select microbial community present especially interesting and the agent responsible 
worth elucidating.  Clostridia spore counts were below 1 CFU/g CG for all treatments 
supported by the lack of butyric acid, and viable mould spores were at a similar low level. 
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Table 3.1.  Measurements of fermented crimped grain feed integrity after 21 d incubation at 20 °C following heat treatment (100 °C, 60 min) or addition of biological and 
chemical additives. The LSMEAN of triplicate silos is shown with the SE and p-value (1 way ANOVA).  Treatment parameters sharing the same letter do not differ significantly 
(p<0.05). 
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SE 
p-
value 
Maltose1 0.5 0.4 0.4 1.0 1.0 0.7 0.2 11.8a 0.8 2.4 <0.001 
Glucose1 5.6 5.6 6.8 7.4 7.8 6.0 5.3b 2.7b 8.1a 0.8 <0.001 
Fructose1 2.3 1.5 1.8 2.9 3.3 3.1 3.0 64.8a 0 8.7 <0.001 
Citric1 3.7 5.5 3.7 5.6 5.7 3.4 5.3 12.0a 1.2 1.7 <0.001 
Lactic1 66.7 65.1 58.5 67.3 77.8 64.5 70.6 24.6b 2.7b 9.3 <0.001 
Acetic1 12.2 7.4b 11.5 14.7 17.3a 10.8 9.9 4.0b 1.6b 2.5 <0.001 
Propionic1 0 0 0 0 0 0 0 10.5a 8.2a 2.6 <0.001 
Ethanol1 35.6 39.4 35.4 40.1 51 41.8 48 22.6 29.2 14.3 0.388 
MRS2 6.02 5.62 5.58 5.38 5.62 5.58 5.93 5.09 6.4 0.5 0.125 
COSA3 3.38 3.32 3.57 3.49 3.04 2.78 3.39 0.98b Nil 0.5 0.003 
pH 4.05 4.17 4.12 4.09 4.00 4.10 3.96 4.02 5.65a 0.5 <0.001 
            
1Water soluble carbohydrates and metabolites (mg/g crimped grain) 
2log10 viable LAB CFU/g crimped grain 
3log10 viable yeast/mould CFU/g crimped grain 
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Figure 3.7.  Dendrogram illustrating the correlation between parameters measured in individual silos 
(correlation coefficient distance, single linkage).  Adjoined parameters are the most similar. 
 
 
Table 3.2.  Pearson correlation coefficients of parameters measured following incubation of crimped 
barley with different treatments.  Somewhat significant interactions (<0.01) are shaded grey.  N = 33 
 
La
ct
ic
 
A
ce
ti
c 
C
it
ri
c 
 
P
ro
p
io
n
ic
 
Et
h
an
o
l 
M
al
to
se
 
G
lu
co
se
 
Fr
u
ct
o
se
 
M
R
S 
C
FU
 
C
O
SA
 C
FU
 
%
 D
O
N
 
re
d
u
ct
io
n
 
Lactic  
0.788 
<0.001 
0.042 
0.836 
-0.785 
<0.001 
0.601 
0.001 
-0.417 
0.030 
0.078 
0.700 
-0.389 
0.045 
-0.331 
0.091 
0.295 
0.136 
-0.717 
<0.001 
Acetic   
-0.053 
0.795 
-0.686 
<0.001 
0.420 
0.029 
-0.413 
0.032 
0.369 
0.058 
-0.393 
0.042 
 
-0.342 
0.081 
0.148 
0.462 
-0.511 
0.006 
Citric    
0.337 
0.086 
-0.004 
0.984 
0.804 
<0.001 
-0.622 
0.001 
0.840 
<0.001 
-0.417 
0.031 
-0.200 
0.318 
-0.457 
0.016 
Propionic     
-0.463 
0.015 
0.676 
<0.001 
-0.230 
0.249 
0.653 
<0.001 
0.015 
0.940 
 
-0.348 
0.075 
0.490 
0.010 
Ethanol      
-0.319 
0.105 
0.194 
0.333 
-0.309 
0.117 
-0.265 
0.181 
-0.039 
0.847 
-0.166 
0.404 
Maltose       
-0.630 
<0.001 
0.979 
<0.001 
-0.161 
0.423 
-0.263 
0.186 
-0.112 
0.579 
Glucose        
-0.710 
<0.001 
0.168 
0.402 
0.014 
0.944 
0.431 
0.025 
Fructose         
-0.218 
0.275 
-0.252 
0.205 
-0.157 
0.434 
MRS CFU          
0.397 
0.040 
0.265 
0.181 
COSA CFU           
-0.203 
0.310 
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3.5 Discussion 
DON contaminated grain has the potential for significant reductions in livestock 
performance and possible toxicosis (D'Mello et al., 1999).  Extensive research has already 
been undertaken regarding the transfer of DON through various levels of food and feed 
preparation (Kostelanska et al., 2009, Binder et al., 2007, Simsek et al., 2012), yet very 
little attention has been directed towards the field of fermented feeds as a route of DON 
bioremediation.  This is the first study to investigate DON in the context of CG feeds, 
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Treatment Figure 3.8.  Relationship 
between measured 
metabolites and reduction in 
DON recovery following a 21 d 
silo incubation with the 
treatments/inoculants stated.  
The linear regression equation 
is also shown.  
DON reduction (%) = 46.5 - 
0.760 Lactic (R-sq = 51.4%, F 
= 26.47, p<0.001) 
DON reduction (%) = 30.4 - 
2.61  Acetic (R-sq = 26.1%, F = 
8.83, p = 0.006). 
Lactic = 16.0 + 1.03 Ethanol     
(R-sq = 36.2%, F = 14.16, p 
<0.001) 
Lactic = 17.6 + 3.80 Acetic   
(R-sq = 62.1%, F = 40.98, 
p<0.001) 
DON reduction (%) =    
- 1.44 + 2.85 Propionic 
(R-sq= 24.1%, F = 7.88, 
p = 0.010) 
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where the high moisture content and the lack of routine MT testing due to the in-house 
nature of the feed requires a different approach to dry commodity feeds.   
Considering the current results, the channelling of contaminated grain into the 
conventional fermented feed process in order to reduce the levels of DON should 
however be undertaken with caution.  As illustrated in the current study the LAB-based 
fermentation or chemical preservative approach to ensiling yields a consistent product 
after 3 weeks with an appreciable degree of biochemical stability, yet levels of DON are 
found to be as equally stable.  This finding is in common with a range of other studies 
where the stability of DON is highlighted in a wide variety of matrices and commodities, 
including maize silage where levels of DON actually increased following fermentation 
(Keller et al., 2013, Pereyra et al., 2008).  Mansfield and co-workers (2005b) conversely 
found levels of DON to decrease within ensiled maize, an effect that could not be 
attributed to physical or chemical properties of the material.  Instead the researchers 
suggested that a microbial element was responsible within the silo and envisaged that 
post-harvest control of DON could indeed be possible and even speculating that these 
microbial agents could extend their beneficial DON degradation effects to within the 
rumen of cattle.  
The ensiled grain samples produced no detectable amounts of D3G, even though the 
barley used for crimping did possess this ability (chapter 5).  The IAC-columns employed 
for clean-up had sufficient cross-reactivity for D3G, as was confirmed by Veršilovskis and 
co-authors (2011).  It may be concluded that the process of crimping and ensiling is 
unlikely to convert DON to D3G within the ensiling timeframe.  It is likely that the grain 
quickly loses the ability for metabolic conjugation during the initial development of 
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fermentation conditions in the silo.  Further work is required to assess the potential de-
conjugation of D3G under fermentation conditions, however exposure to acids and heat 
did not affect D3G measurements in vitro, a result supported by recent studies by Vendl 
et al. (2010) and Berthiller et al. (2011) who suggest only enzymatic hydrolysis could 
cleave the glucoside residue in a cereal context and heat/acid hydrolysis at pH 1.3 were 
ineffective.  An exciting result by Berthiller et al. was that L. plantarum was shown to 
possess the ability for this hydrolysis in media and hydrolysed 62% of D3G over 8 h at 
37 °C.  Since L. plantarum is endemic to fermented feeds, it can be hypothesised that D3G 
may have a short half-life within a silo.  This is investigated in chapter 5. 
In the current study, the only treatment to yield a reduction in levels of DON was the heat 
treated CG treatment, which also surprisingly had the highest bacterial count recorded on 
MRS agar, yet also had the highest pH (5.65).  A homolactic/heterolactic LAB-based 
fermentation phase yields a swift drop in pH suggesting the heat treated silos are still in 
the aerobic phase of ensiling, characterised by a high pH, bacterial counts and WSC 
concentrations.  It is worth mentioning that without a rapid drop in pH, the residual 
carbohydrases and proteases are unhindered to strip the feed of its nutritive value 
(Virtanen, 1945).  Curiously, there is a distinct possibility that this higher pH facilitated the 
enzymatic biotransformation or binding of DON within these silos, although a cause and 
effect explanation is complex, although it is likely that any plant enzymes would have 
been denatured on heating leaving viable bacteria the sole source of such an agent. 
Though the heat treatment deviates from the normal ensiling process with the possibility 
of the feed being inferior nutritionally, of low aerobic stability and possessing a modified 
matrix for bacterial growth, the resulting bacterial assemblage was associated with a 
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significant decrease in DON and is therefore worthy of further investigation in terms of 
the development of silage additives.  Further work is presented in the following chapters 
which involves the isolation of potential candidate bacteria from these silos with selective 
media and determining the efficacy of DON degradation in vitro and in naturally DON-
contaminated grain produced from wheat and barley inoculated under greenhouse 
conditions with F. culmorum.   
The results presented in the current chapter contribute to the overall understanding of 
DON degradation in field-borne and fermentation scenarios.  It is interesting that the 
bacteria able to metabolise DON were originally derived from the spikelets of harvested 
barley.  It could therefore be hypothesised that the metabolic capacity to degrade DON 
stems from the ecological need to compete for compartmentalised resources.  The 
concept of reducing DON in naturally contaminated grain of wheat or barley using a DON-
degrading bacterium derived from the phyllosphere of the wheat or barley itself has been 
recently explored by Ito and co-workers, who isolated a Marmoricola sp. from the heads 
of wheat and applied it to DON-contaminated material, yielding a 66% decrease in DON 
(2012).  The same group has more recently isolated a Sphingomonas sp. from lake water 
which had DON-catalysing capacity via a bacterial P450 enzyme system, illustrating that 
biodegradation pathways of MTs could be both employed for reduction of FHB effects in 
planta and in harvested commodities (Ito et al., 2013).   
CG feeds form an important method of forage preservation in many regions of the globe 
where short growing seasons and disruptive weather patterns preclude conventional dry 
grain animal feeds and can cause increased incidence of FHB and DON contamination.  
Whilst lactic acid fermentative and chemical preservation modes yield a consistent feed, 
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according to the results presented the level of DON in harvested grain is likely to remain 
unaffected following ensiling.  Concerning CG feeds in general, it is apparent that the 
addition of different LAB at sufficient inoculation rates does increase the likelihood of 
that strain playing a part in the overall fermentation and thus shaping the fermentation 
characteristics and community assemblage ecology, yet the final result can be similar to 
that obtained with a natural fermentation providing conditions permit.  Where the 
strategy of adding LAB strains with desired properties has most benefit is firstly 
immediately following anaerobiosis; where swift colonisation, production of organic acids 
and reduction of pH avoids excessive aerobic loss, and secondly; when the presence of 
facultative heterolactic LAB such as L. buchneri convert lactic to acetic acid and thus 
further reducing the pH and inhibiting undesirable microbial activity during storage and 
feed utilisation (Holzer et al., 2003, McDonald, 1981).  For this reason and considering the 
DGGE results in the following chapter, it would be prudent to ensure that the obligate 
heterofermentative L. buchneri is present along with homofermentative LAB such as L. 
plantarum in all on-farm CG strategies where fermentation consistency is critical (Filya et 
al., 2006, Arriola et al., 2011).  Crimpstore® achieved a presumably similar degree of long-
term stability due to the very low yeast counts at enumeration and potential for greater 
increases in LAB and consolidation of low pH due to the amount of WSC remaining.    
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4 Bacterial assemblage analysis in crimped grain mini-silos 
leading to Isolation of potential DON-biotransforming bacteria 
from silos exhibiting a reduction in DON.  
4.1 Aims and objectives 
The objectives are to firstly catalogue the bacterial community assemblage associated 
with each mini-silo fermentation, specifically targeting those which exhibited a 
modulation in DON recovery, and secondly devise a bank of selective media and 
incubation criteria to isolate live bacteria from the silo sample for downstream DON-
degrading applications and characterisation. 
4.2 Introduction 
Biological and chemical-based methods exist for the ensiling of CG for animal feeds.  Both 
strategies involve the use of organic acids to prevent growth of spoilage organisms and 
preserve the nutritive value of the material without affecting the palatability or safety of 
the feed (Dunière et al., 2013).  Conversely, it is hypothesised that such treatments may 
facilitate certain strains of bacteria to colonise the feed and in turn reduce levels of DON 
by biotransformation and binding, therefore increasing feed safety and animal welfare 
yet further (Boudra and Morgavi, 2008). The epiphytic bacterial assemblage associated 
with the grain pre-harvest is likely to be very different to that of the mature CG silage as 
the changing biochemical parameters favour different bacterial groups with a succession 
of species culminating with a community of LAB able to thrive in the anaerobic and low 
pH conditions, such as L. buchneri (Holzer et al., 2003).  It is envisaged that chemical and 
physical conditions prior to ensiling, in addition to the epiphytic inoculum density and 
diversity, will be key to shaping the bacterial assemblage in the fermenting product 
(McDonald et al., 1991).  The results of the last chapter suggested that chemical 
94 
 
 
treatment can reduce bacterial numbers overall and heating the grain can result in large 
latent increases in viable counts; the identity of which will be elucidated in the current 
chapter. 
When the silo material is mixed with LAB culture such as L. buchneri or L. plantarum at an 
adequate seeding density it is hypothesised that these LAB will shape the community by 
acting as keystone species resulting in silage with low pH and low growth of competing 
and harmful microorganisms.  The community associated with a drop in DON recovery 
will be characterised using PCR-DGGE-SEQ (polymerase chain reaction-denaturant 
gradient gel electrophoresis-sequencing), a molecular technique based on the PCR and 
sequencing of the electrophoresis-separated 16S rRNA gene product and aligning it with a 
published bacterial gene sequence using BLAST (NCBI).  DGGE is a technique developed by 
Muyzer et al. (1993) to primarily characterise the complex bacterial assemblage of 
seawater and any successional changes induced by fluctuations in environmental factors.  
Rather than enumerating viable bacteria on a range of selective agar to gain an insight 
into the microbiological community, the genomic content of the sample is analysed to 
identify both cultivable and incultivable bacteria species, therefore potentially yielding a 
far greater understanding of bacterial succession in CG, a subject only previously 
investigated using cultivation techniques (Olstorpe et al., 2010b).  Identification of 
bacterial groups present in each CG treatment allows a directed isolation strategy to be 
formulated with selective media and incubation treatments leading to storage of the live 
strains for further molecular analysis and DON-degradation experiments.  DGGE was 
recently employed to great effect by Li and Nishino (2011) concerning the monitoring of 
bacterial community succession within whole crop maize bunkers inoculated with 
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different LAB.  The authors were able to identify several dominant species of bacteria 
identified in maize (L. acetotolerans, L. panis, Weissella cibaria) and Italian ryegrass silage 
(Erwinia persicina, Pantoea agglomerans) for the first time using DGGE (Li and Nishino, 
2013). 
The effectiveness of an inoculating strain to rapidly colonise the matrix and become the 
dominant entity responsible for the integrity of crimped wheat grain has been 
undertaken previously by Adesogan and co-workers (2003), who found L. buchneri to be 
the most promising LAB in terms of aerobic stability, although Crimpstore; the chemical 
based alternative, was found to yield the least DM losses overall.  Olstorpe and colleagues 
(2010b) evaluated the microbial diversity of CG silage in Sweden following different 
inoculation treatments and observed significant inter-farm differences in assemblage 
succession which was related to wide variations in silage integrity. 
There is a current paucity of studies related to the modulation of MT in CG, let alone 
studies attributing reductions in DON to microbial community components within the 
fermented material.  Some investigators have noted reductions in certain MT from initial 
levels to that in mature maize silage (Boudra and Morgavi, 2008), but as yet no research 
has been published which takes the next step of identifying the biological agents 
responsible and developed them as novel silage additives.  This could be hypothesised as 
being a more effectual method of finding DON-degrading bacteria that screening a bank 
of organisms for a candidate which may not actually be applicable due to the requirement 
of the agent to proliferate and exist within the silage matrix.  Yu et al.(2010) successfully 
used PCR-DGGE to guide the selective isolation of DON-transforming bacteria in chicken 
digesta using a range of antibiotics and found 10 isolates from 4 bacterial groups able to 
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transform DON to DOM-1 when grown and sub-cultured in specific media.  Whether 
these bacteria could be applied to contaminated feedstock for fermented feeds or 
prophylactic gut seeding has yet to be proven, although it could be speculated that the 
latter is more likely due to the requirement of MT treatments to only be used below toxic 
threshold levels. 
Current research in the field of CG microbial assemblage analysis focuses on the aerobic 
stability and quality of the fermentation rather than assigning any differences in 
community to MT degradation in CG.  This molecular investigation characterises the 
promising result in the preceding chapter by identification of potential DON-degrading 
bacteria using DGGE/isolate sequencing whilst discussing the limitations of these 
techniques for CG silage.  
4.3 Materials and methods 
The molecular techniques employed in this chapter aim to elucidate which bacteria are possibly 
responsible for DON degradation in Chapter 3 and could be tested further as potential DON-
degrading candidates in Chapter 5 (Figure 4.1). 
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Figure ‎4.1. Schematic flow diagram highlighting the steps undertaken in chapters 3, 4 and 5. 
4.3.1 DNA extraction of mixed community samples (CG silage). 
DNA extraction of mixed community silo samples was achieved using a FastDNA™ spin kit 
for soil (MP™ Biomedicals, USA) to avoid any skewing of community components that 
may occur with phenol/chloroform-based extraction procedures which may be less 
effective for gram-positives (Promega™ kit gave comparable results, Figure 4.2).  The 
manufacturer’s protocol was followed with a few modifications.  Briefly, 500 mg of re-
suspended CG silage (see section 3.3.4) was added to the Lysing matrix E tube followed by 
978 µl sodium phosphate buffer and 122 µl M-T buffer.  The rack of tubes was then 
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attached to a Vibrax  platform and agitated at full speed for 2 min and the tubes 
centrifuged at 14000g for 10 min with the resulting supernatant added to a 2 ml 
microcentrifuge tube with 250 µl protein precipitation solution and mixed by inversion 10 
times.  The mixture was centrifuged and the supernatant added to 1 ml silica binding 
matrix solution in a 15 ml tube and re-suspended, allowing the solution to settle and 
removal of 500 µl to waste.  The remaining liquid was used to re-suspend the matrix and 
600 µl of the mixture was added to a SPIN™ filter tube and centrifuged at 14000g for 1 
min and the eluent discarded.  The pellet was re-suspended with SEWS-M solution, 
centrifuged (14000g, 3 min) to dry the matrix and SPIN™ filter and 50 µl of molecular 
grade water was added to the matrix and the sample centrifuged (14,000g, 1 min) into a 
fresh tube prior to quantification of DNA by Nanodrop™. 
4.3.2 Extraction of DNA from isolated colonies 
Confluent broth cultures (1 ml of tryptone soya broth, incubated anaerobically for 48 h at 
30°C ) were pelleted and rinsed twice with PBS.  The pellet was then re-suspended in 500 
µl of lysis solution  (1 M sodium acetate, 200 mM tris-HCl, 500 mM NaCl, 10 mM EDTA, 1% 
SDS) and heated for 10 min at 95 °C in 1.5 ml microcentrifuge tubes before chilling on ice 
and adding 500 µl of phenol-chloroform-isoamyl alcohol (25:24:1), inverting and 
incubating at 4 °C for 10 min.  Samples were centrifuged at 10,000g for 6 min and 200 µl 
of supernatant removed to a fresh tube containing 100 µl sodium acetate (3 M, pH 5) and 
1 ml isopropanol (100%, -20 °C), mixed and incubated on ice for 1 h.  Samples were then 
centrifuged at 10,000g for 6 min and the supernatant removed leaving a pellet that was 
rinsed with 0.5 ml 70% ethanol and the pellet air dried by inverting each tube onto a 
sterile tissue in a laminar flow hood before being re-suspended in 30 µl low TE (10x 
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diluted TE buffer, pH 8, to limit enzymatic digestion), analysed using nanodrop for 
purity/yield and diluted down to 30 ng/µl for PCR. 
4.3.3 Polymerase chain reaction for DGGE and 16S rRNA sequencing 
Primers based on those published by Muyzer and co-workers (1993) and were 
synthesised by Eurofins Genomics GmbH (Ebersberg, Germany), reconstituted at 50 
pMol/µl in molecular grade water and stored at -20 °C (Table 4.1).  PCR reactions were set 
up in thin walled dome-lid PCR tubes with 25 µl Taq 2x readymix (Bioline), 2 µl forward 
primer, 2 µl reverse primer, 30 ng DNA template made up to 50 µl with PCR grade H2O 
and run on a Techne TC-512 PCR machine (Bibby Scientific, UK) using the touchdown 
thermocycling program as follows: 5 min 94 °C, 1 min at 94 °C, 1 min 65 °C (decreasing 
every 2nd cycle gradually to 55 °C (I.e., decrease annealing from 65 > 55 °C over 20 cycles), 
1 min 72 °C, then a further 10-15 cycles of this, 1 min at 94 °C, 1 min 55 °C, 1 min 72 °C 
and a final extension at 72 °C for 7 min. 
Table 4. 1.  Primers used for PCR-DGGE and PCR-sequencing. 
Primer specifics Forward Reverse 
16S rRNA GC clamp for 
DGGE 
341F (5'-CGCCCGCCGCGCGCGGCGGGCGGG 
GCGGGGGCACGGGGGGCCTACGGGAG 
GCAGCAG-3') 
540R (5'-ATTACCGCGGCTGCTGG-3') 
16S rRNA for 
sequencing from DGGE 
bands 
341F (5'-CCTACGGGAGGCAGCAG-3') 
 
540R (5'-ATTACCGCGGCTGCTGG-3') 
16S rRNA for 
sequencing from 
cultures 
9F (5'-GAGTTTGATCCTGGCTCAG-3')   1512R (5'-
CGGCTACCTTGTTACGACTT-3') 
PCR  (premixed with loading buffer) products were verified against a 100-1000BP ladder 
(Bioline™ IV) on a 1% agarose gel in TAE buffer (40 mM Trizma-base, 1 mM EDTA-
disodium salt, pH 7.8 with acetic acid) pre-stained with SYBR safe (0.01%, Invitrogen™) 
and run at 90 V for 40 min.  Visualisation was achieved using an Applied Biosystems 
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GelDoc™ system and only single bands with insignificant smearing and low amounts of 
genomic template DNA were chosen for clean-up procedures/DGGE. 
4.3.4 Denaturant gradient gel electrophoresis (DGGE) 
DGGE involves the separation of duplex PCR products on a denaturant gel based on 
sequence G-C content.  A G-C clamp is incorporated in the primer pair which is 
synthesised along with the template and acts as a hinge, preventing the sister strands 
completely separating as they migrate through denaturant and divide into sister strands.  
The G-C content regulates where on the gel denaturing occurs and migration dramatically 
slows forming a band, which can be used for banding pattern analysis and band 
identification by sequence PCR.   
DGGE gels were run using a DCode™ Universal Mutation Detection System (Bio-rad, 
Hercules, USA).  PCR products (20 µl + 2 µl  + blue loading buffer) were pipetted into 
rinsed wells of a 0-30%, 30-60% or 45-70% denaturant gel submerged in tank of 7 L TAE 
buffer at 60 °C.  Several gradients were trialled to find the optimum for fermented feed 
where bands could be spread over the whole length of the gel.  10% acrylamide gels were 
constructed with a Bio-rad gradient system attached to two syringes, each filled with the 
premixed denaturant solutions specific for each gradient made from 0 and 80% stock 
solutions (0%; 33.4 ml 30% acrylamide solution, 2 ml 50x TAE, made up to 100 ml with 
sterile H2O, 80%; as 0% but with 32 ml formamide and 5.6 M urea).  The glass gel plates 
were cleaned with acetone and one surface coated with rain repellent (Halfords, UK), 
clamped in place with PTFE spacers and sealed with high-vacuum grease (Dow Corning, 
USA).  Prior to pouring the gel 100 µl of 10% Ammonium persulphate and 10 µl of TEMED 
(N,N,N-tetramethylethylenediamine) to each of the 25 ml denaturant mixes and aspirated 
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into two syringes attached to the gradient wheel.  Carefully the wheel was rotated with a 
differential amount from each syringe expelled through a silicon tube fitted with a needle 
affixed to the top of the gel mould.  When 1 cm from the top a 20 µl (18 well) comb was 
carefully inserted and the gel left to polymerise for 2 h before placing in the running tank, 
adding the PCR products mixed with loading buffer (4 ml glycerol, 6 ml 1x TE, 25 mg 
bromophenol blue, mixed 1:4 ratio with DNA) into each well and running at 64 V for 16 h 
at 60 oC.  The gel was then separated from the glass plates and incubated for 30 min in 
the staining solution (TAE, 1 x SYBR green) on a shaking platform (IKA Vibrax VXR, 200 
rpm) and visualised on a Gel-Doc system with UV trans-illumination (Gel-doc XR, Biorad).  
A sterile 1 ml filter tip was used to take a gel core from each distinctive band and inserted 
into a sterile 1.5 ml tube with 20 µl molecular grade water which was left for 12 h before 
using as PCR template.  In addition, the DGGE gels were analysed with the Geldoc™ 
software using the presence or absence of bands to produce a binary matrix that was 
analysed in Minitab 16 using multivariate clustering of variables to produce a dendrogram. 
4.3.5 PCR product clean-up, sequencing and BLAST searching 
PCR clean up involves the removal of primers and PCR additives which will hinder the 
sequencing reaction and is achieved using Sureclean™ reagent (Bioline™, UK).  Briefly, 20 
µl of PCR reaction verified by electrophoresis was vortexed with 20 µl Sureclean in sterile 
1.5 ml micro-centrifuge tubes and incubated for 10 min at room temperature and 
centrifuged at 14000g for 20 min.  The supernatant was removed by pipette and the 
pellet re-suspended in 70% ethanol by vortexing for 10 s followed by another 20 min 
centrifugation and the tube upturned onto a piece of sterile Kimwipe until all liquid has 
evaporated (in laminar-flow hood).  Another 70% EtOH wash, centrifugation and 
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evaporation using a fresh Kimwipe® was followed by re-suspending in 20 µl molecular 
grade water and the concentration of DNA measured using a Nanodrop™ 
spectrophotometer and diluted to 1.5 ng/µl of which 15 µl was sent away for Sanger 
sequencing with 10 pmol forward primer only (Eurofins Genomics, Germany).  
Chromatogram data was handled with Mega 5.1 (Tamura et al., 2011.) where sequence 
quality was evaluated before uploading to an online sequence alignment database 
(http://blast.ncbi.nlm.nih.gov) for a BLASTN nucleotide search of similar sequences.  The 
alignment with the highest identities (%) is listed for each bacteria type with the 
accession number.  Only typed full gene sequences were used for alignment.  
4.3.6 Isolation of DON biotransformation candidates in silo samples with 
selective media 
Following analysis by DGGE the original silo extracts were 10x serially diluted with PBS 
and 20 µl plated onto selective agar following the ingredients listed in The Handbook of 
Microbiological Media for the Examination of Food (Atlas, 2006).  Media included: Bacillus 
selective agar (starch, polymixin B): Bacillus spp.; McKonkey agar: Escherichia spp.; 
Slanetz and Bartley agar: gram negative Enterrococci; Bacillus cereus agar: Bacillus spp. 
and SODLAC agar (sodium lactate); lactate metabolising propionic-type bacteria or lactate 
metabolising LAB.  In addition, SODLAC broth was employed by serial enrichment with 
100 ml inoculated with 100 µl of silo extract, incubated anaerobically for 48 h at 25 °C and 
100 µl used to inoculated another 100 ml for 48 h, and repeat, followed by plating on 
MRS (lactic acid bacteria) and SODLAC agar (lactate metabolising bacteria).  The use of 
SODLAC medium stemmed from the metabolites measured in the heat treated silos, 
which included propionic acid.  All isolates were cultured in Tryptone soya broth (25 °C, 
anaerobically), snap frozen with 15% glycerol and prepared for PCR. 
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4.4 Results 
4.4.1 Comparison of Promega™ and MO™ soil kits for DNA extraction 
The similarity in terms of banding pattern of the two different DNA extraction kits 
(Figure 4.2), for example 31 and 31A, suggests that the two different methods of DNA 
extraction yield almost identical community profile and are not excluding any key 
assemblages due to varying membrane tenacity between groups (i.e. Gram 
positive/negative).   The only slight differences in banding patterns, only observable 
with magnified image analysis and illustrated with a dendrogram of similarity (Figure 
4.6), highlight the importance of universal PCR primer design, PCR reaction 
optimisation and accurate DNA concentration measurements designed to eliminate 
bias in the final gel.  Since the differences are not significant for the purposes of 
directing the bacteria isolation strategy, the Promega™ or MO™ kits were considered 
interchangeable, and the MO™ soil kit was used for the remaining extractions.  One 
issue of a potential key bacteria not being represented on the gel is discussed further 
in 4.5.4. 
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Figure 4.2.  A comparison of the DGGE profiles produced with either MO soil or Promega cellular DNA 
extraction kits to check whether different kits would have a bearing on the DNA extraction efficiency and 
possible skew of bacterial community components.  The silo number is given with the treatment, with “a” 
denoting the Promega extraction. 
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4.4.2 Bacterial assemblage differences between treatments following 
treatment of silos with different biological and chemical additives 
 
Figure 4.3.  DGGE gel image comparing triplicate silo treatments (numbered) with sequenced bands 
annotated with a letter that corresponds to an aligned sequence and bacterial species in Table 4.2. 
When identically migrating bands between lanes were excised and sequenced there was 
excellent sequence similarity, which along with the ability to sequence and identify all 
bands attempted illustrates the suitability of this screening technique for CG assemblage 
analysis.  The dendrograms (Figure 4.4, 4.6) illustrate how the presence or absence of 
DGGE bands can be used to derive differences in community make-up between silo 
treatments.  It can be noted that a single bacterial strain may produce more than one 
band on the gel (DGGE of isolate DNA not shown).   
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Concerning the use of additives for influencing the bacterial assemblage in each silo, it is 
apparent that there is a significant difference between the frozen control and all the 
treatments (Figure 4.3, 4.4).  The frozen material in general has a less distinct banding 
consisting of epiphytic bacteria such as Pantoea agglomerans (formerly: Enterobacter 
agglomerans), Erwinia sp. and Escherichia hermannii with those LAB instrumental in 
fermentation not represented significantly at this stage suggesting the level of inoculum 
present initially is not indicative of 21 d fermentative assemblage.   
L. buchneri produced the most significant shift in final community assemblage of the LAB 
treatments, with only hetero and homofermenters significantly represented, the majority 
of which was L. buchneri (Figure 4.3).  Furthermore, the consistency of banding between 
the three silos is indicative of L. buchneri dominating the fermentation, reducing the pH 
and effectively out-competing the other groups.  Conversely, the addition of the L. 
plantarum strains DUN1 and PayG5 did not strictly influence natural succession in this 
case as L. plantarum was also present in the control fermentation, yet they were found as 
distinct clusters according to banding pattern and fermentation characteristics were more 
effective.  Crimpstore® was in an intermediate cluster between the frozen starting 
material and the control fermentation proving how chemical preserved CG still possesses 
the ability to support a natural fermentation profile, albeit at a slower rate and with a 
delayed onset.   
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Table 4. 2.  BLAST search identities and aligned likely bacteria species for excised bands in Figure 4.3.  
Many of the bands are in common with many of the different treatments and others are unique to that 
treatment.  Asterisks indicate sequence relates to plant chloroplasts/mitochondria (evolutionary 
artefacts). 
Band 
code 
Closest relative (accession 
number) 
 Identities (%) 
A Lactobacillus paralimentarius 
(JN863628.1) 
 148/151(98%) 
B Lactobacillus plantarum 
(AB572043.1) 
 31/32 (97%) 
C Bacillus sp. (HM598361.1)  31/31 (100%) 
D Lactobacillus paracasei 
(GU424995.1) 
 52/56 (93%) & 26/28 (93%) 
E, F* Triticum aestivum (wheat 
mitochondrion) (GU985444.1) 
 111/111 (100%) 
G Lactobacillus plantarum 
(JQ712984.1) 
 131/141(93%) 
H Lactobacillus sp. (AB794060.1)  132/146 (90%) 
I Enterobacter sp. (CP000653.1)  137/146 (94%) 
J Pantoea agglomerans 
(AB681812.1) 
 147/149 (99%) 
K Pantoea eucalypti (EF688009.1)  136/145 (94%) 
L Enterobacteriaceae bacterium 
(JX067700.1) 
 133/140 (95%) 
M Erwinia sp.( GQ405203.1)  92/98 (94%) & 17/17 (100%) 
N* Hordeum vulgare subsp. vulgare 
chloroplast (EF115541.1) 
 115/125 (92%) 
O Lactobacillus buchneri 
(JQ249065.1) 
 149/156 (96%) 
P Lactobacillus buchneri 
(JQ612702.1) 
 147/150 (98%) 
Q Lactobacillus plantarum 
(EF439684.1) 
 134/144(93%) 
R Lactobacillus kefiri (AB362680.1)  145/154(94%) 
S Lactobacillus buchneri 
(JQ249047.1) 
 146/148(99%) 
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Figure 4.4 Dendrogram illustrating the clustering of silo treatments in terms of 16S rRNA banding pattern 
following DGGE.  The position of the joiners is indicative of correlational distance (%). 
4.4.3 Identity of dominant bacteria within the heat treated silos where 
DON levels were reduced 
Analysis of the heat treated silos (31, 32, and 33) which had reduced recovery of DON 
(58.9, 24.1, and 10.7% of initial respectively) indicates a far greater diversity between 
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silos than the other treatments in terms of bacterial taxonomy and banding pattern 
differences (Figure 4.5, 4.6).   
 
Figure 4.5.  DGGE gel image to compare heat treated silos (31, 32, 33) with the other treatments with 
sequenced bands annotated with a letter that corresponds to an aligned sequence in BLAST in Table 4.3. 
Table 4. 3.  BLAST search identities and aligned likely bacteria species for excised DGGE bands in Figure 
4.5.  Many of the bands are in common with many of the different treatments and others are unique to 
that treatment.  All DGGE bands able to PCR and sequence for heat treatment silos 31, 32 and 33 are 
shown. 
Band 
code 
Closest relative (accession number)  Identities (%) 
 Heat treated (33)   
1 Weissella cibaria (JN851741.1)  138/147 (94%) 
2 Weissella cibaria (JN851741.1)  146/149 (98%) 
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3 Weissella sp. (EF468052.1)  132/138 (96%) 
4 Weissella cibaria (JN851741.1)  149/150 (99%) 
5 Weissella cibaria (JN851741.1)  138/148 (93%) 
6 Delta proteobacterium (AY162123.1|)  36/37 (97%) 
7 Bacillus coagulans (JQ073764.1)  107/136(79%) 
8 Vibrio sp. (DQ479374.1)  40/42 (95%) & 
33/36 (92%) 
9 Yersinia massiliensis (JX429059.1)  130/150 (87%) 
10 Pantoea punctata (HQ018863.1)  119/147 (81%) 
 Heat treated (32)   
11 Bacillus licheniformis (JN000303.1)  102/111 (92%) 
12 Bacillus licheniformis (JN540805.1)  113/133 (85%) 
13 Bacillus licheniformis (JX912559.1)  118/129 (91%) 
14 Bacillus sp. (FM865970.1)  130/136 (96%) 
15 Bacillus subtilis (HQ425655.2)  140/151 (93%) 
16 Paenibacillus sp. (AJ582394.1)  52/55 (95%) 
17 Micrococcaceae bacterium (AY177727.1)  87/101 (86%) 
18 Bacillus sp. (AY433824.1)  50/54 (93%) 
19 Microbacterium aerolatum (FJ944691.1)  109/128 (85%) 
 Heat treated  (31)   
20 Klebsiella pneumoniae (AF130981.1)  130/149 (87%) 
21 Enterobacter agglomerans (AF130886.2)  131/151 (87%) 
22 Pantoea agglomerans (HM161853.1)  127/150 (85%) 
23 Enterobacter agglomerans  (AF130886.2)  128/149 (86%) 
24 Klebsiella pneumoniae (AB642256.1)  118/135 (87%) 
25 Enterobacter agglomerans (AF130886.2)  118/135 (87%) 
26 Enterobacter agglomerans (AF130886.2)  137/149 (92%) 
27 Escherichia hermannii (JX968501.1)  151/152 (99%) 
28 Enterobacter agglomerans (AF130886.2)  149/151 (99%) 
29 Escherichia hermannii (JX968501.1)  148/150 (99%) 
 Frozen control (19)   
30 Pantoea agglomerans (HM224395.1)  96/113 (85%) 
31 Enterobacter sp. (FJ355965.1)  131/145 (90%) 
32 Enterobacteriaceae bacterium (JX067700.1)  143/146 (98%) 
33 Pantoea agglomerans (EU849113.1)  138/143 (97%) 
34 Pantoea agglomerans (EU849113.1)  139/144 (97%) 
35 Pantoea agglomerans (KC178591.1)  140/143 (98%) 
36 Escherichia hermannii (JX968501.1)  142/146 (97%) 
37 Pantoea agglomerans (DQ065752.1)  123/133 (92%) 
38 Triticum aestivum (wheat mitochondrion) 
(GU985444.1) 
 99/100 (99%) 
 DUN1 (13)   
39 Lactobacillus sakei (JN851763.1)  143/146 (98%) 
40 Lactobacillus plantarum (JN863682.1)  142/147 (97%) 
41 Lactobacillus plantarum  (JN859533.1)  141/147 (96%) 
42 Lactobacillus plantarum  (JN863682.1)  137/142 (96%) 
43 Lactobacillus plantarum (EF439684.1)  132/141 (94%) 
44 Lactobacillus plantarum  (EF439684.1)  135/145 (93%) 
45 Lactobacillus brevis (JN863690.1)  117/142 (82%) 
46 Pediococcus ethanolidurans (AB706354.1)  103/137 (75%) 
47 Lactobacillus crustorum (KC571196.1)  127/141 (90%) 
48 Hordeum vulgare subsp. vulgare (barley chloroplast) 
(EF115541.1) 
 113/118 (96%) 
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Figure 4.6.  The cluster analysis undertaken of the binary tabulated band analysis data is illustrated as a 
centroid dendrogram with treatments linked by correlation coefficient (%).  Silo treatment is shown with 
the silo number. 
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Silo 31, the heat treated silo with the least DON degradation, was generally colonised 
with Pantoea agglomerans, E. hermannii and Klebsiella pneumoniae.  These are species 
more often found in early stage grass silage or late stage high moisture content silage (Li 
and Nishino, 2013).  Silo 32 (24.1% DON recovery) was found to be populated by Bacillus 
sp. such as B. subtilis and B. licheniformis in addition to lesser prominent groups including 
Micrococcaceae, Microbacteriacea and Paenibacillus sp.  These species are usually found 
in aerobically deteriorated silages and are categorised as highly heat resistant spore 
forming silage bacteria by Driehuis (2013).  Silo 33 which had the least recovery of DON 
(10.7%) was predominantly colonised with Weissella cibaria, a lactic acid bacteria in the 
Leuconostocaceae family more often evident in maize silage (Pang et al., 2011), early 
grass silage fermentation, non-spore forming, aerotolerant, heterofermentative and 
generally regarded as safe for consumption (Björkroth et al., 2002).  None of the heat 
treated silos produced any viable yeast counts, therefore only the bacterial assemblage 
analysis was deemed worthwhile. 
4.5.4   Selective and enrichment media derived isolates 
Once the bacterial community of each of the heat treated silos was determined the suite 
of selective agar was employed to isolate vegetative cells from morphologically distinct 
colonies.  Whilst some could be grown directly following dilution of silo extract, others 
required a period of enrichment in SODLAC broth to screen for propionic acid producing 
bacteria and other lactic acid catabolising bacteria.  Hafnia alvei and Leuconostoc 
mesenteroides colonies were only found to be present using this technique as they did 
not appear in the DGGE analysis.   
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Table 4. 4.  Selective agar employed to isolate possible degraders of DON as recorded in the DGGE 
analysis.  Specificities as follows: Bacillus selective agar (starch, polymixin B): Bacillus sp.; MacKonkey 
agar: Escherichia sp.; Slanetz and Bartley agar: gram negative Enterrococci; Bacillus cereus agar: Bacillus 
sp. and SODLAC agar/broth (sodium lactate); lactate metabolising propionic bacteria.  *Anaerobic. 
Selective conditions 
Isolate 
code 
Closest relative (accession number)  Identities (%) 
Silo: 31 Bacillus selective agar* WW1 
Leuconostoc mesenteroides subsp. 
mesenteroides (GU470933.1) 
 
540/543 
(99%) 
Silo: 31 McKonkey agar* WW2 Pantoea agglomerans (HE647624.1)  
528/528 
(100%) 
Silo: 31 McKonkey agar* WW3 
Leuconostoc mesenteroides 
(JN851765.1) 
 
525/525 
(100%) 
Silo: 33 Slanetz and Bartley* WW5 
Leuconostoc mesenteroides subsp. 
mesenteroides (JN863609.1) 
 
526/526 
(100%) 
Silo: 33 Bacillus selective* WW6 
Leuconostoc mesenteroides subsp. 
mesenteroides (JN863609.1) 
 
526/526 
(100%) 
Silo: 32 Bacillus selective* WW7 Bacillus licheniformis (HM753626.1)  
501/522 
(96%) 
Silo: 32 Slanetz and Bartley* WW8 
Leuconostoc mesenteroides 
(JN851765.1) 
 
522/522 
(100%) 
Silo: 33 Bacillus selective* WW9 
Leuconostoc mesenteroides 
(JN851765.1) 
 
524/524 
(100%) 
Silo: 32 Bacillus selective* WW10 Bacillus subtilis (HQ425655.2)  
527/527 
(100%) 
Silo: 32 Bacillus selective* WW11 
Leuconostoc mesenteroides 
(JN851765.1) 
 
525/525 
(100%) 
Silo: 31 Slanetz and Bartley* WW12 
Leuconostoc mesenteroides subsp. 
mesenteroides (KC213923.1) 
 
527/527 
(100%) 
Silo: 31 MacKonkey agar* WW13 Pantoea agglomerans (HE647624.1)  
526/526 
(100%) 
Silo: 31 Bacillus cereus agar* WW14 Pantoea agglomerans (HE647624.1)  
525/525 
(100%) 
PM33ANB SODLAC enrichment broth 
to MRS agar* 
WW15 
Leuconostoc mesenteroides subsp. 
mesenteroides (KC213923.1) 
 
530/530 
(100%) 
P33aii SODLAC broth to MRS agar* WW16 Hafnia alvei (JX480505.1)  
527/527 
(100%) 
33b SODLAC broth to MRS agar* WW17 
Leuconostoc mesenteroides 
(KC213923.1) 
 
525/525 
(100%) 
31 SODLAC broth to MRS agar* WW18 Hafnia alvei (JX480505.1)  
448/452 
(99%) 
P33a SODLAC broth to MRS agar* WW19 Hafnia alvei (JX480505.1)  
518/518 
(100%) 
PM33C SODLAC broth to MRS agar* WW20 
Leuconostoc mesenteroides 
(JN851765.1) 
 
533/533 
(100%) 
P33A 
SODLAC broth to SODLAC agar* 
WW21 Lactobacillus plantarum (JN863682.1)  
525/525 
(100%) 
P33B SODLAC broth to MRS agar* WW22 
Leuconostoc mesenteroides 
(JN851765.1) 
 
525/525 
(100%) 
33A SODLAC broth to MRS agar WW23 
Leuconostoc mesenteroides 
(JN851765.1) 
 
525/525 
(100%) 
P32Anc SODLAC broth to SODLAC 
agar* 
WW24 Bacillus sp. (GU939695.1)  
414/535 
(77%) 
P32Anc SODLAC broth to MRS agar WW25 
Leuconostoc mesenteroides 
(KC213923.1) 
 
515/515 
(100%) 
P32a SODLAC broth to SODLAC agar* WW26 Hafnia alvei (JX480505.1)  
531/532 
(99%) 
P32a SODLAC broth to MRS agar* WW27 Hafnia alvei (JX480505.1)  
529/529 
(99%) 
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Table 4.5.  Bacterial strains isolated from silos 31-33 using SODLAC agar and broth under anaerobic 
conditions (25 °C). 
Isolate code Closest relative (accession number)  Identities (%) 
33A Weissella cibaria (AB761300.1)  841/848 (99%) 
P33BM Leuconostoc mesenteroides subsp. dextranicum (AB795649.1)  831/831 (100%) 
33D Weissella cibaria (AB761300.1)  857/861 (99%) 
M8 PM33ANA Weissella cibaria (HF562960.1)  825/825 (100%) 
M10 PM33ANB Leuconostoc mesenteroides (KC545921.1)  799/799 (100%) 
M11 PM33AM Leuconostoc mesenteroides (KC545921.1)  730/730 (100%) 
M12 33C Weissella cibaria (AB593347.1)  829/834 (99%) 
M14 P33AM Hafnia alvei (JX480505.1)  830/830 (100%) 
M15 33B Leuconostoc mesenteroides (HM218680.1)  838/840 (99%) 
M16 PM32ANC Leuconostoc mesenteroides (JQ680419.1)  843/844 (99%) 
M17 PM32D Leuconostoc mesenteroides (KC545921.1)  842/843 (99%) 
M18 PM32BM Leuconostoc mesenteroides (KC545921.1)  842/843 (99%) 
M19 P32AM Hafnia alvei (JX480505.1)  822/823 (99%) 
M20 P31B(2)M Leuconostoc mesenteroides (JQ680419.1)  829/830 (99%) 
M21 P31BM Leuconostoc mesenteroides subsp. dextranicum (AB795649.1)  
828/828 (100%) 
 
M22 PMAN31CM Leuconostoc mesenteroides (JQ680419.1)  823/824 (99%) 
M23 PM31AM Leuconostoc mesenteroides (JQ680419.1)  819/822 (99%) 
 
Following the apparent abundance of Leu. mesenteroides in the selective media and SODLAC 
enrichment experiments (also H. alvei to a lesser extent) but the conspicuous absence in the 
DGGE gels it was necessary to check that the universal primers prescribed by Muyzer (1993) and 
used in the current PCR-DGGE have specificity required for the 16s rRNA sequence in Leu. 
mesenteroides and H. alvei.  By nesting the DGGE primers (labelled yellow, Figure 4.7) within the 
partial 16s rRNA gene sequence obtained from the isolates in question it was evident that there 
was a primer-sequence mismatch for Leu. mesenteroides (labelled red), but not H. alvei or W. 
cibaria (positive DGGE bands). This would perhaps explain why this PCR fragment did not appear 
in the DGGE gel, and since it could be a major component of the bacterial assemblage in the heat 
treated silos it does illustrate a flaw in the use of these much employed universal primers.  
Further research confirmed that this AT base change is known to be an identifying 
characteristic of the Leuconostocaceae (Walter et al., 2001).  The same author suggests that only 
90-99% of the most numerous species in the community are effectively detected using the 
universal primer technique, therefore to monitor the minority members of the assemblage, more 
selective primers need to be designed based on pilots culture dependant identification 
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experiments.  However, in silico and environmental trialling of a range of universal primers by 
Klindworth et. al. (2013) for classical and next generation sequencing found the 341F-540R primer 
pair (used in the current work) to have the best coverage for bacteria overall, although a larger 
fragment of 464bp could be used with only a slight reduction in species coverage (341F-805R). 
M4; Weissella cibaria gene for 16S ribosomal RNA, partial sequence, strain: qz140 Sequence ID: 
dbj|AB761300.1| 
      301 GATCGGCCAC AATGGGACTG AGACACGGCC CATACTCCTA CGGGAGGCAG CAGTAGGGAA 
      361 TCTTCCACAA TGGGCGAAAG CCTGATGGAG CAACGCCGCG TGTGTGATGA AGGGTTTCGG 
      421 CTCGTAAAAC ACTGTTGTAA GAGAAGAATG ACATTGAGAG TAACTGTTCA ATGTGTGACG 
      481 GTATCTTACC AGAAAGGAAC GGCTAAATAC GTGCCAGCAG CCGCGGTAAT ACGTATGTTC 
M14; Hafnia alvei strain 26 16S ribosomal RNA gene, partial sequence  
Sequence ID: gb|JX480505.1| 
      241 AGAGGATGAC CAGCCACACT GGAACTGAGA CACGGTCCAG ACTCCTACGG GAGGCAGCAG 
      301 TGGGGAATAT TGCACAATGG GCGCAAGCCT GATGCAGCCA TGCCGCGTGT ATGAAGAAGG 
      361 CCTTCGGGTT GTAAAGTACT TTCAGCGAGG AGGAAGGCAT TGTGGTTAAT AACCGCAGTG 
      421 ATTGACGTTA CTCGCAGAAG AAGCACCGGC TAACTCCGTG CCAGCAGCCG CGGTAATACG 
M15; Leuconostoc mesenteroides subsp. mesenteroides strain NM168-5 16S ribosomal RNA gene, 
partial sequence Sequence ID: gb|HM218680.1| 
      301 CACGGCCCAA ACTCCTACGG GAGGCTGCAG TAGGGAATCT TCCACAATGG GCGAAAGCCT 
      361 GATGGAGCAA CGCCGCGTGT GTGATGAAGG CTTTCGGGTC GTAAAGCACT GTTGTATGGG 
      421 AAGAACAGCT AGAATAGGAA ATGATTTTAG TTTGACGGTA CCATACCAGA AAGGGACGGC 
      481 TAAATACGTG CCAGCAGCCG CGGTAATACG TATGTCCCGA GCGTTATCCG GATTTATTGG 
 
Figure 4.7.  Partial 16s rRNA sequences for 3 representative heat-treated silo bacteria, with overlayed 
universal p1, p2 primers highlighted in yellow and base mismatches highlighted in red 
4.5 Discussion 
In general, the PCR-DGGE method of assemblage characterisation has proven to be an 
invaluable screening technique concerning the determination of potential DON degrading 
bacteria in CG feed as there was a high level of concordance between banding patterns of 
the same sample on different gels and almost every excised band yielded good sequence 
data facilitating reliable bacteria identification that could be confirmed when an isolate 
was obtained and sequenced.  Whilst the PCR-DGGE-SEQ data gave sequence similarities 
below the 99% required for authentication, once the corresponding isolate was 
sequenced again with a larger fragment the identification was more robust. 
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Bacterial assemblage analysis of CG silos using PCR-DGGE-SEQ was shown to yield robust 
and reproducible data for all samples leading to directed isolation of viable relevant 
bacteria for further investigation in Chapter 5.  The validity of the technique for 
fermented CG was confirmed following sequencing of colonies in the isolation phase 
which corresponded well to the genomic content of the silos.  The retrospective lack of 
primer specificity for Leu. mesenteroides, a LAB instrumental in the early fermentation 
phase was addressed by employing additional culture dependant methods, although it 
would be prudent for future studies to undertake a pilot colony sequencing experiment to 
verify the universal primers prescribed by Muyzer et al. (1993) give sufficient species 
coverage without significant primer mismatch.  Whilst a 1bp mismatch may not reduce 
the efficacy of PCR for single colonies, the competitiveness nature of the DGGE PCR 
reaction and secondary structure of 16S rRNA may dictate whether a certain product 
appears on the gel (Klindworth et al., 2013, Neilson et al., 2013).  The use of both culture-
dependant and independent techniques can complement each other, although care 
needs to be taken in interpretation.  For example, not all species form CFU under 
laboratory conditions, even if a range of media and incubation conditions are provided.  
DGGE on the other hand yields comprehensive semi-quantitative species information in 
that band intensity can be arbitrarily related to copy number, although bacterial viability 
is not confirmed, and the influence of barley DNA content during the PCR template 
normalisation could bias the reaction by competing with the bacterial DNA for the initial 
PCR cycles.  Moreover, preferential amplification of certain fragments due to the 
secondary structure of the 16S rDNA template, which is hypothesised by Neilson and 
colleagues as the main cause of multiple DGGE bands harbouring identical sequences, 
could be a significant method artefact when considering community diversity analysis 
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(Neilson et al., 2013).  However, the highly reproducible community structure profiles 
that can be obtained with DGGE provide excellent snapshots of functional diversity and 
more generalised shifts in community structure, and DGGE therefore an excellent tool 
when comparing bulk changes in large numbers of samples. 
Alternatively, the use of clone library techniques where metagenome DNA/RNA is 
inserted into recombinant Escherichia coli for generation of clonal fragments, has often 
been viewed as preferential to DGGE as reads can be 5 times the length leading to more 
reliable identification in BLAST and sequences can be obtained from species not exhibited 
as a band on the DGGE gel.  It can also be complementary to DGGE as clonal fragments 
can then be run as nested-PCR products concurrently on a DGGE gel for definitive 
identification of community bands based on migration distance, whilst maximising gene 
coverage (Handschur et al., 2005).  
Recent work has explored the possibility of carrying out DGGE on alternative functional 
genes to 16S rRNA, including those involved in primary metabolism; therefore providing 
phylogenetic and metabolic diversity information within the same DGGE experiment 
(Hallin et al., 2006).  Moreover, the use of non-universal primers enables low abundance 
groups that would not usually yield visible bands to be adequately amplified/identified.  
Taking this further, it may be possible to PCR homofermentative and heterofermentative 
separately or even screen for de-epoxidase/cytochrome p450 genes/RNA within the silo 
and selectively identify/isolate candidate DON-metabolising bacteria, specifically those 
transcribing candidate genes.  Such work is only feasible if the corresponding gene is 
conserved and available in a searchable online database such as BLAST (NCBI) or the 
sequence of a particular DON-degrading enzyme/protein is published enabling 
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degenerate primers designed according to codon sequence to amplify homologous DNA 
or RNA sequences across all microbial taxa with PCR or RT-PCR respectively (Hakki and 
Akkaya, 2001).  With the rapid development of next generation sequencing it is also 
possible to derive species and metabolic diversity by extracting the metagenome, 
translating the DNA/RNA in silico to functional protein structures, which are then linked 
post hoc to taxa with already annotated genomes (Mardis, 2008).  
When considering the current suite of results it is apparent that the initial epiphytic 
community can only predict the integrity and community richness of naturally inoculated 
silage in the early stages of fermentation, as after that it is evident that even if LAB are 
below the limit of detection in DGGE at time zero, they can still go forth to dominate the 
mature silage with bands representing early epiphytic species (i. e., P. agglomerans) 
disappearing as they are diluted out of PCR contention by the more numerous LAB copy 
numbers.  The disappearance of P. agglomerans bands in silage DGGE analysis has been 
previously reported by Wang and co-workers in as little as 2 d for alfalfa silage dominated 
by inoculated L. plantarum and after 20 d when colonised naturally by L. sakei and L. 
kimchi (Wang et al., 2006).     It is worth mentioning the bacteria not producing significant 
bands in DGGE but having a presence in enrichment dependant plating experiments.  Leu. 
mesenteroides is a non-spore forming LAB that occurs epiphytically and initiates 
fermentation in a variety of foods and feeds including sauerkraut and silage (Thunell, 
1995).  Leu. mesenteroides is not acid tolerant and growth only occurs above pH 5.4, 
below which the silage is superseded by Lactobacillus sp. which are more effective at 
reducing proteolysis and spoilage of the feed (Adesogan et al., 2003).  H. alvei are gram 
negative, non-spore forming, facultative anaerobic, enterobacteria found to colonise 
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recently clamped grass silage (Heron et al., 1993) where they outcompete existing 
populations of P. agglomerans (Östling and Lindgren, 1995). 
Variations in the microbial community composition due to chemical and heat treatment 
or inoculation with L. buchneri were well highlighted compared with the control and L. 
plantarum fermentations, which were found to be similar to the fermentation without 
intervention.  It is also apparent that the addition of LAB to unsterilised material prior to 
incubation does not yield a final population consisting of the isolate alone.  Instead it is 
evident from the current results and in many other studies that final counts of both LAB 
and yeast may be more attributed to initial conditions in the silo such as temperature, 
oxygen levels, moisture content, availability of sugars, pH and presence of 
microorganisms and metabolites (McDonald, 1981, Jard et al., 2011, Dunière et al., 2013).  
Perhaps more importantly in terms of formation of stable silage is the succession of LAB 
from facultative homofermentative strains such as L. plantarum to obligate 
heterofermentors such as L. buchneri.  L. plantarum swiftly converts water soluble sugars 
to lactic acid and thus avoiding the proliferation of unwanted organisms such as 
Clostridiaceae, Enterobacteriaceae and yeast by dropping the pH, which also prevents the 
loss of excessive dry matter and protein-lysis in the silage (Driehuis, 2013, Virtanen, 1945).  
L. buchneri is considered a late stage ensiling LAB as it converts lactic acid to acetic acid, a 
more potent biological preservative which increases the aerobic stability of the silage by 
inhibiting yeast and mould when the silo is opened (Holzer et al., 2003).  L. buchneri is 
often found to be the dominant LAB in mature silage due to its resistance to low pH.  For 
these reasons L. buchneri is often inoculated with a homofermentative LAB such as L. 
plantarum or L. pentosus (Arriola et al., Filya, 2003). 
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The role of L. buchneri illustrates how metabolic diversity is as relevant as species 
diversity when concerning the final metabolite make-up of the silage and the feed 
integrity as a whole.  The metabolites produced by one pathway/species can sustain 
another, the kinetics of which being dependant on oxygen saturation, pH and 
temperature (Karlovsky, 2008).  The same inter-organismal processes may be responsible 
for DON degradation within the silo; hence the importance of testing mixtures as well as 
single isolates as it is possible that one bacteria species performs one aspect of the 
degradation with another completing the task.  Conversely, the metabolites produced by 
LAB may hinder the bacterial groups where DON interaction is a possibility.  The current 
results suggest silage colonised by productive LAB or preserved with Crimpstore® do not 
exhibit a decrease in DON, whereas the heat treated samples which contained very 
different assemblages and metabolic diversities, reduced DON considerably.  On one level 
this provides an opportunity for more selective screening of potential DON-degraders, but 
on another is gives an insight into possible the fate of this resilient molecule in the crop 
debris/soil environment and reveals one reason why it does not readily accumulate in the 
soil (Völkl et al., 2004). 
The advantage of using low volume silos is that multiple sampling to gain an idea of 
homogeneous species distribution is not required, as the entire mesocosm is extracted 
for DNA and any spatial differences in species richness within the silo make up the 
common pool of DNA.  Larger scale silos require robust sampling techniques to monitor 
silage communities, as different regions of the silo with varying aerobic properties and 
crop quality may favour specific groups (Li and Nishino, 2011).  One aspect the current 
study does not address is how the community changes over time, the pace of change and 
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which period yields the most significant reduction in DON.  Temporal fluctuations in 
community succession and DON concentration could  be recorded in future incubations 
by undertaking a time-course experiment with an extended incubation time, in line with 
other silage/DON studies such as Boudra et al. (2008) who monitored maize silage right 
up to 9 months.  The CG bacterial community characterisation in the current investigation 
aids in the development of future DON-interacting inoculants.  Firstly, it is apparent that 
silos with a reduced recovery of DON were colonised by a particular group of potentially 
DON-degrading taxa, some which will be isolated as live cultures using selective media 
and tested in the following chapter.  Secondly, it is clear that should an isolate possess 
DON-degradation properties, before it can be used as a silage additive it would need to 
have a proven ability for survival, niche development and DON-degradation efficacy 
within the fiercely competitive silo environment, as illustrated with the current results.   
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5 Testing potential DON degrading isolates in vitro and in F. 
culmorum contaminated crimped barley and wheat fermented 
in mini silos 
5.1 Aims and objectives 
Develop an in vitro DON degradation assay to screen candidate isolates over short and 
intermediate exposure durations with actively dividing and static bacterial cells.  The 
same strains will be inoculated into ensiled crimped barley and wheat previously infected 
with DON-producing F. culmorum as a more realistic remediation scenario. 
5.2 Introduction 
CG silage fermented with LAB forms a large proportion of European cattle total mixed 
ration (TMR) (Finch et al., 2014) , although a good quality silage is often dependant on the 
quality of the starting material, i.e. moisture and carbohydrate content, MT 
contamination and inoculum presence.  Whilst a lot of work has focussed on the 
development of CG silage LAB and yeast additives (Adesogan et al., 2003, Olstorpe et al., 
2010b) for producing consistent fermentations, little attention has been shown to testing 
cereal epiphytic isolates for both the ability to degrade MTs as bio-control agents (BCAs) 
and partake in adequate CG fermentation.  The use of BCAs is a rapidly expanding 
research area due to the need for effective fungal pathogen treatments which yield food 
and feed free from MT contaminants, antibiotics and fungicidal residues (Pal and 
Gardener, 2006).  BCAs offer a self-perpetuating solution to selected agricultural issues, 
including the inhibition of MT-producing moulds in the field (Dalie et al., 2010) and 
degrading MTs in stored produce (Hawar et al., 2013).  
Recent developments in terms of DON amelioration by beneficial bacteria/BCAs have 
been made by Ito and co-workers (2012, 2013) who applied a DON-metabolising bacteria 
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isolated from FHB-infected wheat heads to harvested contaminated material and 
recorded a 66% reduction in DON when incubated with the addition of the surfactant, 
Tween-80.  The bacteria tested in this final chapter were also isolated from a matrix 
where DON could reside naturally, and where DON recovery was significantly reduced, 
and therefore could potentially be the biological agents responsible for this decrease.  
Whether DON could be subjected to interaction with any of these bacteria, either by 
binding or metabolism, is investigated in the current chapter, firstly in vitro then in a mini 
silo scenario.  The bacteria should be able to survive and proliferate in such a matrix as 
they were isolated from a similar environment originally.  This property could be valuable 
considering the application, whereas other bacteria with DON remediation ability would 
be physiologically unsuitable for fermented feed, i.e. aquatic sources (Völkl et al., 2004).  
The strains chosen for further in vitro and in silo testing include prominent bacterial 
groups determined in DON degrading assemblages deemed to be non-pathogenic, have 
an ability to culture readily under laboratory conditions and be relevant for the 
application of fermented grain feeds.  Pantoea agglomerans (Enterobacteriaceae) is 
currently applied as a bio-control agent (BCA) in orchards and fruit packing houses (Nunes 
et al., 2002), and whilst some strains are potentially opportunistic plant and human 
pathogens (Cruz et al., 2007), the reports where P. agglomerans has made a large 
proportion of microbial mass in Scandinavian grain destined for ensiling (Olstorpe, 2008) 
and the BCA potential, makes it an interesting candidate bacteria to test. 
Another bacteria present worth pursuing is Weissella cibaria, a heterofermentative LAB 
also found to be effective as a BCA in pomology, through the inhibition of Penicillium 
expansum, the mould responsible for patulin production (Trias et al., 2010).  In a multi-
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farm screening of candidate ensiling bacteria, W. cibaria made up 34.4% of maize silage 
bacteria (average of 5 locations in Beijing) and the silage at 9 months was considered high 
quality (Pang et al., 2011).  W. cibaria is also present in Scandinavian CG silage, although 
in common with Leuconostoc mesenteroides, it is usually only abundant in the early 
stages of CG fermentation (Olstorpe et al., 2010a).  Leu. mesenteroides is a LAB with GRAS 
status used in the production of sauerkraut among other food-grade fermentations.  Leu. 
mesenteroides also gave ensiling results comparable, but slightly inferior to L. buchneri in 
terms of DM losses when inoculated into crimped wheat (Adesogan et al., 2003).  L. 
buchneri is included in this study to act as a positive control for high quality fermentation, 
and a negative control for DON interaction.  Hafnia alvei (Enterobacteriaceae) has 
previously been trialled as a BCA against Fusarium wilt following isolation from the 
rhizosphere of the affected plants (Sneh et al., 1985), although the work focused on 
conidia germination rather than degradation of virulence compounds.  When comparing 
between the other Enterobacteriaceae sp. found in grass silage during a typical 
fermentation, H. alvei was found to proliferate swiftly within the first 4 d and outcompete 
the initially dominant P. agglomerans, although once the LAB fermentation is initiated all 
gram negatives decline rapidly (Östling and Lindgren, 1995). 
The current chapter involves firstly characterising these isolates in terms of growth and in 
vitro DON-metabolism.  This is designed to screen for and define potential detoxification 
mechanisms.  Secondly, a more robust proof of concept experiment is carried out by 
testing isolates in a more realistic CG scenario in mini-silos as used previously.  The grain 
used for ensiling will be from in house grown wheat and barley infected with a toxigenic F. 
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culmorum strain under greenhouse conditions to produce a naturally DON-contaminated 
matrix for detoxification.   
5.3 Materials and methods  
5.3.1 Verification of DON conjugation in grain used for crimping and 
generation of contaminated grain for degradation studies 
Barley (cv. Westminster, spring) was planted in sterilised loam in 1 L pots under unheated 
greenhouse conditions at 200 plants/m2.  At anthesis the barley heads were inoculated 
with F. culmorum (see below) for 21 d with moisture levels kept high using polythene 
bags (200 µl of 104 macro-conidia / ml / barley head).  The F. culmorum (309344) strain 
was obtained from CABI (UK) and genotyped for the trichothecenes and DON producing 
genes using the Tox5-1/Tox5-2 (Niessen and Vogel, 1998) and Tri13F/Tri13DONR 
(Chandler et al., 2003) primer pairs for identifying trichothecene and DON producers 
respectively using the PCR program of Kammoun et al. (2010) and visualisation using a 45 
min electrophoresis of product in 1% agarose stained with SYBR safe(R).  F. culmorum was 
maintained on SNA-FP (Spezieller Nährstoffarmer Agar-filter paper) or on autoclaved 
barley for spore production in 500 ml Erienmeyer flasks (50 g of 12% moisture barley 
autoclaved twice at 110 °C / 25 min, adjusted to 40% w/w moisture with sterile H2O, 
inoculated with 104 conidia / ml 7% NaCl / 0.05% Tween-80 harvested from agar and 
incubated for 7 d at 25 °C).  Five days before harvest a group of 20 non-inoculated barley 
plants were spiked with purified DON (50 µl of 50 µg/ml per barley head) and grown in a 
20 °C incubator (16 h light).  At 21 d, the grain was harvested and the grains processed by 
hand.  The barley was at the “soft cheese stage” and the wheat was “hard cheese stage”, 
slightly more mature.  IAC-HPLC analysis was undertaken as stated previously to confirm 
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the presence of DON and D3G.  Wheat (cv. Claire, winter) was also inoculated and treated 
in the same way as a comparison (in 30 cm x 30 cm x 25 cm pots) and to generate 
contaminated material for future ensiling experiments. 
Table 5. 1. Primers employed for determining the presence of Fusarium sp. virulence genes. 
Primer specificity Forward Reverse 
Tox5-1/Tox5-2 for 
determination of 
trichothecene 
producing ability 
Tox5-1  
(5’-GCTGCTCATCACTTTGCTCAG-3’) 
Tox5-2 
 (5’- CTGATCTGGTCACGCTCATC-3’) 
Tri13F/Tri13DONR 
for determination 
of DON production 
ability 
Tri13F 
 (5’- CATCATGAGACTTGTKCRAGTTTGGG-3’) 
(K: A or G, R: G or T) 
Tri13DONR (5’- 
GCTAGATCGATTGTTGCATTGAG-3’) 
5.3.2 Growth curves of each strain with different inoculation amounts 
Strains identified as potential DON-degraders in the last Chapter for further screening 
were inoculated from frozen stocks (TSB, 10% DMSO at -80 °C) into 50 ml TSB (tryptone 
soya broth) in pre-weighed 50 ml centrifuge tubes and incubated at 30 °C in 2.5 L 
anaerobic jars (Oxoid, UK) with 1 Anaerogen™ sachet for 24 h.  Cultures were centrifuged 
(10000g, 10 min) and washed with PBS and the cell pellet and tube weighed in order to 
calculate the number of bacteria present (determined with pellet weight/plating out 
calibration curve experiments where serial dilution of confluent broth were centrifuged 
and weighed, then resuspended in 1 ml PBS and enumerated on TSA) which was then 
diluted to 106 CFU/ml by addition of minimal salts medium (MSM).  Six candidate strains 
were inoculated at different cell densities into 500 µl TSB as 10 µl volumes in a 48-well 
plate (Nunc, UK), flushed with nitrogen and sealed with parafilm™.  The plate was 
incubated at 25 °C in an Infinity-200 plate reader (Tecan, Austria) for 144 h with readings 
every 30 min.  
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5.3.3 Preliminary In vitro DON degradation experiment 
A 24 h culture was obtained by sub-culturing each strain into 50 ml of TSB broth (100 µl of 
confluent inoculum) and incubating anaerobically at 25 °C in a pre-weighed 50 ml 
centrifuge tube.  The tube was centrifuged (10000g/10 min) to yield a pellet that could be 
weighed and the cell count determined indirectly.  The pellet was re suspended in MSM 
to 1010 cells/ml and divided into 500 µl microcentrifuge tubes (with holes in the lid to 
permit anaerobic condition to occur, made with 21G hypodermic needle) which were 
centrifuged (10000g/5 min) and the supernatant removed and replaced with either MSM 
or TSB containing 50 µg/ml DON.  The tubes were then incubated at 25 °C under 
anaerobic conditions for 24 h and 2 wk without shaking.  Tubes were then centrifuged 
(10000g, 10 min) and the supernatant filter sterilised (0.22 µm) into a micro HPLC vial 
(250 µl, Fisher) and capped.  The P. agglomerans treatment was not easily filtered, so 
required the additional use of a 30,000 MW molecular sieve (Sigma) centrifuged at 3000g 
for 20 min.  50 µl of sample was injected into the HPLC with the DON gradient program as 
used previously.  The DON integrated peak area was compared between the bacterial 
incubations and the sterile control treatments.  Any metabolites were compared to 
injected standards that included; 3AcDON, 15AcDON, DOM-1.   
5.3.4 In vitro DON degradation time course experiment 
Strains exhibiting reduction in DON recovery in the 24 h and 2 wk exposures tested again 
in a more comprehensive time course experiment.  To prevent the loss of anaerobic 
conditions during sampling all experiments were undertaken in 5 ml syringes (Gillette, UK) 
with a sheathed 21 gauge hypodermic needle (blunt) to allow sterile sampling by 
expelling contents into microcentrifuge tubes for processing as stated above.  A latex gas 
balloon filled with nitrogen attached to a piece of silicone tubing and blocked one end 
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served as a way of adding 0.5 ml of nitrogen gas to enable mixing of syringe contents 
prior to sampling.  A syringe needle pushed diagonally into the tube and withdrawn 
would allow the tubing to reseal.  Bacteria were suspended in MSM with 50 µg/ml DON at 
a density of 1010 cells/ml.   All syringes were placed in anaerobic jars between samplings 
and inverted twice daily (Figure 5.1).  Five hundred µl of each sample expelled was serially 
diluted in DPBS and 20 µl of each dilution from 10-3 to 10-10 was dropped onto quartered 
TSB plates and incubated anaerobically at 25 °C before enumeration. 
 
 
 
 
Figure 5. 1.  Diagram of sampling processes for anaerobic time-course experiment.  The provision of 
nitrogen gas in the syringe allowed mixing of contents prior to sampling without compromising anaerobic 
conditions.  All syringes were placed in an anaerobic jar between sampling and inverted daily. 
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5.3.5 Testing of candidate bacteria for DON reduction in Fusarium 
enriched crimped wheat and barley grain.  
In order to verify the DON-reducing capacity of Weissella cibaria, Hafnia alvei and Pantoea 
agglomerans a final ensiling experiment was undertaken as in chapter 3 with some important 
modifications.  The grain employed was more realistically contaminated with DON (Figure 5.2) 
rather than spiked with a standard (the Barley was diluted with uncontaminated grain at  4̴0% 
moisture to provide enough material for the experiment, which was additionally spiked with DON 
(to make   4̴ µg/g moist grain).  The grain was then gamma irradiated (Co60 25 Gy, Becton-
Dickinson, Plymouth) in individually weighed aliquots in polythene bags (  5̴0 g Barley,  ̴35 g 
Wheat) and then frozen until ensiling (-20 °C).  The grain was thawed, “gently crimped” with a 
sterile mortar and pestle in a laminar flow hood (Bassaire, UK) and compressed into either 50 ml 
polystyrene pots (Barley) or within the sealed bags (Wheat). 
 
Figure 5. 2. Culture, inoculation and crimping of wheat and barley for determination of DON conjugation 
capacity and to generate naturally contaminated material for future degradation experiments.  A; Spores 
harvested from F. culmorum (309344) cultured on sterile barley, B; glass house grown wheat inoculated 
with F. culmorum spores with polythene bags increasing humidity therefore aiding colonisation, C; 
crimped barley prior to ensiling. 
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The cultures were added at 105 CFU/g moist CG as before with the grain 35-40% moisture.  
In addition, a mixed treatment consisting of W. cibaria, H. alvei, P. agglomerans and L. 
buchneri, each inoculated at 2.5 x 104 CFU/g CG.  This essentially served as a check to see 
if DON levels are more easily reduced in a more realistic assemblage/metabolic diversity 
scenario.  L. buchneri was also tested in isolation as a positive control for silage integrity 
purposes.  Once sealed, the triplicate mini-silos were contained in sealed plastic boxes 
and incubated at 25 °C for either 2 or 4 weeks before extraction in DPBS as described 
previously, enumeration on TSA plates (anaerobic, 25 °C, 48 h), lactic/acetic acid analysis 
and IAC-HPLC for determination of DON and D3G recovery differences from the time-zero 
control.   
5.4 Results 
5.4.1 Evaluation of F. culmorum 309344 virulence using genotyping 
Following PCR of extracted F. culmorum DNA it was apparent that although both 309344 
and the non-toxigenic strain were positive for trichothecene synthesis pathway genes 
(650bp), only 309344 was positive for the gene responsible for DON production (282bp).  
Genotyping can only indicate the potential for these strains to produce these MTs, and 
Reverse transcriptase-PCR / actual enzyme activity / measured MT production / effect of 
plant growth would be required for confirmation of virulence (Figure 5.3). 
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Figure 5. 3. Confirmation of F. culmorum toxin producing ability using PCR of key trichothecene (Tox5, 
650bp) and DON (Tri13, 282bp) genes.  Lane A; Tox5 toxigenic strain 309344, B; Tox5 309344 repeat pcr, C; 
Tox5 Non-toxigenic strain, D; Tox5 Non-toxigenic strain repeat PCR, E; Tri13 309344, F; Tri13 Non-
toxigenic strain. 
5.4.2 Verification of DON and D3G production in barley used for crimping 
The ability of the barley cultivar (Westminster) used in the current study to conjugate 
DON to D3G was illustrated following exposure of growing immature barley kernels to the 
purified DON (21.9% was D3G form), yet the F. culmorum 309344 infected grain yielded 
extremely low levels of D3G (<0.1% D3G) even though levels of DON were similar to that 
spiked with the purified toxin (Table 5.2, Figure 5.4).  Since the exposure periods differ, it 
is difficult to state whether the DON found with F. culmorum was because of 
accumulation over the 21 d or over a much shorter period.  It is possible that a 
mechanism exists where the mould is able to de-conjugate D3G as an additional virulence 
pathway whilst colonising the grain.  Further work is required to assess this possibility.  It 
is equally possible that a weak plant is unable to yield sufficient conjugation products to 
be measured and a healthy plant exposed over a much shorter time has a greater ability 
for detoxification of DON.  Since the F. culmorum infected grain was used for the final 
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experiment, it is important to note that no D3G was detected for either commodity 
before or after ensiling.  This suggests the levels of D3G were not sufficient to contribute 
to the overall level of DON. 
 
 
 
Figure 5. 4.  Comparison of DON and D3G levels in barley and wheat infected with F. culmorum (anthesis-
14 d) or DON-treated barley heads (anthesis- 7 d) 
Table 5. 2. Summary of DON and D3G yields in planta following two methods of contamination.  Results 
from pooled samples.  
Barley treatment 
Incubation 
time 
Concentration of 
DON 
Concentration of D3G (% of 
total yield) 
Inoculated with toxigenic   
F. culmorum 
21 d 637.1 µg/kg 0.5 µg/kg (<0.1%) 
Spiked with DON standard 7 d 533.4 µg/kg 149.5 µg/kg (21.9%) 
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5.4.3 Growth curves of each strain in broth with different inoculation rates 
 
   
Figure 5. 5. Comparison of representative growth curves and inoculation concentration of Pantoea 
agglomerans, Hafnia alvei, Weissella cibaria, Bacillus subtilis, Bacillus licheniformis and Leuconostoc 
mesenteroides (10µl inoculant as log10 dilution series from 2.0 x 10
8
 to 2.0 x 10
2 
CFU / ml) incubated in 
tryptone soya broth for 6 d at 25 °C and the absorbance read every 30 min at 600 nm.   
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 In general the growth curves aid in confirming the relatedness of the six strains in terms 
of proliferation characteristics (figures 5.5).  It is evident that the Bacillus sp. have 
homologous curves and similar maximum rates of absorbance change, suggesting that 
growth characteristics between similar species are not sensitive enough for identification 
purposes alone.  W. cibaria, Leu. mesenteroides and H. alvei were found to not differ 
significantly in regards to the maximum growth rate and formed the same cluster, yet P. 
agglomerans was significantly different to these and the Bacillus sp. (ANOVA, F = 794.2, 
<0.001, n = 42).  Logarithmic growth generally reaches a plateau phase within 24 h, 
therefore sub-culturing for experiments was undertaken every 24 h.  Whilst there was a 
lag phase linked to the inoculant density, it did not affect the maximum population 
growth rate. 
5.4.4 In vitro degradation experiments 
 
Spike and recovery experiments in DPBS, MSM and TSB were undertaken to verify that 
TSB could be used for a degradation experiment providing a sufficiently high DON 
concentration was used (50 µg/ml, visual evaluation of chromatogram), although 
DPBS/MSM gave less chromatogram interference (Figure 5.6).  The HPLC method 
employed for determination of DON in media was very effective for separation of 
possible DON-metabolites such as deepoxyDON (DOM-1), 3-AcetylDON, 15-AcetylDON 
and potential homologous structures (Figure 5.8).   
  
Figure 5. 6. The identification and measurement of different concentrations of DON in tryptone soya broth, minimal salts medium and phosphate buffered saline 
(Dulbecco’s A). 
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Figure 5. 7.  HPLC analysis of a range of DON metabolites that include DON, DOM-1, 3AcDON, and 
15AcDON showing adequate separation required for degradation studies.  Some unknown peaks were 
also present, perhaps degradation products of the standards.   
The percentage recovery of DON following static 24 h incubation of 1010 bacteria 
indicated that all treatments showed a reduction in recovery over the control, although 
after 2 wk; P. agglomerans, B. licheniformis and Leu. mesenteroides treatments returned 
to control DON recovery levels (Figure 5.8, 5.9).  B. subtilis produced a variable response 
with H. alvei and W. cibaria reducing DON recovery significantly (11.3 and 6.2% recovery, 
p<0.05, ANOVA). The same incubation in TSB with presumably proliferating bacteria 
min 
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yielded chromatograms with too many additional peaks to decipher DON content and 
was abandoned. 
 
Figure 5. 8. Percentage recovery following a 24 h (grey) and 2 week (white) incubation at 25 °C of 6 
bacterial species at a density of 10
10
 cells/ml to 50 µg/ml DON in MSM (triplicate tubes). 
 
 
Figure 5.9.  Stacked and time-offset chromatograms of 50 µg/ml DON in MSM incubated for 2 wk 
different bacterial inoculations or left sterile.  Each chromatogram is representative of triplicate 
incubations.  
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Figure 5.10. Time course DON degradation experiment in MSM.  Bacteria were suspended in minimal 
medium containing 50 µg/ml DON at a density of 10
10
cells/ml and incubated for up to 384 h at 25 °C 
under anaerobic conditions in 5 ml syringes.  The mean of triplicate syringes is shown with the standard 
error. 
A more comprehensive time-course degradation experiment was devised which would 
enable sampling to take place without compromising anaerobic conditions.  Even though 
cell counts were extremely high initially there was no reduction in DON recovery over the 
entire incubation (Figure 5.10).  P. agglomerans produced the only deviation from the 
control with a 30% increase in DON concentration at time-zero following re-suspension of 
the cell pellet in the MSM.  This was the same sample group which required alternative 
centrifugal molecular sieve filtration methods in preparation for HPLC due to the 
gelatinous hydrophobic extracellular polysaccharide exudate produced by P. agglomerans 
for the purpose of early colonisation of surfaces prior to biofilm synthesis (Sutherland, 
2001, Amellal et al., 1999).  This prevented passage through a 0.22 µm syringe filter, even 
with extensive pre-centrifuging of supernatant.          
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Figure 5.11. Enumeration of bacteria exposed to DON in MSM over time.  Initial densities of   ̴10
10
 cells/ml 
were achieved by weighing a confluent pellet of cells and using a calibration curve.  Mean of duplicate 
counts is shown with the standard error. 
The viable counts for H. alvei and W. cibaria correspond well to the 1010 viable cells 
required initially (Figure 5.11).  The P. agglomerans count was 100 fold more 
concentrated at time zero, but declined rapidly over 48 h followed by modest reduction in 
viable counts.  At 384 h cellular viability for all species was still considerable at between 
1.9 x 107 and 1.5 x 109 CFU/ml with H. alvei CFU counts reducing only slightly throughout 
the experiment.  This result does suggest binding or biodegradation of DON does not 
occur within this timeframe without the substrates available for growth.  This conflicts 
with the earlier experiment where DON removal was evident, suggesting a potential 
physiological difference between the bacteria in the two in vitro experiments due to 
biological changes or subtle differences in growth conditions. 
5.4.5 Crimped grain DON-recovery experiments 
The naturally DON contaminated crimped wheat and barley experiments were designed 
to determine whether DON degrading bacteria could be used to degrade DON in a semi-
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realistic mini-silo scenario.  The CFU counts at 2 and 4 wk were similar in barley with pH 
dropping for LAB treatments but less so for the Enterobacteriaceae which corresponded 
to the acid content measured by HPLC (Figure 5.12).  The difference in counts between 2-
4 wk showed a trend of constant counts for the LAB and a 10-fold drop in 
Enterobacteriaceae counts.  The wheat showed a more significant drop in counts 
between 2 and 4 wk although the pH and acid content were largely unchanged. 
The controls for the wheat and some of the barley silos at 4 wk, which were supposedly 
sterile, did happen to have a background count of bacteria or yeast, although from the 
counts, pH and acids content they do not appear to be LAB.  The frozen sample had low 
levels of lactic and acetic acid implying a degree of fermentation had occurred during the 
defrosting of the aliquoted grain during the gamma irradiation process.  
Following verification of sample dilution requirements by observing when the peak area 
changed in proportion to the dilution amount, it was decided that a 5-fold dilution in 
addition to the 3 fold dilution in PBS during extraction (15x dilution in total) was 
necessary for wheat samples to prevent quenching of the column.   A 3 fold (9x dilution in 
total) dilution was necessary for barley.  This would allow any deviation from the initial 
DON level to be measured.  The barley was actually within the capacity of the column, 
although close to the limit (Figure 5.13).  The effect of the irradiation process on the 
depolymerisation of cellulose and the breaking of the D3G-glucosidic bond in the grain 
was not evaluated, but may explain why D3G was not found in any of the current 
experiments.  Also, the biocidal effects irradiation was not 100% effective with some of 
the control silos yielding colonies, although LA/AA levels were low.   
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Figure 5. 13  Determination of sample dilution requirements before IAC purification.  The mean peak area 
(mAU) of duplicate frozen wheat/barley samples is shown with the standard error.  The arrows highlight 
where the recovery of DON was limited by the capacity of the column and is therefore an under-
representation. 
 
 
Figure 5. 14. Recovery of DON in naturally contaminated wheat and partially naturally contaminated 
barley following a 4 wk incubation with different inoculated silage bacteria under anaerobic conditions at 
25 °C.  The mean of triplicate silos is shown with the standard error.  ‘A’ denotes a significant (P<0.05) 
increase in DON recovery over the other treatments whilst ‘B’ indicates a significant reduction in recovery.    
Of the silos chosen for DON determination at 4 weeks, only the W. cibaria treatment in 
wheat showing a significant reduction in DON recovery compared with the other 
treatments including the frozen time-zero control (ANOVA, F = 3.92, p =0.036, Anderson-
Darling statistic= 0.63, P =0.081, n = 15) with a mean reduction in DON recovery of 
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32.8±14.4% averaged from 7.0%, 34.7% and 56.7% for each mini-silo (Figure 5.14).  This 
highlights the variability found with this complex matrix when dealing with inoculation of 
bacteria.  H. alvei actually increased DON recovery over the frozen control which could be 
explained by this strain having the enzymatic capability to release locked up DON within 
the kernel without DON degradation.  The barley data was suggestive of DON reductions 
in the W. cibaria, control fermentation and mixed treatments but not to a significant level.    
Furthermore, the barley did not produce the level of homo- and heterolactic metabolism 
seen with wheat even though the counts were comparable at 2 wk and with less of a 
decline at 4 wk. 
5.5  Discussion 
This aim of this chapter and the thesis as a whole was to isolate a biological agent able to 
degrade DON in a fermented feed scenario.  Whilst more work is needed to characterise 
the nature of the interaction between W. cibaria and DON, the promising results 
measured in vitro and in the more realistic crimped wheat, reinforce the notion that a 
biological agent isolated from the agronomic environment and able to thrive in a 
fermentative context would be the most ideal solution to post-harvest DON-
contaminated grain, or even as an epiphytic preventative pre-harvest treatment.  Such an 
approach has already been successfully utilised by Ito et al. (2012) with a novel DON 
degrading Actinomycete isolated from wheat heads. 
In the preliminary in vitro study, unmixed W. cibaria and H. alvei were shown to reduce 
DON, whereas in the time course sampling experiment the cells produced no such 
response, suggesting the interaction may not be as simple as metabolism of DON as a 
carbon source for survival.  It is possible that co-metabolism, membrane binding or 
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internal compartmentalisation may be responsible for the decrease.  Further experiments 
would optimise conditions for maximal effect whilst determining the exact nature of the 
interaction in broth and then within a contaminated grain matrix.  It has been found by 
some workers that DON degradation can be transitory with the bacteria losing the ability 
under laboratory subculture (Shima et al., 1997).  Furthermore, some bacteria need to be 
primed before they perform certain metabolic tasks, a phenomenon discussed by Guan 
and co-workers (2008) who used a period of low nutrient culture with coumarin as a sole 
carbon source to induce AFB1 degradation pathways.  Indeed, screening for DON 
degrading bacteria usually employs a sole carbon source approach (Völkl et al., 2004), 
(although for sufficient growth a large amount of DON needs to be purified from 
contaminated media, which does have serious safety implications (Ito et al., 2012)). 
The DON co-metabolism theory may be supported by gene cloning work undertaken by 
Ito and co-workers (2013), who found DON to be effectively biotransformed to the lesser 
toxic 16-hydroxyDON by a redox pathway suite of enzymes and cofactors that include 
P450, ferredoxin reductase, ferredoxin and NADH.  Unfortunately, in the current in vitro 
experiment there was little indication of the DON-biotransformation product DOM-1 or 
homologous structures which would give definitive evidence of interaction as was the 
case with patulin (Hawar et al., 2013).  
The possibility that binding is responsible for the decrease would require the pellet to be 
lysed and extracted as was achieved by El-Nezami and co-authors (El-Nezami et al., 2002, 
El-Nezami et al., 2004) with DON and ZEA using LAB.  It must be questioned however as to 
why the second in vitro experiment did not yield any indication of binding whatsoever, 
even though the cell count was the same initially and the only differences being the 
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overall volume, the syringe delivery of sample and the daily mixing.  It is possible that this 
mixing element be crucial to the reduction in DON-recovery in the supernatant.  When 
the bacteria are allowed to settle for an extended period of time they can form a biofilm 
with polysaccharide and protein which either encapsulates DON as a form of binding, or 
provides a biological interface where DON can accumulate for enzymatic catabolism.  The 
mixed time series samples did not have this stable period of bio-concentration and more 
work is required to characterise the exact mechanism, especially if binding is involved 
since DON will likely be re-released in vivo during digestion.  Whether a binding 
mechanism is responsible for the reduction in DON recovery in the first experiment 
(chapter 3), or the reduction in the current wheat mini-silos requires further optimisation 
of the extraction process.   
The difficulties faced with obtaining sufficiently DON-contaminated grain at the correct 
stage for crimping that could be used for larger scale experiments is logistically complex 
(hence the requirement for in-house grown and FHB-infected grain in the current study). 
Testing for DON contamination is usually carried out post-harvest on dried grains 
channelled into the food and feed industries.  By this point the grain is beyond the stage 
where crimping can occur (although LF formulations can be employed for some 
production animals such as swine (Brooks, 2008)).  In addition, the grain destined for use 
as home grown animal feed for cattle and sheep and harvested at 35-45% moisture is 
unlikely to be tested MTs, although a visual check and vigilant use of the HGCA risk 
assessment may indicate Fusarium MTs are present (HGCA, 2014).  Furthermore, the 
ensiled CG is not likely to be tested prior to feeding, yet anecdotal and measured 
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evidence of feed refusal, reduction in animal productivity and behavioural changes may 
be cause for concern and worthy of further investigation.     
Grain found to be DON-contaminated in the field would be an opportune subject for 
biotransformation experiments in a CG ensiling context where W. cibaria could be trialled 
under realistic conditions and with genuinely contaminated material.  Whilst the focus 
would remain on DON, other co-occurring Fusarium MTs including D3G, 3AcDON, 
15AcDON, Diacetylscirpenol, Nivalenol, T2/HT-2 toxin and ZEA could be monitored using 
LC-MS/MS with a “dilute and shoot” strategy employed to measure the suite of 
metabolites and conjugates which might be associated with irreversible bacterial 
metabolism (Sulyok et al., 2007).  Furthermore, a range of TMR components including; 
whole crop maize (the most important cattle fodder globally (Dunière et al., 2013)) and 
bioethanol co-product; which is hypothesised to contain a larger relative proportion of 
MTs to the starting grain, especially since inferior grain may be channelled to this process 
by default (European-Commission, 2006b, Gallagher, 2008).  Further work would be 
required to determine the distribution of the MTs within in the grain and whether only a 
proportion of present MTs are able to be degraded due to surface distribution or 
compartmentalisation, for it is well known that different flour milling fractions in wheat 
contain different concentrations of DON (Cheli et al., 2013b).  An observation in the 
current study was the absence of D3G in the silo samples, yet D3G was present in small 
quantities in the freshly harvested grain for both wheat and barley.  It is possible that the 
process of ensiling releases more DON from the grain than during normal extraction and 
the IAC is proportionally overwhelmed by DON.  This would also explain why extra 
dilution was necessary for IAC purification.  Furthermore, the microbial assemblage and 
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plant enzymes present between harvesting and gamma irradiation, and the irradiation 
itself could break the glucosidic bond prior to the experimental incubation.  L. plantarum 
has previously been found to effectively cleave D3G under laboratory conditions by 
Berthiller and co-workers (2011), which could help explain this anomaly. 
Whilst in terms of proof of concept the inoculation of non-LAB into silage may yield a 
reduction in DON, however this could be at the expense of fodder quality.  The Nobel 
prize winning pioneering research on pH and fodder preservation by Virtanen (1945) 
states that providing the material has a pH of between 3-4 and is free of oxygen there will 
be minimal losses of protein, vitamins and carbohydrate and the fodder will retain the 
same nutritive qualities as the starting material.  This was the basis of his AIV fodder 
preservation process which involved the addition of mineral acids to harvested material 
to swiftly reduce the pH (this is the early version of Crimpstore® 2000s formulated by 
Kemira AIV, Finland), yielding year-round, high quality feed provision.  LAB fermentation 
can reach the same pH threshold, but at the cost of a lag phase where a larger proportion 
of DM is lost.  The addition of a LAB inoculant able to degrade DON whilst reducing the pH 
and not producing any anti-nutritional factors would be a preferable approach, hence 
why W. cibaria would be a better candidate for further testing compared to H. alvei, 
which only reduced the pH to 5.4-5.6 from 6 over 4 wk and W. cibaria which produced a 
pH of 4.3, only slightly below that of L. buchneri (4.1).  The levels of acetic acid are also 
similar in wheat, which is fruitful as acetic acid production in silage is usually a decent 
indicator of aerobic stability on silo opening, hence why L. buchneri-based silage additives 
work so effectively, in crimped grains and whole-crop maize (Driehuis et al., 1999). 
148 
 
Whilst there is a paucity of research on crimped barley and wheat silage in the literature, 
there is more information on whole-crop maize silage due to its greater utilisation in 
global agriculture (Driehuis et al., 2008).  Maize is actually a promising subject for 
remediation of DON and Fusarium MTs.  Maize silage has similar moisture properties, 
WSC content and microflora to CG whilst being more susceptible to Fusarium sp. infection 
yielding a DON content that can exceed that found in wheat.  Research focussing on MT 
level modulation in maize has yielded some interesting results, with levels of DON 
reduced by almost 100% in low DM silage over 3 months (Boudra and Morgavi, 2008).  
The role of DM content, silage compression, use of additives and temperature in the 
biochemical reduction of MTs were discussed as important factors.  The same authors 
attempted to isolate epiphytic LAB capable of DON transformation, but without success, 
although many of the LAB could reversibly bind Fusarium MTs (Niderkorn et al., 2007, 
Niderkorn et al., 2006).   
This chapter is a culmination of the preceding chapters with an ongoing theme being the 
irreversible removal of DON using bacteria in fermented feed.  Some research groups 
have attempted to isolate such a bacteria previously (Karlovsky, 2011), although the ideal 
candidate remains elusive despite some promising results presented here.  Should a 
bacteria species be found which is confirmed to offer robust biodegradation of DON 
under fermented feed conditions; it will be considered a valuable addition to the armoury 
in the relentless battle against the debilitating effects caused by DON in feed. 
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6 Interactive toxicological effects of deoxynivalenol and 
retrorsine, two potentially co-occurring cereal contaminants, 
on an established human liver cell line (HepG2),   
6.1 Aims and objectives 
Explore the possibility that DON may contribute to the toxicity of co-occurring food and 
feed-borne genotoxins such as retrorsine; a pyrrolizidine alkaloid produced by Senecio sp.  
Furthermore, evaluate the mechanism by which an interactive relationship could develop 
using a suite of different assays to characterise the interaction in terms of organelle and 
biomolecule susceptibility. 
6.2 Introduction 
Fusarium culmorum has a particularly wide distribution in the temperate cereal growing 
regions of the world (McMullen et al., 1997).  However, it must be considered that DON is 
just one of many natural toxins that co-contaminate the same harvest commodity, with 
many other trichothecene mycotoxins derived from Fusarium likely to be present, such as: 
D3G, 3AcDON, 15AcDON and zearalenone, which contribute to the overall burden of 
toxicity mixtures for the consumer and health, welfare and productivity issues for 
livestock (Speijers and Speijers, 2004).  The toxicity profile of these Fusarium toxins is 
broadly similar to that of DON and multi-residue testing strategies have been developed 
which could enable future prevention of dietary exposures to MT mixtures, although 
current safety legislation only considers each MT separately (Berthiller et al., 2007).  
Other natural toxins identified using such methods include those derived from Ergoflavus 
sp., Aspergillus sp. and the plants of the group Asteraecea (Ates et al., 2014). The toxins 
derived from these plants belong to the large pyrrolizidine alkaloid (PA) group and include 
retrorsine (RET) derived from ragwort (Senecio jacobea) and other Senecio sp. throughout 
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the globe where they are considered a serious food/feed contaminant and a cause of 
hepatic veno-occlusive disease (VOD) in humans with possible carcinogenic capacity 
(Prakash et al., 1999b).  RET has been trialled extensively and successfully in liver failure 
transplantation studies where endogenous non-hepatocyte cells are mitotically inhibited 
by the application of RET to prevent them outgrowing the implanted hepatocytes (Okita, 
2004).  The toxicity profiles of RET and DON, independently and in combination in a 
human liver cell line forms the basis of the current investigation.  
A large amount of recent toxicological research has focused on DON and associated 
trichothecene MTs exposed independently or as co-existing mixtures (Wan et al., 2013, 
Alassane-Kpembi et al., 2013, Ficheux et al., 2012, Ruiz et al., 2011a, Ruiz et al., 2011b), 
yet there is a paucity of data on co-occurrence and co-exposure of trichothecene MT and 
PAs leading to interactive toxicity.  The cytotoxicity of DON is well characterised; it 
inhibits cellular protein synthesis at the translation stage leading to a ribotoxic stress 
response and apoptosis in the liver (Pestka, 2007) and impaired intestinal membrane 
function (Akbari et al., 2014) including a compromised ability for cellular uptake of 
important nutrients in intestinal cells (Maresca et al., 2002).  Conversely, the induction of 
DNA damage (genotoxicity) by DON is less understood with conflicting data in the 
literature.  For example; in vitro HepG2 exposures of 3.75-60 µM DON were found to 
produce DNA damage associated with an increased ROS production, as confirmed using 
co-incubation of antioxidants in the alkaline comet assay (Zhang et al., 2009). Bony et al. 
(2006) found realistic and very low dietary concentrations of DON (0.01-0.5 µM) to yield 
significant increases in DNA damage in Caco-2 intestinal epithelial cells over 72 h (also 
measured using the alkaline comet assay), especially those undergoing proliferation 
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rather than fully differentiated cells.  The same authors confirmed these doses were 
below the threshold level to induce apoptosis and cytotoxicity using nuclear staining and 
colorimetric assays.  DON was conversely found to be negative as an in vitro genotoxin in 
microbial mutagenesis, with and without S9 metabolic enhancement, by Takakura and co-
workers (2014).  The same authors only found an increase in micronucleus formation, i.e. 
chromosome breakage/loss, when the cytotoxicity reached 55% in human lymphoblastoid 
cells (TK6) and speculated that at such a dose the relevance of genotoxicity is 
questionable as micronuclei can be artefactually formed during karyolysis following 
apoptosis induction.  Likewise, HepaRG (human hepatoma) cells exposed to 5-35 µM DON 
produced an increase in apoptosis rather than genotoxicity.    
RET also exerts its damage primarily in the liver due to the presence of cytochrome P450 
enzymes produced by hepatocytes which metabolise RET to a reactive ester pyrrole 
intermediate, which crosslinks DNA and proteins causing genomic instability, 
megalocytosis and resultant VOD (Prakash et al., 1999b, Hincks et al., 1991).  Wang and 
co-authors (2005) concluded that there was adequate in vivo data in rodents to suggest 
that RET could be a human carcinogen.  Mutation spectra studies with the related PA 
riddelliine in transgenic rats, highlight the probable genotoxic carcinogenic mechanism of 
these PA as being gene transversion and tandem base substitution mutations caused by 
pyrrole adducts attaching preferentially to G-C base pairs (Mei et al., 2004).  Less subtle 
inter-, intrastrand DNA and protein-DNA crosslinks caused by bifunctional pyrrole adducts 
following metabolic activation of RET can be attributed to the megalocytosis/VOD 
phenomenon and cellular senescence observed by several groups (Hincks et al., 1991, Fu 
et al., 2002), in addition to mitotic and chromosomal aberrations as recorded in the 
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micronucleus assay.   Micronucleus formation, a proxy for clastogenecity and aneuploidy, 
was found to be increased significantly following a 24 h exposure to 5-50 µM RET in 
HepG2 cells without metabolic enhancement (Kevekordes et al., 2001).  
To warrant an investigation on interactive toxicology it is essential that the toxins of 
interest (or related structural homologues) should exhibit a degree of co-occurrence in 
the field or during storage which results in co-ingestion and cellular co-exposure.  Whilst 
the co-occurrence of FHB and Senecio sp. in the same harvest is not recorded as being a 
current issue in modern European agriculture, there are regions of the globe that rely on 
subsistence farming where weed/fungi control and grain sorting is insufficient to prevent 
human/animal toxicosis (Prakash et al., 1999b).  Furthermore, the components of 
compound feeds/silage/human food products can come from several harvested 
commodities from diverse agricultural regions that are affected by climate change and 
non-native plant incursions.  In South Africa there have been reports of DON issues in 
maize (Marasas et al., 1979), geographically close to areas rampant with the several 
toxigenic Senecio sp. (Dimande et al., 2007).    The temporal overlap between cellular 
exposures for each toxin needs to be such that the resulting measured toxicity can be 
directly linked to an interactive relationship.  The simplest approach with this 
consideration, and the one employed in the current study, is to incubate both toxins 
simultaneously in a multifactorial in vitro dosing strategy.  This constitutes an acute 
cellular exposure which enables putative identification of toxicity mechanisms over short 
temporal scales, however the toxicokinetic behaviour of each toxin within the cell and the 
time needed for excretion, up-regulation of enzymatic detoxification genes and induction 
of damage mean the results presented are a snapshot in time, and not the definitive 
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response characterisation.  To compensate for this, a bank of several different cellular 
genotoxicity and cytotoxicity assays as was employed in a stepwise fashion using a 
metabolically competent human liver cell line (HepG2), with the results interrogated as a 
whole in an attempt to establish the nature of the toxicological interaction.  A logarithmic 
dose range of at least 4 different concentrations of each toxin is tested to give an 
impression of dose dependant responses whilst reducing the number of samples to a 
manageable level.  To help validate the assays for specific toxicological modes of action 
and help explain the responses recorded with RET/DON, two positive controls found 
widely in the literature are incorporated into each experiment; mitomycin-c (MMC) as a 
potent bifunctional, alkylating-crosslinking agent to verify concordance of the assays and 
aphidicolin (APH) to act as a polymerase A inhibitor to both increase sensitivity of 
genotoxicity assays by accumulating unrepaired damage (Speit et al., 2004) and to act as 
a comparative co-carcinogen control.   
Food and feed-borne toxicosis is a real threat to humans and production animals 
worldwide.  Preventative measures can only be adopted following the setting out of 
toxicological risk.  DON and RET have been shown to be toxic in a range of toxicological 
models when tested separately and EU food/feed safety legislation supports this, 
although since MTs/toxins rarely exist in isolation in food/feed this approach may be 
questionable (Grenier and Oswald, 2011).  This study evaluates whether this is a valid 
approach with binary exposures of DON and RET and will attempt to establish if an 
interactive toxicity model is more suitable.  
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6.3  Material and methods 
6.3.1 Cell culture and toxin treatment strategy 
HepG2 cells (Human Caucasian hepatocyte carcinoma, epithelial adherent) were 
purchased from the European Collection of Cell Cultures (ECCAC, 85011430, Lot number 
11C013, passage 101) and were cultured in MEM medium (Minimal Eagles medium, 10% 
foetal bovine serum (FBS), 1% non-essential amino acids, 4 mM L-glutamine, without 
phenol red, Gibco, Invitrogen UK) at 37 °C in a humidified 5% CO2 atmosphere.  Cells were 
grown in 25 cm2 flasks (Iwaki, Japan), sub-cultured every 6 d and re-fed every 3 d.  Sub-
culturing was achieved by rinsing the 90% confluent cells thrice with DPBS (Dulbecco’s A 
phosphate buffered saline), pouring off the excess and adding 1 ml of 0.25% trypsin for 10 
min until the cells were detached when 5 ml of  MEM medium was added and the cells 
re-suspended with gentle pipetting and counted on a haemocytometer (Neubauer™).  
The cell suspension was diluted to 1 x 105 cells/ml and 5 ml added to a new flask.  
Triplicate experiments were carried out on passage 2-10 and cultures were handled at 
ACDP Category 2 containment.   
All toxins were of ≥99% purity except RET (≥90%) and purchased from Sigma (Poole, UK).  
DON, APH and hydroxyurea (HU) were dissolved in molecular grade H2O (Fisher), RET and 
MMC in cell culture grade DMSO.  Log10 serial dilutions were undertaken in respective 
solvents to yield x1000 working stocks which were filter sterilised (0.22 µm) and solvents 
were used for controls.  In each experimental well 2 µl of medium was removed for each 
1000 µl medium and replaced with 1 µl of each toxin in a multifactorial combination 
strategy. 
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6.3.2 Comet assay 
The single cell gel electrophoresis or comet assay is a widely used in genotoxicology 
where endpoints include damage to the DNA induced by xenobiotics or reactive oxygen 
species leading to oxidation of bases and nucleotide instability.  The consequent 
enzymatic removal of the damaged entity or direct strand breakage leaves a gap that on 
separation of the sister strands at high pH, facilitates electrophoretic migration of 
shortened fragments of DNA visible as a cloud extending from the spherical nucleoid.  
Different pH conditions before and during electrophoresis yield changes in the DNA 
structure which allow customisation of the assay for elucidation of different damage.  The 
pH 10 comet yields double stranded DNA fragments caused by certain crosslinking agents 
such as mitomycin-c (MMC) which require excision of complementary nucleotides leaving 
a transitory double strand break, whereas the pH 13 comet assay is more sensitive for a 
lower severity of damage such as oxidised bases.  
In preparation of employing the technique for DON and RET treatments the assay was 
optimised and the measurable parameters validated at both pH 13 and pH 10 using MMC, 
a positive crosslinker yielding interstrand and intrastrand links, and hydrogen peroxide 
(H2O2),  a positive reactive oxygen species agent producing free radical damage to DNA.  
In addition, APH, a nucleotide excision repair inhibitor was used as a concurrent positive 
control and to facilitate the accumulation of measurable DNA damage.   
The comet assay was undertaken according to Tice and Vasquez (1999).  HepG2 cells were 
seeded at 105 cells/ml in 12 well plates (IWAKI, Japan) and the medium changed (1 ml) 24 
h later followed by addition of toxins as 1 µl volumes.  Cells were incubated for 48 h, 
thrice rinsed with DPBS and washed off the base of the well with repeated pipetting 
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(trypsin increases measurable DNA damage).  Cells were centrifuged at 1000g for 3 min 
and the pellet re-suspended in 500 µl 0.75% low melting point agar (Sigma) at 37 °C prior 
to 85 µl added to a pre-coated glass slide (covered with 1% normal melting point agar in 
DPBS and air-dried) to make one of two gels topped with a 22 mm x 22 mm glass 
coverslip and chilled at 4 °C for 15 min.  Both coverslips were removed and the slides 
were immersed in lysis buffer (2.5 M NaCl, 100 mM EDTA, 10 mM Trizma base, 1% Triton 
X-100, 10% DMSO, pH10 with 10 M NaOH) for 24 h in the dark at 4 °C.  Slides were then 
positioned lengthways in an electrophoresis chamber just submerged in either pH 10 or 
pH 13 (300 mM NaOH, 1 mM EDTA) running buffer for 40 min unwinding time plus 20 min 
running time at 25 V/300 mA/0.74 V/cm in the dark.  Slides were removed to 
neutralisation buffer (0.4 M Tris, pH 7.5) for 15 min and dehydrated with ice cold MeOH 
and stored at room temperature until scoring.  Gels were stained with 20 µl of ethidium 
bromide (2 µg/ml in water) and scored using a Leica-R epifluorescence microscope and 
x20 objective linked to a CCD camera with Komet 4 software (Kinetic Imaging, Liverpool, 
UK) with a 540 nm excitation/605 nm emission filter cube.  Slides were blind scored and 
50 cells randomly analysed for each of 2 gels per slide and the data pooled.  A general 
linear model (GLM, Minitab 16) following square root transformation (to achieve 
normality) was employed for multifactorial experiments. 
6.3.3 Cytokinesis-blocked micronucleus assay 
Whereas the comet assay shows chemically induced DNA damage that may or may not be 
repaired, the cytokinesis-blocked micronucleus (CBMN) assay gives the proportion of cells 
with induced damage that escapes repair prior to mitosis and hence can be responsible 
for permanent cellular mutagenesis leading to carcinogenesis. 
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Such genotoxicity is scored by the presence of micronuclei which are fragments of DNA 
that are lost during mitosis and not incorporated into daughter nuclei, the mechanisms of 
loss being either clastogenic when an induced double strand break is not repaired prior to 
mitosis leading to loss of chromosomal material or aneugenic, when a mitotic spindle 
malfunction or damaged kinetochore leads to the loss of a whole chromosome.  Both are 
catastrophic as far as cellular survival is concerned and apoptosis is the most desirable 
outcome.  In order for the assay to confirm such irreversible damage is occurring it is 
necessary for cells to be actively dividing following exposure to allow irreversible loss of 
genetic material.  This is achieved by allowing mitosis to complete, then inhibiting 
cytokinesis with cytochalasin-B leaving a binucleated cell.  If a micronucleus or 
nucleoplasmic bridge is present it is likely to have been induced by exposure to the 
chemical treatment during the previous cell cycle.  The ratio of mononucleated cells to 
binucleated, trinucleated and tetranucleated cells in addition to the number of apoptotic 
cells gives the nucleoplasmic division index (NDI), another toxicological parameter. 
The MN and NDI assays were carried out according to Vevers and Jha (2008) with minor 
changes as described below.  Cells were seeded in 12 well plates at 1 x 105cells/ml for 24 
h (1 ml medium/well), rinsed with DPBS and medium renewed (1000 µl) before addition 
of toxins.  Plates were briefly mixed by hand and incubated for 48 h.  Wells were then 
rinsed thrice with DPBS and medium added with 10 µM cytochalasin-B (in DMSO) 
inclusion for 24 h to inhibit actin formation and thus cytokinesis following mitosis.  Cells 
were then rinsed with DPBS, trypsinised (0.5%), re-suspended in 250 µl freezing medium 
(10% glycerol in 0.075% KCl) for 10 min and stored at -80 °C in an insulated box.  Scoring 
of cells was achieved by taking a single tube, thawing rapidly and removing 25 µl to a 
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glass slide followed by addition of 25 µl staining solution (10 µg/ml ethidium bromide in 
PBS with 0.05% Triton-X) and a 20 mm x 50 mm coverslip.  Cells were viewed as the 
comet assay with 1000X magnification and under oil immersion (Leica-R).  1000 
binucleated cells were scored from each treatment in addition to all mononucleated, 
trinucleated, tetranucleated and apoptotic cells observed in the process for the compiling 
of a nuclear division index (NDI).  Aberrations recorded include those mono-, bi-, tri- and 
tetranuclated cells exhibiting one, two or more micronuclei, nucleoplasmic bridges, 
nuclear budding, mitotic catastrophe or apoptotic bodies based on the scoring criteria of 
Fenech et al. (2003), but also adopting the MN cytome approach (Fenech, 2006).  The 
binucleated cell data is used for the main analysis as that represents the cells that have 
undertaken mitosis following toxin exposure.  An online Fisher exact test 
(http://www.graphpad.com-/quickcalcs/contingency1) was employed to determine 
significant (p<0.001) increases in micronucleus induction over the control for individual 
treatments and a GLM was used for multifactorial experiments. 
6.3.4 Cellular vitality/viability assays 
Cellular viability and vitality are highly important endpoints in regards to acute and 
chronic toxicological effects that include reduced integrated metabolic function and 
impaired ability to proliferate, both which contribute to the impaired capacity for efficient 
working of the tissue and thus the organism as a whole.  There is a balance between 
cellular stress and the ability of the cell to limit the effects with provision of repair 
mechanisms and use of alternative biochemical pathways.  When the severity of the 
damage is beyond rescue the cell instigates the process of apoptosis, or controlled cell 
death, where cellular components are put out of action and mitosis halted to prevent 
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oncogenesis.  A suite of several assays which encompass toxicological effects spanning 
mitochondrial function (MTT), cellular proliferation (NDI) and membrane integrity (trypan 
blue) were employed in the current study.  When dealing with genotoxicity data it is 
imperative that cellular viability assays are also carried out to determine whether 
clastogenic and aneugenic endpoints are linked to the process of apoptosis and whether 
genotoxicity is only evident when the dose causes cell death and is therefore less potent 
in regard to carcinogenesis.  The assays utilised in the current investigation for 
determination of different facets of cellular viability/vitality are listed in Table 6.1. 
Table 6. 1.  A brief description of the assays used in this investigation. 
Assay Measurable endpoints Procedure 
Comet 
DNA crosslinking/strand 
breaks/alkali labile sites 
Exposed single cells are embedded in agarose, 
treated with lysis solution, electrophoresed and 
the degree of DNA fragment migration is 
measured with image analysis software. 
Micronucleus 
Mitotic aberrations, 
nucleoplasmic aberrations, 
chromosome loss and 
chromosome fragment 
loss 
Adhered cells are treated for one cell cycle with 
the test compound, treated with cytochalasin-B 
to prevent cytokinesis for 1 cell cycle and the 
binucleated cells scored for presence of 
micronuclei and other mitotic aberrations as 
indicative of aneugenicity and clastogenecity. 
NDI Rate of cell proliferation 
The ratio of mononucleated cells to binuc-, tri- 
and tetranucleated cells following the 
cytochalasin-B treatment in the micronucleus 
assay is indicative of mitotic cycle effects. 
Lactate dehydrogenase 
(LDH) leakage 
LDH assayed in spent cell 
culture medium is a proxy 
for membrane leakage 
Following 48 h exposure to toxins the exposate is 
incubated with sodium pyruvate whilst the 
amount of NADH converted to NAD (coenzyme, 
redox reaction) is measured 
spectrophotometrically. 
MTT Mitochondrial vitality 
Toxin treated cells incubated with MTT solution 
for 2 h, solubilised with DMSO and amount of 
tetrazolium salt (purple) produced is correlated 
to mitochondrial activity. 
Carboxyfluoroscein-
diacetate metabolism/ 
propidium iodide uptake 
Mitochondrial metabolism 
and cellular membrane 
integrity 
Cells are incubated with carboxyfluoroscein 
diacetate/ethidium bromide for 5 min and when 
analysed with fluorescent microscopy/flow 
cytometry viable cells are green and red cells are 
membrane compromised. 
48 h cell density (mm
2
) Rate of cell proliferation 
Set up as MTT assay and after 48 h each well was 
visualised with an inverted microscope and cells 
counted in a set area. 
Trypan blue exclusion 
Loss of membrane 
integrity 
As above but with addition of a dye which only 
penetrates compromised outer membranes so 
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non-viable cells appear blue and viable cells 
clear. 
Total cellular protein Rate of cell proliferation 
Setup as above, and after 48 h the cells were 
rinsed thrice with PBS and the total cellular 
protein content of each well determined using a 
BCA kit. 
Shot-gun proteomics 
Regulation of protein 
group enrichment 
Extracted protein purified, digested with trypsin 
to peptides which are analysed with mass 
spectrometry to give protein group 
identifications. 
Crosslinking assay 
Determination of DNA-
DNA and DNA-protein 
crosslinks 
Extracted DNA purified, denatured at 95 °C and 
analysed using both spectrophotometry and gel 
electrophoresis to determine if crosslinking 
scaffolds are present to enable a swift return to 
double stranded DNA on cooling. 
 
6.3.4.1 MTT assay 
The MTT assay was carried out according to Cetin and Bullerman (2005).  HepG2 cells 
were seeded in 96 well plates (Iwaki, Japan) at 2 x 104 cells/ml (200 µl) and incubated for 
48 h (MEM without phenol red, 10% foetal bovine serum, 1% non-essential amino acids, 4 
mM L-glutamine (all Gibco, UK), 37 °C, 5% CO2).  Cells were rinsed with PBS (Dulbecco’s) 
and serially diluted treatments added for 48 h.  40 µl of MTT solution (5 mg/ml, 3-(4, 5-
dimethylthiazol-2-yl)-2, 5-diphenyl tetrazolium bromide, Sigma, UK) was then added for a 
further 2 h in the dark (37 °C). The exposate was completely removed and retained whilst 
150 µl of DMSO was added to the adhered monolayer and mixed thoroughly for the 
metabolised purple tetrazolium salt to solubilise.  The retained exposate was then added, 
the plate left to settle for 5 min, 200 µl transferred to a new 96 well plate and the 
absorbance at 560 nm recorded.  The absorbance for each treatment was normalised as a 
percentage of control drawn from triplicate wells in triplicate experiments.  An additional 
experiment with D3G, DON and patulin was undertaken for validation purposes. 
6.3.4.2 Lactate dehydrogenase leakage assay 
Determination of extracellular membrane leakage of lactate dehydrogenase (LDH) in 
treated cells was carried out using a protocol devised by Bergmeyer and Bernt (1974).  
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For each sample 50 µl of cell-free supernatant (CFS) was added to one well of a 96 well 
microtitre plate and 250 µl assay mix was added (180.9 µM NADH, 4.55 mM sodium 
pyruvate in 10 ml 50 mM potassium phosphate buffer pH 7.5).  The decrease in 
absorbance at 340 nm was monitored on a Spectromax plate reader every 11 s for 30 min 
and represents the redox conversion of the coenzyme NADH to NAD+.  The initial gradient 
of absorbance decrease was used for comparison between treatments and compared 
with a serial diluted LDH activity unit standard (  ̴140 U/mg, Sigma). 
6.3.4.3 Carboxyfluorescein diacetate metabolism assay 
This fluorescence based live/dead assay was undertaken according to Tice and Vasquez 
(1999).  Briefly, HepG2 cells were treated with toxins for 48 h, rinsed with PBS and 
trypsinised (0.05%) and re-suspended with MEM medium with FBS.  The cells (2 x 105) 
were centrifuged at 1000g for 2 min and the supernatant replaced with 10 µl of 
carboxyfluoroscein diacetate (CFDA): propidium iodide working solution (62 µg 5-6,-
carboxyfluorescein diacetate, 12 µg propidium iodide in 1 ml DPBS) for 5 min at 37 °C.  
The pellet was rinsed twice with DPBS, re-suspended in 1 ml DPBS in FACS tubes and 
analysed within 1 h using a flowcytometer (excitation 520 nm/emission 620 nm, FACS 
Aria, Becton Dickinson, San Jose, USA).  The acetate is cleaved by cytosolic esterases in 
viable cells leaving a fluorescent product.  10,000 events were characterised with green 
fluorescence an indication of cellular viability and red fluorescence an indication of 
compromised membranes and low viability.  The same population of cells was dropped 
on a microscope slide for manual scoring and saving images using a Nikon epifluorescence 
microscope using BR Elements image analysis (Nikon).  200 cells were scored to confirm 
flowcytometric gating and analysis. 
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6.3.4.4 Determination of apoptosis by annexin V-FITC staining 
Apoptosis was determined using a kit from eBioscience Inc. (UK) following the supplied 
protocol as follows.  Exposed cells were trypsinised (as described previously), pelleted and 
rinsed with DPBS, binding buffer, then re-suspended at 1 x 106 / ml prior to mixing 100 µl 
of this cell suspension with 2.5 µl of fluorescein isothiocyanate (FITC)-conjugated Annexin 
V for 15 min at room temperature.  Cells were washed in binding buffer, and re-
suspended in 300 µl binding buffer, counter stained with 7.5 µl of propidium iodide 
solution (as previously used) and analysed both with flowcytometry (FACS aria, set up as 
previously) and fluorescent microscopy (as described previously).  Fluorescent annexin V 
conjugates bind to phosphatidylserine which is presented on the surface of apoptotic 
cells but can however attach to phosphatidylserine on the cytoplasmic surface of cells 
with compromised membranes and therefore the membrane impermeable propidium 
iodide is also added to distinguish necrotic cells from apoptotic cells. 
6.3.4.5 Trypan blue and monolayer cell density 
Cells were treated as per the MTT assay, the cells rinsed with DPBS and the supernatant 
removed and replaced with 20 µl 0.4% trypan blue stain (Gibco) for 20 min prior to 
counting at x40 on an inverted microscope (Nikon, UK) with an eyepiece graticle counting 
grid in the eyepiece.  Both viable (clear) and non-viable membrane compromised (blue) 
cells were recorded.  A 2 mm stage micrometer was used to calculate the area highlighted 
by the eyepiece graticule (1 mm2).  Microscopic examination of cell numbers is 
exceptionally important when considering colorimetric cytotoxicity data. 
6.3.4.6 Protein assay 
Determination of cellular protein was undertaken using the bicinchoninic acid method 
(BCA kit, Pierce) using the manufacturer’s instructions.  Briefly, cells exposed in 96 well 
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plates were carefully rinsed thrice with DPBS (to prevent interference from FBS) prior to 
addition of 250 µl of the freshly mixed working reagent (1:50 mix of A and B) to each well 
and incubation at 37 °C for 45 min in the dark.  The plate was gently vortexed (IKA plate 
shaker, 60 rpm) and 200 µl was removed to a fresh well in a new plate for absorbance 
reading at 562 nm and determination of protein content using a calibration plot made 
using 10 µl of BSA standards (0.1-2 mg/ml).   
6.3.5 Proteomics 
6.3.5.1 Preparation of cellular protein for proteome analysis 
Proteomic preparation and analysis was undertaken according to Edwin Lasonder (pers. 
comm.).  All reagents were LC-MS grade (Sigma) and manipulations were undertaken 
using strict aseptic technique to prevent human and ovine keratin contamination prior to 
trypsinisation.  The cells from 3 replicate experimental well treatments were pooled (500 
µl of each) and centrifuged at 8000 g in Lo-bind tubes (Eppendorf) for 3 min prior to 
addition of 500 µl RIPA (Radio-immunoprecipitation assay) buffer (50 mM Tris, 150 mM 
NaCl, 0.1% SDS, 0.5% sodium deoxycholate, 1% TritonX-100, cocktail protease inhibitor 
(Sigma), pH 8).  The protein content was determined using a BCA kit (Pierce) and diluted 
to 1 mg/ml prior to 30 µl being mixed with 10 µl Biorad gel loading buffer (4X) and 
pipetted into a Biorad Criterion XT 10% Bis-tris gel and electrophoresed at 100 V for 2 h in 
SDS running buffer (25 mM Tris, 192 mM glycine, 0.1% SDS, pH 8.3).  This enabled 
cleaning the proteins of residual contaminants.  The gel was then fixed (1% AA, 40% 
MeOH) for 1 h on an orbital shaker (45 rpm, SSL1, Stuart Scientific, UK).  The gel was then 
stained with Coomassie blue (0.1%, Sigma) and then de-stained (10% AA, 25% MeOH ) for 
several days on a laboratory orbital shaker.  When only the separated bands were visible 
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the gel was cut with a sterile scalpel into 4 equal fractions for each lane and placed in a 
Lo-bind tube and centrifuged briefly.  The excised gel piece was de-stained by repeating 
the following cycle: addition of 100 µl  50 mM ammonium bicarbonate (ABC, Sigma, LC-
MS grade) for 5 min then discarding all liquid, addition of 100 µl 50% ACN and discard, 
followed by 100 µl of 100% ACN and discard.  To achieve protein reduction the slice was 
incubated at 50 °C with 100 µl of 10 mM dithiothreitol in H2O.  The gel slice was then 
dehydrated in 100% ACN (5 min) prior to addition of 50 mM 2-chloroacetimide (in ABC, in 
the dark) to alkylate the proteins.  To equilibrate the slices, 100 µl of 100% ACN was 
added, incubated for 5 min, then the same with ABC and this cycle repeated twice more.  
The gel slices were then immersed in enough digestion buffer (12.5 ng/µl trypsin (Thermo 
high fidelity) in ABC) over the course of 30 min to allow complete absorption by the gel 
slices plus enough to cover them for incubation at 37 °C for 16 h to digest the proteins 
down to peptide precursors.  The tubes were then sonicated for 20 s (Fisher, UK), 
centrifuged briefly and 50 µl of 2% trifluoroacetic acid in H2O (TFAA, Sigma) added prior 
to a 15 min incubation at 1400 rpm (Thermomixer Comfort, Eppendorf)  and 
centrifugation to collect supernatant to a fresh tube.  This was repeated with buffer B (80% 
ACN, 0.5% acetic acid (AA), 1% TFAA) and both supernatants pooled and concentrated 
down in a vacuum centrifuge (Centrivap micro IR, LabConCo, USA) at 45 °C, 1000g with 
lids off until all ACN had evaporated (by drawing a line after first amount of supernatant 
added) and 5 µl of 100% TFAA added to acidify the samples.   Peptides were cleaned up 
by passing the sample through C18 stage tips.  The stage tips were constructed as follows:  
A sheet of C18 membrane was wetted with MeOH and 2 mm discs were cut out using a 
cut off 200 µl tip.  A Hamilton syringe was used to push 2 discs (1 at a time) into a new 
200 µl tip.  This stage tip was then inserted into the lid of a new lo-bind centrifuge tube.  
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Stage tip activation was accomplished as follows: 50 µl of MeOH was added and 
centrifuged at 1000g for 2 min (same settings for all following steps), 50 µl of buffer B was 
then added and centrifuged followed by 2 cycles of 25 µl buffer A (0.5% AA, 1%TFA in 
H2O).  Sample was then added to the stage tip followed by 50 µl buffer A to remove 
unbound peptides.  The sample was then eluted with 2 cycles of 25 µl buffer B into a fresh 
tube, vacuum centrifuged to a total volume of 8 µl, 25 µl of buffer A added to each tube 
and the contents transferred to 300 µl glass vials (Chromacol, UK). 
6.3.5.2 Nano-HPLC 
A Dionex Ultimate 3000 U-HPLC (Thermo Scientific, Hemel Hempstead, UK) was employed 
for the separation of the peptides prior to mass spectrometry.   5 µl of digest was injected 
using the µl pick-up facility onto a trap column (Pepmap 75 µm x 2 cm, Thermo) for 5 min 
(loading pump, buffer A, 1 µl/min) to remove contaminants.  The valve position was then 
changed to include a Pepmap 100 analytical column (C18, 3 µm, 75 µm x 25 cm, Thermo) 
for the main peptide separation using the following gradient settings at 0.3 µl/min: 0 min 
4% buffer B (80% ACN + 0.5% AA), 9.8 min 4% buffer B, 10 min 5% buffer B, 129 min 32% 
buffer B, 130 min 90% buffer B, 140 min 90% buffer B, 141 min 4% buffer B and 155 min 4% 
buffer B.  The autosampler was kept at 5 °C and the column compartment at 32 °C.  Two 
blank injections were run between 4 fractions of the same sample (4 vials). 
6.3.5.3 Mass spectrometry 
An LTQ Velos Pro (Thermo Scientific ,Hemel Hempstead, UK) equipped with an Orbitrap 
fourier transformed mass spectrometer (FTMS) was externally calibrated and the U-HPLC 
separate peptide sample nebulised by Nanospray ionisation (NSI, spray voltage 2.5 KV, 
capillary temperature 275 °C).  The first scan event was achieved in the FTMS using the 
following settings:  mass range of 350-1500 Da, resolution of 60000, full scan type, 
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positive polarity, CID isowidth of 1.0, normalised collision energy of 35, Act Q of 0.250, 
Act time of 10 ms.  The second scan event (MS2) was undertaken in the ion trap with a 
normal mass range and scan rate. 
6.3.5.4 Analysis of mass spectrometry data with MaxQuant 5.1 and DAVID database 
searching 
MaxQuant 5.1 (Max Planck Institute, Germany) was employed to determine total number 
of protein groups and the prevalence of each protein using label-free quantification (using 
ion intensities).  An experimental design grouped the four fractions analysed in U-HPLC 
together for each treatment and the 16 mass spectrometry data files (4 x 4) using the 
following settings: modifications = oxidation and deamidation, max number of 
modifications per peptide (2), first search (20 ppm), second search (6 ppm), max charge 
(5), MS/MS tolerance of FTMS (20 ppm, 10 peaks per 100 Da), Fixed modification 
(Carmidomethyl (c)) with contaminants included.  The FASTA files used for searching were 
human.first.search.fasta,  IPI.Human.V3.68.FASTA and were downloaded from NCBI (USA) 
with search identification and quantification settings as follows: peptide FDR (0.01), side 
FDR (0.01), max peptide PEP (0.001), min (0), min peptide length (6). 
Output data was uploaded as IPI format to DAVID, a proteomic enrichment tool 
(http://david.abcc.ncifcrf.gov/home.jsp), and grouped by biological functions including: 
protein biosynthesis, translational elongation, apoptosis, membrane function, response 
to toxin and cell cycle regulation.  The top 100 proteins in terms of integrated intensity 
peak value in the control for each category was taken for comparison between 
treatments and displayed as cumulative intensity in order of descending prevalence.  In 
addition, any protein with enrichment 4-fold deviation (25 / 400% of control expression) 
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from the control was identified and grouped into the previous functional groups if 
possible.  An additional group of proteins of special relevance is also given. 
 
Figure 6.1. Simplified schematic diagram of sample preparation and analysis required for shot-gun 
proteomics.  A, toxin treated HepG2 cells extracted for total protein and diluted to normalise between 
treatments; B, extracted proteins separated with SDS-PAGE, stained and gel slices dissected; C, gel-bound 
proteins incubated with trypsin to produce peptides that are extracted from the gel; D, peptides cleaned 
using C18 membrane stage tips; E, peptides separated by U-HPLC; F, separated peptides ionised, 
fragmented and analysed by Orbitrap™; G, mass spectra data of top 10 peptides for each scan event 
saved; H, data interrogation yielding protein group identification and label free quantification between 
groups with MaxQuant 5.1; I, protein group enrichment and gene functional annotation clustering 
analysis using DAVID™ bioinfomation database software.  Velos Pro diagram and chromatograms 
courtesy of Thermo Scientific™.  
A 
B 
C 
D 
E F 
G 
H 
I 
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6.3.6 Crosslinking assay 
To determine the degree of crosslinking occurring following combinational exposure an 
absorbance based and gel based assay was devised based on earlier work by Tang et al. 
(2008b). Briefly, triplicate experimental treatments (in 25 cm2 flasks) were pooled and 
DNA was extracted with a Promega™ mouse tail DNA extraction kit using the 
manufacturer’s instructions.  DNA purity and concentration was measured using a 
Nanodrop and the concentration normalised to 100 µg/ml by dilution with TE buffer.  25 
µl of diluted sample was added to a microcentrifuge tube and subjected to denaturing at 
95 °C for 10 min on a heating block (Techne, UK) and then put on ice, then  2 µl was 
removed and absorbance measured at 280 nm on a nanodrop spectrophotometer (time 
zero) and two further readings taken at 20 min intervals.  An increase in absorbance 
indicative of strand separation and a rapid annealing suggestive of crosslinking scaffolds 
speeding up alignment. 
A similar approach was employed for a gel-based analysis of crosslinking utilising the 
ability of denatured DNA to anneal more swiftly when crosslinking scaffolds are in place 
and are hence less likely to migrate as single stranded DNA fragments.  Following 
denaturing the 25 µl of DNA put on ice and 8 µl was mixed with 2 µl loading buffer (X5, 
Bioline, UK) before pipetting into a well in a 1% agarose gel in TE buffer, staining with 0.01% 
SYBR safe (Invitrogen, UK) and running it at 100 V for 2 h at 4 °C under red lighting.  
Positive controls for denaturing consisted of DNA ladders (Easyladder I (2Kb-100bp) and II 
(5Kb-500bp), Bioline, UK) treating in the same way as the samples with 10 µl applied.  The 
gel was then visualised on a GelDoc system (Applied Biosystems). 
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6.3.7 Statistical analysis 
Statistical analysis was undertaken using Minitab 16 Statistical Software (Minitab Inc.).  
Unless stated separately, a general linear model (GLM) was undertaken for each assay 
with the interaction term made up of different concentrations of DON and RET.  A post-
hoc Tukey’s comparison was used for defining significant differences between groups 
where necessary (an asterisk represents significant departure from the control, or shared 
letters represent those treatments do not deviate significantly, all at P<0.05).   
6.4  Results 
6.4.1 Comet assay 
6.4.1.1 Validation results 
When attempting to obtain reliable comet data with crosslinking and free radical agents it 
is imperative to develop a robust assay protocol that is dependent on cell type and type 
of damage anticipated.  An unwinding time of 40 min and electrophoresis time of 20 min 
resulted in a consistent and measurable response in the controls that enabled both an 
increase (strand breaks) and reduction (cross-linked strands) in DNA migration to be 
recorded (dependant on the mode of genotoxicity).  The pH of the electrophoresis buffer 
was a substantial factor regarding the presentation of measureable damage (Figure 6.2, 
6.3). There are a wide range of measurement parameters in the comet assay which can 
be used to assess DNA modifications that include tail length, percentage of DNA in the tail 
and Olive tail moment (length and intensity).  All three of these are compared with 
positive controls for free radical damage (H2O2) and crosslinking adducts (MMC) in order 
to find the parameter which gave the best dose response and concordance (Table 6.2). 
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In general pH 13 and tail length gave the greatest r-square values for both H2O2 and MMC 
treatments, in addition to the data fitting a normal distribution allowing parametric 
statistics to be undertaken.  H2O2 increased tail length dose dependently at both pH10 
and 13. For MMC induced crosslinking the pH 10 comet yielded opposite responses to 
that of pH13 in terms of correlation plots.  This suggests major DNA fragmentation such 
as incidence of double stand breaks decreases with dose, yet there is an increase in pH 
labile single strand breaks at pH 13 as damage surpasses a threshold.  All future comets 
were undertaken at pH 13 with tail length the most appropriate parameter to use for 
statistics.  All comet data was square root transformed to achieve normality. 
Table 6. 2. Comet validation data with comparison of different comet measurement parameters following 
exposure to MMC or H2O2 with comet assay conditions of pH 10 or pH 13.  The suitability of each 
parameter is derived by comparing the degree of correlation between treatment dose and comet 
parameter value, the suitability of the data for ANOVA  employing an Anderson-Darling test of normality 
and the robustness of ANOVA (R2 value, F-statistic and significance) leading to confidence in deriving 
significant difference between doses. 
Treatment 
 pH 10 Comet parameters pH 13 Comet parameters 
Statistics 
% Tail 
DNA 
Olive tail 
moment 
Tail length % Tail DNA 
Olive tail 
moment 
Tail length 
MMC 
Correlation 
0.361, 
<0.001 
0.462, 
<0.001 
-0.514, 
<0.001 
-0.115, 
<0.001 
-0.198, 
<0.001 
0.409, 
<0.001 
Normality 
0.998, 
0.068 
0.990, 
<0.01 
0.984, 
<0.01 
0.993, 
<0.01 
0.963, 
<0.01 
0.987, 
<0.01 
ANOVA 
16.48%, 
F=52.34, 
<0.001 
26.49%, 
F=95.64, 
<0.001 
27.67%, 
F=101.49, 
<0.001 
14.77%, 
F=45.99, 
<0.001 
22.15%, 
F=75.50, 
<0.001 
30.10%, 
F=114.28, 
<0.001 
H2O2 
Correlation 
0.063, 
0.077 
0.028, 
0.433 
0.505, 
<0.001 
0.513, 
<0.001 
0.614, 
<0.001 
0.379, 
<0.001 
Normality 
0.999, 
<0.1 
0.998, 
<0.1 
0.988, 
<0.01 
0.991, 
<0.01 
0.978, 
<0.01 
0.987, 
<0.01 
ANOVA 
13.6%, 
F=41.76, 
<0.001 
14.87%, 
F= 46.33, 
<0.001 
33.37%, 
F=132.86, 
<0.001 
46.40%, 
F=229.69, 
<0.001 
55.99%, 
F=337.62, 
<0.001 
43.54%, 
F=204.62, 
<0.001 
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Figure 6.2. Comparison of parameters for the validation of the comet assay using DNA damage caused by exposing HepG2 cells to a range of H2O2 concentrations for 
10 min followed by electrophoresis at pH10 or pH13 in the comet assay.  The mean, standard error and pooled individual data points of triplicate experiments is 
shown.  Treatments sharing the same letter are not significantly different (<0.001). 
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Figure 6. 3. Comparison of parameters for the validation of the comet assay using DNA damage caused by exposing HepG2 cells to a range of MMC concentrations 
for 40 min followed by electrophoresis at pH10 or pH13 in the comet assay.  The mean, standard error and pooled individual data points of triplicate experiments is 
shown.  Treatments sharing the same letter are not significantly different (<0.001). 
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6.4.1.2 Multifactorial comet experiment 
The multifactorial comet assay involved exposing HepG2 cells for 48 h to binary exposures of 0, 1, 
10 and 100 µM RET combined with 0, 0.1, 1 and 10 µM DON or 1.5 µM APH (Figure 6.4).  The 
mean tail length is shown with the individual cell values for each treatment to give an idea of 
clusters indicative of apoptosis, chromatin condensation or stalling of the cell cycle.  Figure 6.5 is 
provided to more clearly illustrate the differences between treatments. 
 
Figure 6. 4. Comet tail length as representative of DNA damage and crosslinking caused by DON and RET 
with APH (µM) as positive control for DNA repair inhibition.  The mean is shown with the standard error 
in addition to individual data points pooled from 3 experiments. 
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Figure 6. 5. Comet tail length as representative of DNA damage and crosslinking caused by DON and RET 
(µM).  Data points sharing the same letter to not differ significantly (P<0.05).  The mean is shown with 
the standard error from 3 experiments.  Enlarged version of 6.4. 
The comet assay data gives the impression that the interaction is more complex than a 
linear dose dependant relationship, although RET in isolation does yield a clear bi-phasic 
dome-like relationship.  This RET-induced restriction in migration is presumably due to 
DNA-DNA and DNA-protein crosslinking of DNA, and is particularly evident as nucleoids 
with virtually non-existent migration of DNA at the highest dose (100 µM).  DON in 
isolation does not cause any difference in DNA migration in the lowest doses and even 
reduces migration at the highest dose (10 µM), the opposite to the hypothesis of the 
higher dose yielding more apoptosis and hence, more diffuse and longer comet tails.  The 
lack of cell division and translation of RNA may mean the DNA is compact as replication 
and protein synthesis is halted (presumably the histones are not being synthesised either).  
When we consider the interaction of RET with DON it becomes highly complex.   Low 
concentration of DON both decreases the migration of DNA at low doses of RET 
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suggesting either lesions are not occurring or overwhelmed DNA-repair is not excising 
nucleotides to leave a gap.  A high dose of DON (10 µM) with 100 µM RET gives a 
suggestion of crosslinking inhibition.  Addition of APH yielded a similar response to DON 
in that both increases and decreases in migration were reduced.  The plotting of 
individual cell migration length in addition to the mean allows better interrogation of the 
dose response in terms of effects on the cell cycle chromatin condensation dynamics and 
karyorrhexis/karyolysis during apoptosis.  When comparing the mean with the actual 
spread of the data it is apparent that the mean can be quite misrepresentative of the 
outlying groups of cells falling into the apoptotic and cross-linked categories, a 
phenomenon perhaps more important with crosslinking mechanisms.  
An increase in MMC concentration yielded a significant increase in tail length compared 
with the control and 0.1 µM MMC (as found in the validation experiments).  This response 
was increased with 10 µM DON co-exposure suggesting a mechanism exists that results in 
non-repair of damage and possible disruption of DNA metabolism (Figure 6.6).  This 
interaction is different to RET/DON where DON reduces migration.  APH 1.5 µM increased 
the response found with 10 µM MMC in isolation which suggests inhibition of polymerase 
does result in single strand gaps following NER of cross-linked nucleotides.  It also 
supports the theory that APH can be used to increase comet assay sensitivity.  A 48 h 
H2O2 exposure produced a linear response of oxidation damage which was reduced 
compared with a 10 min exposure and it is apparent from the wide distribution of tail 
lengths that apoptosis has been initiated in the highest concentration. 
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Figure 6. 6. Comet tail length as representative of DNA damage 
and crosslinking following a 48 h exposure of HepG2 cells to 
varying µM concentrations of MMC and DON (top left), MMC and 
APH (lower left) and H2O2 for 48 h in MEM medium (above).  The 
mean is shown with the standard error in addition to 300 
individual comet lengths (µm) pooled from 3 experiments. 
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6.4.2 Cytokinesis blocked micronucleus assay 
6.4.2.1 Preliminary 48 h Micronucleus assay with RET and MMC 
 
Figure 6. 7. The mean incidence of micronuclei/1000 binucleated cells is shown following 48 h exposure 
to RET and MMC.  The nucleoplasmic cytotoxicity index and standard error of triplicate experiments is 
shown with asterisks denoting a significant difference to the control (P<0.05). 
There was a significant correlation between RET dose and irreversible loss of genetic 
material (either whole or fragments of chromosomes) when tested with concentrations 
reported in the literature.  The MMC dose of 0.1 µM gave an adequate positive control 
result.  The NDI (nuclear division index) values indicate DMSO had a slight effect on 
cellular integrity and turnover, with this increasing with each concentration of RET.  The 
dose of MMC used as a control has a NDI index comparable with the control indicating 
genotoxicity induced without excessive cytotoxicity illustrating the potential for MMC to 
act as a potent carcinogen and be a suitable positive control for such effects.   
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6.4.2.2 Preliminary 48 h Micronucleus assay with DON, APH, hydroxyurea and MMC 
 
Figure 6. 8. The mean incidence of micronuclei / 1000 binucleated cells is shown following 48 h exposure 
to APH, hydroxyurea (HU), DON and mitomycin-c (MMC).  The standard error of triplicate experiments in 
shown along with the nucleoplasmic cytotoxicity index.  Significant micronucleus incidence above the 
control is shown with an asterisk and below control frequency (#). 
 
6.4.2.3 Multifactorial micronucleus assay 
Table 6.3. Mean incidence of specific aberrations scored in the micronucleus assay following 48 h 
treatments of DON, RET, MMC and APH. The mean counts/1000 BNC of 3 experiments is shown with the 
SE. 
DMSO 
DON 
0 
µM 
±SE 
DON 
0.1 
µM 
±SE 
DON 
1 
µM 
±SE 
DON 
10 
µM 
±SE 
DON 
100 
µM 
±SE 
APH 
0.5 
µM 
±SE 
BNC with 1 x MN 33 9 35 13 27 9 22 4 55 5 55 23 
BNC with 2 x MN 0 0 3 3 10 10 17 7 10 10 15 7 
BNC with 2+ x MN 5 5 0 0 13 9 10 6 15 15 24 9 
BNC with bleb 12 6 19 1 3 3 3 3 15 15 13 10 
BNC with bridge bleb 5 3 6 3 5 5 5 5 10 10 16 9 
BNC with nucleoplasmic bridge 39 18 82 11 74 33 51 26 145 45 60 22 
RET 1 µM 
DON 
0 
µM 
±SE 
DON 
0.1 
µM 
±SE 
DON 
1 
µM 
±SE 
DON 
10 
µM 
±SE 
DON 
100 
µM 
±SE 
APH 
0.5 
µM 
±SE 
BNC with 1 x MN 33 9 23 3 57 21 53 34 40 30 58 4 
BNC with 2 x MN 19 12 7 3 10 10 27 12 15 5 12 7 
BNC with 2+ x MN 6 3 0 0 18 4 7 7 10 0 18 11 
BNC with bleb 14 5 3 3 14 8 3 3 20 20 8 2 
BNC with bridge bleb 14 2 3 3 15 9 17 12 30 0 15 5 
BNC with nucleoplasmic bridge 55 12 110 42 78 18 107 41 145 45 50 15 
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RET 10 µM 
DON 
0 
µM 
±SE 
DON 
0.1 
µM 
±SE 
DON 
1 
µM 
±SE 
DON 
10 
µM 
±SE 
DON 
100 
µM 
±SE 
APH 
0.5 
µM 
±SE 
BNC with 1 x MN 51 19 26 5 65 17 44 6 56 8 57 5 
BNC with 2 x MN 18 6 9 6 17 1 10 6 20 4 37 14 
BNC with 2+ x MN 13 7 3 3 5 5 0 0 12 4 19 7 
BNC with bleb 13 13 15 9 8 8 3 3 0 0 5 5 
BNC with bridge bleb 15 9 15 7 15 4 3 3 8 8 9 5 
BNC with nucleoplasmic bridge 81 32 42 14 69 11 51 24 216 32 59 17 
RET 100 µM 
DON 
0 
µM 
±SE 
DON 
0.1 
µM 
±SE 
DON 
1 
µM 
±SE 
DON 
10 
µM 
±SE 
DON 
100 
µM 
±SE 
APH 
0.5 
µM 
±SE 
BNC with 1 x MN 32 8 30 6 27 9 57 19 42 18 69 20 
BNC with 2 x MN 7 7 2 2 7 3 23 23 0 0 11 7 
BNC with 2+ x MN 3 3 10 10 18 7 3 3 4 4 19 10 
BNC with bleb 3 3 2 2 12 7 10 10 4 4 15 9 
BNC with bridge bleb 21 6 2 2 12 7 23 23 24 16 22 4 
BNC with nucleoplasmic bridge 57 12 32 13 58 14 67 9 120 40 50 6 
MMC 0.1 µM 
DON 
0 
µM 
±SE 
DON 
0.1 
µM 
±SE 
DON 
1 
µM 
±SE 
DON 
10 
µM 
±SE 
DON 
100 
µM 
±SE 
APH 
0.5 
µM 
±SE 
BNC with 1 x MN 53 20 83 38 57 9 47 9 
TOXIC 
77 26 
BNC with 2 x MN 43 3 10 10 13 7 7 3 20 12 
BNC with 2+ x MN 20 6 17 12 13 7 10 6 30 17 
BNC with bleb 7 3 7 7 13 3 7 3 0 0 
BNC with bridge bleb 3 3 7 7 3 3 27 15 7 7 
BNC with nucleoplasmic bridge 37 9 93 24 100 35 87 3 73 35 
Linear dose responses for APH (aphidicolin), HU (hydroxyurea) and DON were found in a 
further validation micronucleus experiment.  The nuclear division cytotoxicity index 
decreases with dose indicating increased cell division with increasing doses of all 
treatments apart from APH.  When the sum of all aberrations scored is compared (MN, 
bridges, blebs, bridge-blebs) between the doses of RET in isolation, the dose response 
shows a dome shape in common with the comet assay results.  An increase in RET 
concentration yields a stepwise increase in number of MN and nucleoplasmic bridges 
from 1 to 10 µM with the top dose of 100 µM producing a reduction in the amount of 
recordable aberrations.  When considering the combinational response these non-
significant trends lead to a diminished dome-like response.  GLM analysis (R-Sq = 44.2%) 
suggests DON yields the main effect (F = 4.08, P = 0.008), with concentration of RET (F = 
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1.37, P = 0.266) and interactive components (F = 0.757, P = 0.68) not contributing 
significantly (Figure 6.9).   
With an increase in DON concentration to 100 µM this trend is heightened with the 
number of scorable aberrations doubling, however the middle concentrations of DON 
have a far more complex relationship.  It is apparent that a small amount of RET (1 µM) 
induces a degree of damage that is modulated in a DON-dose dependant way.  Due to the 
complex toxicological response it is impossible to describe the interaction as purely 
antagonistic, additive or synergistic.  There was a great amount of variation in terms of 
blebs and bridge blebs between treatments which means it is difficult to derive any 
association with the stressors, although there does seem to be similar modulation in 
response between 10 µM and 100 µM DON and blebbing/bridges are considered part of 
late stage apoptosis (Table 6.3).  When considering the scored micronuclei and 
nucleoplasmic bridges it is apparent that there is an increase in aberrations due to dose of 
DON compared with the control, although RET yielded modulation of this effect.  In 
isolation, RET caused an increase in aberrations until 100 µM when the amount 
decreased, due presumably to excessive crosslinking preventing mitosis.  APH (0.5 µM) 
increased the incidence of nucleoplasmic aberrations at all concentrations of RET when in 
combination, except at 10 µM RET when the damage had seemingly reached a 
thresholded limit.  A combination of DON doses with 0.1 µM MMC yielded a significant 
proportional increase in aberrations with the same dose-relationship as DON in isolation 
(F= 6.39, P<0.001, 74.2% of variation explained by DON dose, Figure 6.9). 
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Figure 6. 9.  The incidence of total nucleoplasmic aberrations following 
48 h exposure of HepG2 cells to different concentrations of DON and 
RET (above left), RET and MMC with APH (above) or DON/APH and 
MMC (left) in isolation and in combination.  Recorded aberrations 
include: micronuclei, nucleoplasmic bridges, blebs, bridge-blebs and 
mitotic catastrophe.  The mean count per 1000 cytokinesis-blocked 
binucleated cells is shown with the standard error of triplicate 
experiments. Treatments yielding a significant increase in incidence 
over the control are shown with an asterisk (*). 
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6.3.5.5 Nuclear division index (NDI) assay 
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Figure 6. 10.  The effects of a 48 h exposure of DON and RET 
(top left), MMC (0.1 µM) and DON/APH (above) or APH and 
MMC/RET (left) on the proportion of mononucleated cells 
within the population of cells exposed to cytochalasin-B for 
24 h.  The mean and standard error of triplicate 
experiments is shown with an asterisk denoting a significant 
difference compared with the corresponding  non-APH or 
non-MMC treatment.  
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The proportion of cells undertaking mitosis can be determined by counting the number of 
mono-, bi-, tri- and tetranucleated cells following the blocking of cytokinesis with 
cytochalasin-B.  A higher proportion of mononucleated cells equates to a reduction in 
cellular turnover.  An increase in DON concentration reduces cellular turnover 
significantly (F = 22.19, P<0.001) across all treatments with 64.4% of variance associated 
with DON dose. RET (F = 0.80, P = 0.50) either in isolation or in combination with DON (F = 
0.85, P<0.60) did not surprisingly restrict mitotic turnover.  MMC (0.1 µM) reduced cell 
turnover by a factor of 2 for low doses of RET, yet high doses of DON and APH restricted 
this effect (Figure 6.10).   
6.4.3 MTT assay 
 
Figure 6.11. MTT absorbance as indicator of cellular vitality following a 48 h exposure to toxin.  Means of 
triplicate wells and triplicate experiments shown with SE. 
Cellular viability (including mitochondrial vitality) and cellular proliferation measured by 
MTT metabolism was significantly reduced with concentration of DON (F = 15.25, p<0.001) 
with an indication of antagonistic effects found with RET at low doses (Figure 6.11).  No 
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synergism was determined using a GLM (R-Sq = 60.6%).  MMC at 0.1 µM showed a 50% 
reduction or more over the control and 0.5 µM APH gave a similar response to low doses 
of DON.  The MTT assay was also used for DON-3-glucoside and patulin for comparison in 
a separate validation experiment (Figure 6.12).  DON (Pearson correlation -0.720, 0.008) 
was comparable in terms of toxicity to Patulin (-0.918, <0.001), an RNA synthesis inhibitor 
produced by Penicillium expansum.  The D3G dose tested did not elicit a reduction in MTT 
metabolism in HepG2 cells compared with DON, indicating that the glucoside conjugate is 
not only instrumental in preventing toxicosis in plants, but remains un-cleaved in HepG2 
cells and is therefore innocuous over 48 h. 
 
Figure 6.12. MTT absorbance as indicator of cellular vitality following a 48 h exposure to 
DON, D3G and Patulin (Penicillium expansum) for assay validation.  Means of triplicate 
wells and triplicate experiments shown with SE. 
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6.4.4 Lactate dehydrogenase leakage assay 
 
Figure 6.13. Lactate dehydrogenase measurements in the medium of HepG2 cells exposed to different 
combinational concentrations of DON and RET for 48 h.  Relative LDH units is related to a standard curve 
constructed using a purchased standard solution.  The mean of three experiments is shown with the SE. 
 
Figure 6.14. Standard curve of a lactate dehydrogenase concentration against the gradient decrease of 
NADH absorbance (362 nm, i. e. the rate of NADH to NAD
+
 conversion).  The equation 8829.9x
0.8427
 fits 
94.5% of the data. 
Lactate dehydrogenase measured via NADH to NAD+ conversion did not show any 
significant response with the treatments used in the current study (ANOVA; F = -0.26, P = 
0.802).  This agrees well with the trypan blue membrane integrity result which suggests 
cellular leakage was not an endpoint associated with the DON/RET doses used. 
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6.4.5 Carboxyfluorescein diacetate assay (flow cytometry) 
 
Figure 6.15. Example of selection gates used for CFDA flow-cytometry experiment.  P2 equates to 
metabolically competent cells, P3 to advanced membrane damage and P4 to compromised membranes.  
Cells were exposed to fluorescein diacetate and propidium iodide following a 48 h 0.1 µM MMC 
treatment exposure. 
The proportion of cells unable to metabolise CFDA as measured with flow cytometry 
followed a dome like response with concentrations of DON with 1 µM yielding an increase 
in FITC positives and only 100 µM yielding a decrease compared with the control (1-way 
ANOVA, F = 17.78, P<0.001, Dunnett’s pairwise comparison with control at P<0.05).  An 
increase in RET dose actually increased the proportion of FITC positive cells with a 
combinational exposure having antagonistic effects at low DON levels and a diminished 
influence at 100 µM DON.  DON seemingly played a similar role with MMC as 1 µM-10 µM 
increased FITC positives, only for 100 µM to reduce it again, but not down to the MMC 
0.1 µM or 10 µM levels.  RET decreased the proportion of FITC positive cells when treated 
with 0.5 µM and 1.5 µM APH in a dose dependant dome-like trend. 
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Figure 6.16. CFDA assay results determined 
using flow cytometry following a 48 h 
exposure HepG2 cells to DON and RET (µM) 
(top left), DON and MMC (above) or RET and 
APH (left).  10000 events were gated using 
FITC for healthy cells and propidium iodide 
as indicative of loss of membrane integrity 
with the mean category percentage shown 
of 3 experiments with the standard error 
and an asterisk denoting a significant 
difference to the control at P<0.05. 
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6.4.6 Carboxyfluorescein diacetate assay (fluorescent microscopy) 
 
Figure 6.17.  CFDA assay results determined using 
fluorescence microscopy following a 48 h exposure HepG2 
cells to DON and RET (µM) (above left), DON and MMC 
(above) or APH and RET/MMC (left).  200 cells were 
categorised into viable (FITC green, shown) and non-viable 
(propidium iodide red).  The mean category percentage 
shown of 3 experiments with the standard error. 
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When the same population of cells that were analysed by flow cytometry were observed 
and categorised by light microscopy a similar dose dependant relationship was found with 
RET and DON and the other treatments. 
6.4.7 Annexin V-FITC apoptosis assay (flow cytometry) 
 
Figure 6.18.  Flow cytometry plots of Annexin V-FITC (black) and propidium iodide (red) stained HepG2 
cells following 48 h exposure to: A, control; B, DON 10 µM; C, DON 10 µM + RET 10 µM; D, DON 10 µM + 
MMC 0.1 µM; E, DON 10 µM + MMC 10 µM.
 
Figure 6.19. Flow cytometry data grouped by quadrants following treatment of HepG2 cells to DON, RET 
and MMC.  Apoptotic cells (V-FITC) fluoresce green with an increase in intensity resulting in an increase in 
cells in Q4.  An increase in Q2 indicates an increase in apoptosis and compromised membrane integrity.  
10,000 cells were analysed for each triplicate experimental treatment with the mean percentage of 
control treatment quadrant value shown with the standard error. 
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The flow cytometry results derived from annexin V5 treated cells indicate all treatments 
apart from MMC 10 µM tend to increase the proportion of cells in quadrant 4, an 
arbitrary method of dividing scatter data in this case indicating high FITC intensity cells 
representing cells presenting annexin V5 in the process of apoptosis.  MMC 10 µM 
treatment reduces this intensity and shifts the cluster to an increase in red fluorescence.   
6.4.8 Annexin V-FITC apoptosis assay (fluorescence microscopy) 
 
Figure 6.20.  Percentage of apoptotic cells exhibiting Annexin V5  as determined using fluorescent 
microscopy.   Cells analysed were exposed for 48 h to combinations of DON (10 µM), RET and MMC.  The 
mean is shown with the standard error of triplicate experiments (200 cells). 
The proportion of those cells displaying phosphatidylserine on the cytoplasmic surface of 
cells suggests the initiation of apoptosis was around 25% in the untreated cells.  The 
addition of 10 µM DON increases this to over 50% and the addition of 10 µM RET 
increases this to over 75%.  Replacing RET with MMC 0.1 µM yielded  similar response to 
DON in isolation, although a necrotic dose of 10 µM reduced apoptosis induction 
presumably through the damage exceeding checkpoint capacity and damaging the 
membranes. 
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6.4.9 Trypan blue and monolayer cell density 
Cellular membrane integrity as determined by trypan blue exclusion indicates that only 
the highest doses of DON (GLM 67.8%, F = 19.6, P<0.001) (Figure 6.21).  The evidence 
suggests damage inflicted is not membrane associated, but subtly affects other cellular 
aspects, for example in the nucleus. 
 
Figure 6.21. Percentage of cells excluding trypan blue stain following a 48 h toxin exposure.  Means of 
triplicate wells and triplicate experiments shown with SE. 
 
Figure 6.22. The cell count per mm
2
 of HepG2 cells seeded at 5 x 10
4
 cells/ml
 
and incubated for 24 h 
followed by 48 h exposure to toxins.  Means of triplicate wells and; triplicate experiments shown with SE. 
The results of the cell count experiment broadly agree with that of the protein assay with 
DON concentration the only significant stressor affecting cell proliferation (GLM, R-Sq = 
65.2%, F = 17.38, p<0.001).  The APH treatment reduced cell number as did the MMC 
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dose which indicates cell number and amount of protein may not be the definitive story 
and cell morphology and size may provide more information than these two endpoints.   
6.4.10 Protein assay 
 
Figure 6.23. Cellular protein contents per well following a 48 h toxin exposure.  Means 
of triplicate wells and triplicate experiments shown with SE. 
The effects of both toxins on cellular turnover measured by determining the total 
adhered cellular protein content of each well following 48 h of exposure indicates DON 
was the main contributor to reduced cellular turnover and protein content in each well 
(GLM, R-Sq = 83.8%, F = 47.14, p<0.001).   The protein assay results closely resemble that 
found with MTT metabolism confirming that both give a good measure of cellular vitality 
reinforced by absolute cell counts and NDI. 
6.4.11 Proteomics 
Analysing all the proteins by cluster analysis indicated that In general the RET/DON 
treatment yielded substantially different values across the whole proteome compared 
with the similarity found with the other treatments (Figure 6.24).  
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Figure 6.24. Dendrogram of 1749 protein groups determined with mass spectrometry following 
treatment of HepG2 cells for 48 h to DON (10 µM), RET (10 µM) or both (10 + 10 µM, pooled flasks in 
triplicate).  The label-free peak intensity values for each protein group can be grouped and compared 
between treatments in terms of similarity by looking at the position of the joining partition. 
It must be considered that prior to sample preparation the extracted protein was 
normalised between treatments to 1 mg/ml BSA levels and the pooled label-free 
quantification intensity recorded was very similar for each treatment (2.26, 2.17, 1.94 and 
2.09 x 109 for control, DON (10 µM), RET (10 µM) and RET/DON (10 + 10 µM) respectively).  
It is only when we delve into specific protein groups that interesting differences can be 
elucidated.   
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Table 6.4. Summary of the key biological functions focussed on with proteomic analysis. 
Biological 
function 
Gene ontology 
term  
Definition (UNIPROT) 
Translational 
elongation 
GO:0006414 
The successive addition of amino acid residues to a nascent polypeptide 
chain during protein biosynthesis. 
Protein 
biosynthesis 
GO:0006412 
The cellular metabolic process in which a protein is formed, using the 
sequence of a mature mRNA molecule to specify the sequence of amino 
acids in a polypeptide chain. Translation is mediated by the ribosome, 
and begins with the formation of a ternary complex between 
aminoacylated initiator methionine tRNA, GTP, and initiation factor 2, 
which subsequently associates with the small subunit of the ribosome 
and an mRNA. Translation ends with the release of a polypeptide chain 
from the ribosome. 
Apoptosis GO:0006915 
Protein involved in apoptotic programmed cell death. Apoptosis is 
characterized by cell morphological changes, including blebbing, cell 
shrinkage, nuclear fragmentation, chromatin condensation and 
chromosomal DNA fragmentation, and eventually death. Unlike 
necrosis, apoptosis produces cell fragments, called apoptotic bodies, 
which phagocytic cells are able to engulf and quickly remove before the 
contents of the cell can spill out onto surrounding cells and cause 
damage. In general, apoptosis confers advantages during an organism's 
life cycle. 
Response to 
organic 
substance 
GO:0010033 
Any process that results in a change in state or activity of a cell or an 
organism (in terms of movement, secretion, enzyme production, gene 
expression, etc.) as a result of an organic substance stimulus. 
Membrane GO:0016020 
Protein which is membrane-bound or membrane-associated. A 
membrane is the layer which forms the boundary of cells and 
intracellular organelles. It is composed of two oriented lipid layers in 
which proteins are embedded and acts as a selective permeability 
barrier. 
Cell cycle 
regulation 
GO:0051726 
Any process that modulates the rate or extent of progression through 
the cell cycle. 
 
In an attempt to establish bulk proteome changes resulting from DON and RET treatment 
the identified protein groups were grouped by biological function, i.e. translational 
elongation (Table 6.4, 6.5), and the expression of the top 100 protein groups in size order 
related to the control were compared using cumulative ion count curves in addition to 
the construction of dendrograms to illustrate treatments which have significant protein 
expression differences (Figure 6.25).  In addition, the 4 fold protein expression differences 
of particularly relevant functions are listed in Table 6.6 (with a full list in appendix 
10.1/10.2). 
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When the proteins were grouped by using DAVID® it was readily apparent that the 5 most 
profuse proteins in each functional group were broadly similar between all treatments.  
Translational elongation, the aspect of protein synthesis known to be most impacted by 
DON exposure was found to be significantly enriched with DON and DON/RET, whilst both 
these groups had reduced quantity of proteins related to protein synthesis.     
Apoptosis linked proteins were most numerous for DON, less so for DON/RET followed by 
RET.  The control had the least quantity of apoptosis associated proteins as a whole.  This 
is the same relationship concerning cell cycle regulation proteins, which are likely to be 
closely related to apoptosis induction.  Membrane-bound /-associated protein provision 
was interesting as the top 5 proteins for the toxin treatments were skewed to 
mitochondrial associated enzymes for all treatments with broadly similar proportions of 
each, which could be considered housekeeping proteins within each proteome against 
which other fluctuations are compared.  Bulk shifts in enrichment suggest RET to have a 
more equal spread of membrane proteins in terms of quantity compared with the control 
which had a larger proportion of higher count proteins, or the DON and DON/RET 
treatments which were consistently lower across the top 100 proteins identified.  RET can 
be seen to reduce the protein expression related to a response to an organic substance, 
especially when combined with DON.  This would have effects on general liver cell 
function including microsomal activity.  The suite of proteins found at the highest levels in 
this gene ontology group for all treatments includes heat-shock proteins (similar 
presence), in addition to epoxide hydrolase (2-fold increase with DON, DON/RET) and 
NM23A, an important nucleoside synthesis and DNA endonuclease (3 to 4-fold less with 
RET/DON).  The main observation is that these toxin treatments reduce enrichment of 
196 
 
proteins applicable to the response from organic substances, rather than eliciting an 
expected increase. 
The overriding result regarding 4 fold deviations from control conditions (only universally 
expressed protein groups across treatments analysed) would be the sheer number of 
proteins increased by the DON treatment and amount reduced following DON and 
DON/RET exposure (Table 6.6, 6.7).  DON exposure led to the 4-fold increase in 118 
protein groups, whereas RET and RET/DON led to 20 and 18 respectively.  4-fold 
reductions in 51, 9 and 73 protein groups were found with DON, RET and RET/DON 
respectively.  A few of the most expressed and relevant identities are evaluated further.  
Actin (gamma 1), an omnipresent cytoskeleton protein which has been shown by 
Coulombe Jr et al. (1999) to be the most likely protein involved in DNA-protein crosslinks 
by PAs and MMC, was found extensively in all treatments without significant variation.   
Microsomal and cytosolic glutathione-s-transferases (GST) are membrane bound phase II 
excretion enzymes crucial to xenobiotic detoxification within the cell (Strange and Hayes, 
2000).  Regarding the GST family, only GST-1 was found to be present in elevated 
amounts (9 fold in DON) compared with GST-2 and 3 which were equivalent to the 
control.   Glutathione reductase, an enzyme involved in ROS reduction within the cell on 
the other hand was only increased in the RET/DON combination.  Interestingly, DON 
exposure led to an increase in mitochondrial membrane proteins, specifically those 
involved in respiration (cytochrome-c oxidase etc.).  Whilst cellular turnover may be 
reduced, it seems the metabolic status of the cell is increased by DON leading to potential 
ROS production and apoptosis induction.  
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In terms of cytotoxicity, DON and RET/DON produced the greatest expression of proteins 
associated with apoptosis, an effect seen with the other experimental endpoints.  The 
lack of enrichment of mitogen-activated protein kinase 1 (MAPK-1) suggests this specific 
pathway of ROS-induced apoptosis is not employed by the cells.  A disruption in the 
balance of apoptotic to anti-apoptotic protein groups will have a pronounced effect on 
cell functionality.  UDP-glucuronosyltransferase saw a three-fold increase for DON and 
RET and increased by half for RET/DON.  Whilst this is less than a 4-fold difference, it does 
confirm presence of this phase II system in HepG2 and tentatively this could be viewed as 
an upregulated mechanism for both RET and DON excretion, which is noteworthy 
considering this is the main route of DON excretion in mammals (He et al., 2010b, Maul et 
al., 2014).  The most enriched protein group in the DON treated cells with a 57x increase, 
was found to be catenin δ1; a cell-cell adhesion protein and DNA-transcription regulator.  
In RET the catenin response was 5x and in RET/DON it was at control levels.  Lactate 
dehydrogenase (LDH) was found to be very low for all treatments (at least 500x less than 
control).  Unfortunately this cannot be linked to LDH leakage or cell density data and 
remains unexplained for now.   
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Table 6.5. The top-5 expressed proteins in each Gene-ontology category for each treatment.  Protein 
groups of especial relevance are highlighted with an asterisk. 
   
Biological function Control  
 Protein group Ion intensity 
Translational elongation 
(1) 
protein disulfide isomerase family A, member 3 11310000 
2 
annexin A6 10692000 
3 
heterogeneous nuclear ribonucleoprotein A1-like 3 9839600 
4 
eukaryotic translation elongation factor 1 alpha-like 7 6949400 
5 
insulin-like growth factor 2 mRNA binding protein 1 4434500 
Protein biosynthesis (1) 
aminoacyl tRNA synthetase complex-interacting multifunctional protein 2 6949400 
2 
ribosomal protein S16 pseudogene 1 5245400 
3 
threonyl-tRNA synthetase 4342300 
4 
eukaryotic translation initiation factor 2B, subunit 4 delta, 67kDa 3385400 
5 
glutamyl-tRNA synthetase 2, mitochondrial (putative) 3291500 
Membrane (1) 
ATPase, H+ transporting, lysosomal accessory protein 1 78014000 
2 
ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide 51901000 
3 
phospholipase C, eta 1 31067000 
4 
ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1 25321000 
5 
prolyl 4-hydroxylase, beta polypeptide 18303000 
Apoptosis (1) 
hypothetical gene supported by AF216292; NM_005347; heat shock 70kDa protein 5 
(glucose-regulated protein, 78kDa) 
49712000 
2 
API5-like 1; apoptosis inhibitor 5 33711000 
3 
non-metastatic cells 1, protein (NM23A) expressed in; NME1-NME2 readthrough 
transcript 
27976000 
4 
tubulin, beta 2C 26436000 
5 
heat shock 10kDa protein 1 (chaperonin 10) 20699000 
Response to organic 
substance (1) 
non-metastatic cells 1, protein (NM23A) expressed in; NME1-NME2 readthrough 
transcript 
27976000 
2 
heat shock 10kDa protein 1 (chaperonin 10) 20699000 
3 
heat shock 70kDa protein 8 11843000 
4 
protein disulfide isomerase family A, member 3 11310000 
5 
annexin A6 10692000 
Cell cycle regulation (1) 
histone cluster 1, H4l; histone cluster 1, H4k 103900000 
2 
ATPase, H+ transporting, lysosomal accessory protein 1 78014000 
3 
actin, gamma 1 60755000 
4 
ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide 51901000 
5 
hypothetical gene supported by AF216292; NM_005347; heat shock 70kDa protein 5 
(glucose-regulated protein, 78kDa) 
49712000 
Total cell protein (1) 
histone cluster 1, H2bb 183870000 
2 
general transcription factor II, i; general transcription factor II, i, pseudogene 156790000 
3 
histone cluster 1, H4l; histone cluster 1, H4k;  103900000 
4 
ATPase, H+ transporting, lysosomal accessory protein 1 78014000 
5 
histone cluster 2, H2aa3; histone cluster 2, H2aa4 64870000 
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Biological function DON  
 Protein group Ion intensity 
Translational elongation 
(1) 
heterogeneous nuclear ribonucleoprotein A1-like 3 25517000 
2 eukaryotic translation elongation factor 1 alpha-like 7 11677000 
3 ribosomal protein S3A pseudogene 5 5553300 
4 ribosomal protein S3 pseudogene 3; ribosomal protein S3 5475800 
5 annexin A6 5164700 
Protein biosynthesis (1) aminoacyl tRNA synthetase complex-interacting multifunctional protein 2; stromal 
antigen 3 
11677000 
2 ribosomal protein S19 pseudogene 3; ribosomal protein S19 5553300 
3 ribosomal protein L18 5475800 
4 ribosomal protein S4, Y-linked 1 4390400 
5 ribosomal protein S5 4376400 
Membrane (1) ATPase, H+ transporting, lysosomal accessory protein 1 56494000 
2 solute carrier family 25 (mitochondrial carrier; adenine nucleotide) 26273000 
3 ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1, 25760000 
4 ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide 23802000 
5 voltage-dependent anion channel 1 19722000 
Apoptosis (1) API5-like 1; apoptosis inhibitor 5 41848000 
2 non-metastatic cells 1, protein (NM23A) expressed in; NME1-NME2 readthrough 
transcript 
26751000 
3 tubulin, beta 2C 20746000 
4 hypothetical gene supported by AF216292; NM_005347; heat shock 70kDa protein 5 
(glucose-regulated protein, 78kDa) 
16673000 
5 Prohibitin 13111000 
Response to organic 
substance (1) 
non-metastatic cells 1, protein (NM23A) expressed in; NME1-NME2 readthrough 
transcript 
26751000 
2 heat shock 70kDa protein 8 13941000 
3 heat shock protein 90kDa alpha (cytosolic), class B member 1 10531000 
4 heat shock 10kDa protein 1 (chaperonin 10) 7063000 
5 epoxide hydrolase 1, microsomal (xenobiotic)* 6973300 
Cell cycle regulation (1) histone cluster 1, H4l 94259000 
2 ATPase, H+ transporting, lysosomal accessory protein 1 56494000 
3 actin, gamma 1 29462000 
4 non-metastatic cells 1, protein (NM23A) expressed in; NME1-NME2 readthrough 
transcript 
26751000 
5 ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1, cardiac 
muscle 
25760000 
Total cell protein (1) general transcription factor II, i; general transcription factor II, i, pseudogene 111920000 
2 histone cluster 1, H4 94259000 
3 histone cluster 1, H2bb 76123000 
4 histone cluster 2, H2aa3; histone cluster 2, H2aa4 61655000 
5 ATPase, H+ transporting, lysosomal accessory protein 1 56494000 
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Biological function RET  
 Protein group Ion intensity 
Translational elongation 
(1) 
protein disulfide isomerase family A, member 3 8578300 
2 insulin-like growth factor 2 mRNA binding protein 1 5945000 
3 eukaryotic translation elongation factor 1 alpha-like 7 5658600 
4 heterogeneous nuclear ribonucleoprotein A1-like 3 5626900 
5 Tu translation elongation factor, mitochondrial 4572100 
Protein biosynthesis (1) ribosomal protein S16 pseudogene 1 10550000 
2 aminoacyl tRNA synthetase complex-interacting multifunctional protein 2 5658600 
3 threonyl-tRNA synthetase 4572100 
4 eukaryotic translation initiation factor 2B, subunit 4 delta, 67kDa 4075000 
5 ribosomal protein S27 pseudogene 29 4064400 
Membrane (1) ATPase, H+ transporting, lysosomal accessory protein 1 71751000 
2 ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide 38328000 
3 ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1,  24337000 
4 solute carrier family 25 (mitochondrial carrier; adenine nucleotide) 14292000 
5 voltage-dependent anion channel 1; similar to voltage-dependent anion 12527000 
Apoptosis (1) hypothetical gene supported by AF216292; NM_005347; heat shock 70kDa protein 5 
(glucose-regulated protein, 78kDa) 
55566000 
2 heat shock protein 90kDa beta (Grp94), member 1 25106000 
3 API5-like 1; apoptosis inhibitor 5 25078000 
4 non-metastatic cells 1, protein (NM23A) expressed in; NME1-NME2 readthrough 
transcript 
18668000 
5 tubulin, beta 2C 17174000 
Response to organic 
substance (1) 
non-metastatic cells 1, protein (NM23A) expressed in; NME1-NME2 readthrough 
transcript;  
18668000 
2 heat shock 70kDa protein 8 14014000 
3 heat shock 10kDa protein 1 (chaperonin 10) 13092000 
4 heat shock protein 90kDa alpha (cytosolic), class B member 1 9208400 
5 protein disulfide isomerase family A, member 3 8578300 
Cell cycle regulation (1) histone cluster 1, H4l 116790000 
2 ATPase, H+ transporting, lysosomal accessory protein 1 71751000 
3 hypothetical gene supported by AF216292; NM_005347; heat shock 70kDa protein 5 
(glucose-regulated protein, 78kDa) 
55566000 
4 actin, gamma 1 50923000 
5 ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide 38328000 
Total cell protein (1) histone cluster 1, H4lb 116790000 
2 histone cluster 1, H2bb 108540000 
3 histone cluster 2, H2aa3; histone cluster 2, H2aa4 105900000 
4 ATPase, H+ transporting, lysosomal accessory protein 1 71751000 
5 H3 histone, family 3B (H3.3B) 57523000 
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Biological function RET/DON  
 Protein group Ion intensity 
Translational elongation 
(1) 
eukaryotic translation elongation factor 1 alpha-like 7 12091000 
2 heterogeneous nuclear ribonucleoprotein A1-like 3 9169500 
3 ribosomal protein L4; ribosomal protein L4 pseudogene 5; ribosomal protein L4 
pseudogene 4 
7278800 
4 insulin-like growth factor 2 mRNA binding protein 1 6957200 
5 annexin A6 6658400 
Protein biosynthesis (1) aminoacyl tRNA synthetase complex-interacting multifunctional protein 2; stromal 
antigen 3-like 3 
12091000 
2 glutamyl-tRNA synthetase 2, mitochondrial (putative) 5435100 
3 glutaminyl-tRNA synthetase 5095200 
4 eukaryotic translation initiation factor 2B, subunit 4 delta, 67kDa 4833800 
5 ribosomal protein L11 4306000 
Membrane (1) ATPase, H+ transporting, lysosomal accessory protein 1 48220000 
2 ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide 42414000 
3 ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1 29454000 
4 ribophorin I 14825000 
5 coiled-coil domain containing 90B 13084000 
Apoptosis (1) tubulin, beta 2C 27689000 
2 API5-like 1; apoptosis inhibitor 5 20380000 
3 hypothetical gene supported by AF216292; NM_005347; heat shock 70kDa protein 5 
(glucose-regulated protein, 78kDa) 
19909000 
4 Prohibitin 9215400 
5 synovial apoptosis inhibitor 1, synoviolin 7146400 
Response to organic 
substance (1) 
heat shock 70kDa protein 8 19581000 
2 heat shock protein 90kDa alpha (cytosolic), class B member 1 17986000 
3 insulin-like growth factor 2 mRNA binding protein 1 6957200 
4 annexin A6 6658400 
5 epoxide hydrolase 1, microsomal (xenobiotic)* 6282600 
Cell cycle regulation (1) histone cluster 1, H4l 107880000 
2 ATPase, H+ transporting, lysosomal accessory protein 1 48220000 
3 ATP synthase, H+ transporting, mitochondrial F1 complex, beta polypeptide 42414000 
4 actin, gamma 1 38779000 
5 ATP synthase, H+ transporting, mitochondrial F1 complex, alpha subunit 1, cardiac 
muscle 
29454000 
Total cell protein (1) histone cluster 1, H2bb 183870000 
2 histone cluster 1, H4l 103900000 
3 H3 histone, family 3B (H3.3B) 57014000 
4 histone cluster 2, H2aa3; histone cluster 2, H2aa4 64870000 
5 ATPase, H+ transporting, lysosomal accessory protein 1 78014000 
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Figure 6.25. Cumulative ion intensities (1) and comparative correlation dendrogram (2) of the top 100 
protein groups in different biological functions found following exposure to 10 µM DON, RET, RET and 
DON combined or control conditions as relative to the control.  The biological functions include the 
control for 6 different GO-terms including A (Translational elongation), B (Protein biosynthesis), C 
(Apoptosis), D (Response to organic substance), E (Membrane) or F (Cell cycle regulation). 
Table 6.6. Key protein groups for discussion.  Green = enriched levels, yellow = equal to control levels and 
red = less than the control (magnification shown by gradation of colour) 
   
 
DON RET DON/RET
0 lactate dehydrogenase A (Anaerobic respiration) 0.2 0.1 0.1
1.99E-05 Mitogen-activated protein kinase 1 (MAPK, ROS-specific apoptosis) 105.3 98.4 123.9
1.60E-158 catenin (cadherin-associated protein), beta 1, 88kDa (cell adhesion, cancer cells) 44.4 88.1 23.5
5.17E-14 catenin (cadherin-associated protein), alpha 1, 102kDa (cell adhesion, linking actin) 40.8 106.3 25.8
4.71E-17 catenin (cadherin-associated protein), delta 1 (cell adhesion, DNA transcription) 5673.9 524.4 138.7
1.68E-06 UDP glucuronosyltransferase 2 family, polypeptide B7 (DON excretion/ detoxification) 294.2 327.5 146.1
5.27E-14 beta-1,3-glucuronyltransferase 3 (glucuronosyltransferase I) (DON excretion/detoxification) 37.8 50.1 80.6
2.06E-120 microsomal glutathione S-transferase 1 (DON/RET-specific excretion) 943.1 236.4 270.6
7.01E-06 microsomal glutathione S-transferase 2 (DON/RET-specific excretion) 145.4 100.6 113.3
3.17E-29 microsomal glutathione S-transferase 3 (DON/RET-specific excretion) 28.3 93.2 40
1.10E-06 Glutathione-S-transferase omega 1 (soluble cytosolic, DON/RET-specific, excretion) 243.9 70.8 0
1.14E-48 glutathione S-transferase kappa 1 (mitochondrial) 58.6 112.8 62.7
4.93E-09 glutathione synthetase (DON/RET-specific, glutathione synthesis) 49.5 82 26.5
1.51E-65 glutathione reductase (DON specific, oxidative stress) 83.7 173.3 478
0.000452 Cytochrome c oxidase subunit 3 (RET-specific activation enzyme) 95.1 68.3 33.6
4.29E-105 cytochrome b5 type B (outer mitochondrial membrane) 1221.0 328.6 172.0
1.89E-36 cytochrome c oxidase subunit IV isoform 1(mitochondrial) 819.3 213.4 129.7
5.82E-95 Cytochrome c oxidase subunit 2 (mitochondrial) 197.5 198.2 128.7
1.09E-21 cytochrome c oxidase subunit Vib polypeptide 1 (ubiquitous) 211.1 137.9 149.1
0.0000113 P450 (cytochrome) oxidoreductase 111.4 195.6 22.0
9.43E-13 cytochrome c oxidase subunit VIc 48.4 106.6 82.7
2.3E-83 ubiquinol-cytochrome c reductase core protein I 65.3 83.8 97.5
8.83E-06 oxidase (cytochrome c) assembly 1-like 42.0 59.5 41.9
4.72E-274 histone cluster 1, H1b 61.6 83.5 100.5
0 histone cluster 1, H1c 17.3 26.3 33.9
0 histone cluster 1, H1e 42.2 56.5 69.8
0 histone cluster 1, H2ac 280.7 206.4 100.1
0 histone cluster 1, H2ag; histone cluster 1, H2ah 3988.0 4813.2 387.3
0 histone cluster 1, H2bb 41.4 59.0 95.5
0 histone cluster 1, H2bd 0.0 5.1 17.9
8.92E-07 histone cluster 1, H2bj 46.5 69.3 43.4
1.49E-35 histone cluster 1, H2bm 108.9 183.3 158.4
0 histone cluster 1, H2bo 0.0 7.8 18.1
0 histone cluster 1, H4l 90.7 112.4 103.8
0 histone cluster 2, H2aa3; histone cluster 2, H2aa4 95.0 163.2 97.0
1.61E-78 histone cluster 2, H2ab 396.7 101.2 79.4
0 histone cluster 2, H2be 0.0 0.9 8.9
0.0050646 H1 histone family, member 0 125.8 71.5 213.1
2.9E-36 H1 histone family, member X 72.2 90.9 58.1
3.27E-16 H2A histone family, member V 2521.9 157.1 342.9
1.31E-64 H3 histone, family 3B (H3.3B) 34.0 100.9 167.5
Percentage of control ion intensity
Gene Name                         PEP
Protein group 
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6.4.12 DNA-crosslinking assays 
 
Figure 6. 26. The change in absorbance (260 nm) of HepG2 DNA following 48 h cellular 
exposures to combinational exposures of DON 10 µM, RET (R) 10 µM/100 µM, MMC 0.1 
µM and APH 1.5 µM.  Extracted DNA was subjected to denaturing at 95 °C and recovery 
on ice for 20 or 40 min with an increase in absorbance indicative of strand separation 
and a rapid annealing suggestive of crosslinking scaffolds speeding up alignment. 
A preliminary UV-absorbance analysis of native, denatured and renatured extracted DNA 
samples suggested that heating to 95 °C and immediately determining absorbance 
yielded a 18-70% hyperchromatic response for all samples consistent with the separation 
of sister strands (Figure 6.26).  As the strands realigned the absorbance in the control 
dropped back to initial levels, whilst there was more fluctuation in the treated, with 100 
µM of RET / 10 µM of DON (the highest cytotoxic dose) producing a much lower response 
than the initial.  This suggests the denaturing has made the DNA more organised or 
removed a component that initially increased absorbance at room temperature.  Contrary 
to this, DON and RET at 10 µM yielded a reduction at 20 min followed by an increase at 40 
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min and MMC with APH yielded a more surprising result with annealing for 20 min 
resulting in a transitory 50% increase in absorbance, perhaps because the annealing has 
occurred too quickly and the strands are not aligned properly.  By using a different aliquot 
of the same DNA to undertake the same denaturing process, but this time running the 
sample on an agarose gel, it was possible to observe the different fragment sizes making 
up the native and denatured fractions (Figure 6.27.).  The first observation is the value of 
the DNA markers to provide a positive control for denaturing and an idea of the 
differential distance single stranded fragments migrate compared with non-denatured 
DNA, for example it is not a proportional relationship with 250bp actually migrating faster 
in duplex form.   The second observation is the different array of bands/smears in terms 
of position and intensity for each non-denatured lane.  This illustrates the difficulty of 
undertaking a study with crosslinked genomic DNA where normalisation between 
samples using spectrophotometry becomes troublesome due to the different size trends 
present in the sample.  It would have been simpler to use a uniform fragment size (i. e. a 
single band from a plasmid) to evaluate crosslinking and annealing dynamics. 
RET treated DNA is retained in the well with denaturation bands tending to disappear 
rather than appear as the single stranded form indicating unrepaired labile nucleotide 
excision repair gaps along the strand were prevalent leading to a range of small single 
stranded DNA fragments that migrate to leave a smear rather than distinct bands.  The 
mechanism is thus similar to the comet assay in that a labile or excised base leaving a gap 
leads to a strand break on denaturation.  The total amount of DNA remaining in the well 
seems to decrease on denaturation illustrating at least a proportion is only retained due 
to inter- and intra-stand DNA and protein linkages.   A dose of 10 µM DON results in very 
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little genomic DNA remaining in the well indicating that karyolysis/karyorrhexis has 
already occurred in the majority of cells resulting in fragments of a range of shorter sizes 
do not form a band. 
 
Figure 6.27. DNA crosslinking assay comparing the migration pattern of denatured and 
normal DNA extracted from HepG2 cells exposed to different combinations of DON (10 
µM), RET (10 µM) and APH (1.5 µM) 48 h.  DNA from each treatment was normalised to 
100 µg/ml,   denatured at 95 °C for 10 min prior to 25 µl transferred into a 1% agarose 
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gel for electrophoresis (labelled yellow) with DNA ladders used as a positive control for 
denaturation 
6.4.13 Results Synopsis 
Table 6.7. Summary of all cytotoxicity and cellular viability assays with GLM regression 
statistics.  The main effects attributed to DON or RET or an interaction is given   The 
individual cell data was used for regression in the comet assay where wide variation 
and clustering requires interrogation of raw data, hence the contribution to R-Sq values 
are low. 
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Comet 
DNA 
crosslinking/ 
strand breaks 
1.2%, F = 
24.32, 
p< 0.001 
4.0%, F = 
70.96,  
p<0.001 
4.2%, 
F=24.32, 
p< 0.001 
4799 9.3%* 
Dome response to RET 
reduced by exposure to 
DON.   
Micronucleus 
Mitotic 
aberrations, 
chromosome 
and fragment 
loss 
25.3%, F 
= 4.08, 
p=0.008 
6.23%, F 
= 1.37, P 
=0.266 
12.69%, F 
= 0.68,  p 
=0.757 
55 44.2% 
Increase in micronuclei with 
DON. RET in isolation yields a 
dome response. 
NDI 
Rate of cell 
proliferation 
59.2%, F 
= 15.25, 
p<0.001 
1.5%, F = 
0.52, p 
=0.674 
4.4%, F = 
0.38, p 
=0.963 
55 65.1% 
Inhibition of cellular 
proliferation significantly 
linked to DON concentration 
only 
MTT 
Mitochondrial 
viability 
46.0%, F 
= 31.12, 
p<0.001 
10.9%, F 
= 7.35, 
p<0.001 
3.8%, F = 
0.84, p 
=0.579 
95 60.6% 
DON significantly reduces 
mitochondrial vitality whilst 
RET actually reverses it 
Carboxy-
fluoroscein-
diacetate 
metabolism/ 
propidium 
iodide uptake 
Mitochondrial 
metabolism 
and cellular 
membrane 
integrity 
22.1%, F 
= 3.52, p 
=0.024 
1.4%,F = 
0.34, p 
=0.716 
1.2%, F = 
0.09, p 
=0.996 
47 
24.7% 
 
DON concentration major 
contributor to 
mitochondrial/membrane 
compromise 
48 h cell 
density (mm
2
) 
Rate of cell 
proliferation 
60.5%, F 
= 17.4, 
p<0.001 
1.5%, F = 
0.58, p 
=0.634 
3.2%, F = 
0.31, p 
=0.984 
59 65.2% 
Inhibition of cellular 
proliferation significantly 
linked to DON concentration 
only 
Trypan blue 
exclusion 
Loss of 
membrane 
integrity 
63.0%, F 
= 19.59, 
p<0.001 
1.3%, F = 
0.52, p 
=0.671 
3.5%, F = 
0.37, p 
=0.968 
59 67.8% 
Membrane integrity 
significantly linked to DON 
concentration only 
Total cellular 
protein 
Rate of cell 
proliferation 
71.5%, F 
= 47.14, 
p<0.001 
6.7%, F = 
4.47, p 
=0.010 
5.6%, F = 
1.23, p 
=0.314 
47 83.8% 
Inhibition of cellular 
proliferation significantly 
linked to DON concentration 
only 
Proteomics 
Determination 
of differences 
in protein 
group 
enrichment 
DON and RET/DON produced the greatest expression of proteins associated with 
apoptosis.  DON was found to effect protein synthesis in two different ways; by 
reducing the protein groups related to protein synthesis as a whole, but increasing 
the proteins related to translational elongation.  DON induced the most 4 fold 
protein group increases and decreases compared to the control. 
Crosslinking 
assay 
Determining 
the degree of 
crosslinking of 
DNA 
Crosslinking adducts yield breaks and increase in fragmentation rather than acting 
as scaffolds keeping sister strands attached.  The possibility that protein crosslinks 
make up a significant portion of the lesions is suggested. DON (10 µM) produces 
DNA which is already undergoing karyorrhexis. 
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6.5 Discussion 
The current investigation focuses on the genotoxicity and cytotoxicity of RET and DON 
exposed singly and in combination to a human liver cell line; HepG2.  In addition to a suite 
of different assay endpoints, the study incorporates positive controls for crosslinking and 
inhibiting repair of DNA, to aid in toxicity mechanism characterisation.  Analysis of DNA 
crosslink stability and proteome enrichment further describes the effect of these toxins 
on exposed cells, although the data collected suggests the relationship between these 
cytostatically potent dietary toxins is far from simple and requires tentative interpretation. 
6.5.1 DNA and protein crosslinking 
RET was found to exert a dome-like log10 dose dependant genotoxic response in both the 
comet and MN assays.  Low doses increased tail length and MN frequency indicating 
presence of strand lesions, whilst a dose of 100 µM yielded a reduction suggesting 
excessive crosslinking.  This reduces the potential for strand separation and fragment 
migration in the comet assay and initiation of mitosis in the MN assay, which is in 
agreement with other HepG2 toxicological studies (Kevekordes et al., 2001).  The cell 
cycle has a significant influence on comet assay data and it is possible that as DON 
reduces cellular turnover the dome-like RET response is reduced as the cells are 
essentially stalled in interphase by DON and any accumulated damage can be repaired 
(Tiemann et al., 2003), including labile sites formed by a single alkylation at low doses or 
migration-limiting DNA/protein crosslinks at the highest RET dose.   
Work by Kim et al. (1995) suggests DNA-protein crosslinks make up around 50% of the 
total crosslinks in the cell following exposure to the pyrrole forming PAs, of which a large 
proportion are actin-DNA crosslinks, presumably acting as chromatin scaffold proteins in 
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the nucleus and consequently being adjacent to the DNA.  In the current study, PA-
exposed cellular DNA was run on an agarose gel with and without denaturing (95 °C).  It 
was highlighted that several bands disappeared completely compared with the native 
DNA.  If it was cross-linked duplex DNA, it would have been unlikely that the sister strands 
would irreversibly separate according to work by Tang and colleagues (2008), and when 
comparing the single strand and duplex ladders it would have been expected that the 
same key band would have reappeared a short distance down the gel.  It seems sensible 
to hypothesise that the key band is in fact a DNA-actin crosslink that on denaturing is no 
longer visible, and it is an oversight that an immuno-blotting technique or proteinase-K 
comet was not employed at the time to confirm this, as it could aid in explaining some of 
the complex genotoxicity results.  DNA-protein crosslinks can be seriously detrimental to 
cells in that they are bulky DNA adducts which inhibit DNA metabolism leading to mitotic 
arrest and the existence of megalocytosis (Kim et al., 1993).  Since the candidate proteins 
are likely nuclear matrix associated proteins such as actin, which are intrinsic to DNA 
replication, transcription and repair processes (Miller et al., 1991), it could be twice as 
disruptive to nuclear and cellular function.  The increase in nucleoplasmic aberrations 
observed with RET treatment in the micronucleus assay could be linked to this 
phenomenon.  It must be remembered that following a 48 h exposure to the toxins there 
is a 24 h incubation with the MT cytochalasin-B, an actin polymerisation inhibitor that 
could disrupt the cytoskeleton function yet further (MacLean-Fletcher and Pollard, 1980).  
When considering the use of the CBMN assay with interacting genotoxins and cytostatics, 
it needs to be considered that only micronuclei associated with BNC are scored to prevent 
confounding effects caused by suboptimal cell division kinetics, a factor that could be 
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significantly important when the two mechanisms are concurrent.  Logistically, the 
reduction in the proportion of BNC due to reduced nuclear division makes the scoring 
process longer.  This suggests that the only cells exhibiting genotoxicity are those able to 
divide unhindered and not damaged sufficiently to undertake apoptosis.  This is 
exacerbated by the addition of Cytochalasin-B which inhibits cytokinesis by interacting 
with actin polymerisation.  If a cytostatic is tested in the CBMN test it is impossible to 
exclude the interaction of this mechanism with cytochalasin-B, as although rinsing with 
PBS prevents carry over, the modification to cell cycle kinetics/protein enrichment could 
influence cytokinesis. 
One theory that could be applied to the antagonistic response of DON to DNA damage 
and crosslinking by RET is the element of recovery time.  As DON reduces cellular 
turnover (especially at 0.1 µM), the time required to repair lesions in increased resulting 
in less migration in the comet assay and less chromatin loss in the CBMN assay.  However, 
there is a point where a DON concentration threshold is reached and apoptosis is 
prevalent (10 µM), or with both toxins (10 + 10 µM) when apoptosis is increased further 
by 25% and there is additional disruption to the cell cycle proteome leading to cellular 
senescence and megalocytosis.  The balance between DON-associated apoptotic 
induction and RET-related cellular senescence governs the latent effects of acute toxin 
exposure.  Hincks et al. (1991) found cells exposed to RET remained megalocytotic / 
senescent for a long period of time without undergoing apoptosis.  This is notably 
mirrored in vivo where chronic PA exposure causes unrepairable and accumulative 
damage in the liver leading to VOD and cirrhosis in livestock (Molyneux et al., 1988) and 
humans (Kakar et al., 2010).  If the same cells had undergone apoptosis, the harmful 
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chronic accumulation of megalocytosis would be avoided along with the risk of 
carcinogenesis.    
The current investigation employed positive controls; APH as a DNA-repair and replication 
inhibitor, MMC as a potent DNA-crosslinker, to validate the assays whilst providing 
additional indices of toxicological interaction.  APH not only inhibits DNA repair by 
interacting with at least three of the mammalian polymerases, it also prevents DNA 
replication and therefore nuclear division (Levenson and Hamlin, 1993) and yields double 
strand breaks (Kurose et al., 2006).  The accumulation of incision sites following agent 
exposure with the addition of APH has been proposed to increase the sensitivity of 
genotoxicity assays (Speit and Schütz, 2008).  The current results with APH treatments 
however indicate that reductions in cellular turnover, membrane integrity and esterase 
activity were more pronounced than any noticeable increases in accumulated DNA 
damage, indicating that the cells may be stalled in one stage of the cell cycle.   
Apoptotic processes are intrinsically linked to cell cycle progression checkpoints and 
arrest.  In fact, the stage of the cell cycle exposed can determine the susceptibility of the 
cell to certain toxins; including DNA replication inhibitors and crosslinking agents.  For 
example, APH was found by Kurose et al. (2006) to be most inhibitive during S-phase 
(actively replicating) and ineffective during the G1 (Initiation of cell division, non-
replicating) and G2 (DNA repair, commitment to mitosis, non-replicating) checkpoint gap 
phases.  Furthermore, cells may be already stalled in these non-replicating phases due to 
a binary exposure with another toxin, RET for example, therefore cell cycle phase-specific 
toxicity could be altered.  Taking this further, a cell arrested in G2 would have a larger 
volume due to the doubling of DNA and enrichment of enzymes and metabolic pre-
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cursors required post-cytokinesis.  Consequently, cells stalled at this stage may have a 
greater individual capacity for metabolism of xenobiotics (i. e. MTT, CFDA) due to the 
increased presence of specific enzymes and comet tail length could be increased by the 
presence of double the amount of DNA.  Likewise, arresting cells in G2 enables the repair 
of mitotic aberrations, which can reduce damage measured in the CBMN assay with a 
reduction in cell turnover.  This can be considered another level of complexity regarding 
interactive toxicity that needs to be considered     
MMC yielded robust crosslinking responses in the genotoxicity assays, which aided in 
explaining the dome-like RET response.  The effect on cellular proliferation and DNA 
fragmentation of a slightly crosslinking (0.1 µM) and lethally crosslinking (10 µM) dose 
was clear, although cellular esterase activity was reduced whilst protein levels were 
strangely increased, perhaps driven by a stress response or the cell cycle effects 
mentioned above.  DON and MMC co-exposure yielded a broadly similar interactive 
response to DON and RET.   
6.5.2 Oxidative stress and apoptosis induction 
A dose related increase in DON-associated aberrations scored in the micronucleus assay 
may be explained by the increased prevalence of cytome phenomena such as 
nucleoplasmic budding and bridging, caused by disrupted nuclear membrane and 
cytoskeleton integrity rather than direct DNA damage-yielding micronuclei, an 
observation also recorded by Yang and co-authors (2014) with human lymphocytes.  The 
same group suggested that any DNA damage stemming from DON exposure was due to 
oxidative stress due to depletion of mitochondrial cytochrome-c rather than direct 
interaction.  This fits well with the proteomic data in the current study where such 
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enzyme groups were upregulated with DON to presumably compensate for reduced ROS 
depletion capacity.  Li and co-workers (2014) found DON to induce effects in chicken 
embryo cells including mitochondrial membrane disruption, apoptosis and disruption of 
the cell cycle.  Zhang and co-workers (2009) exposed HepG2 cells to DON over a 1 h 
period with and without an antioxidant and concluded that the DNA damage recorded 
when exposed to 3.75-30 µM DON was due to ROS, although significant increases in ROS 
measurement were only found at a higher dose of 60 µM.  DON was however not found 
to increase DNA migration in the current study and instead a prevalence of apoptosis is 
recorded, which could be due to the 48 h incubation permitting initiation of apoptosis 
(yielding un-scorable cloud-like nucleoids), whereas a shorter exposure would observe an 
increase in oxidative DNA lesions.  Key research has suggested plasma membrane damage 
is less encountered than late stage apoptosis and DNA damage in regards to DON 
cytotoxicity (Minervini et al., 2004).  This agrees well with the current findings where 
trypan blue results are not as conclusive as apoptosis and cellular turnover assays.  The 
progenitor cause of this oxidative stress could be the downstream effects of DON-
ribotoxicity; the inhibition of peptide elongation in the ribosomes, specifically those 
required for enzymes used in the modulation of ROS concentration.  Pan and co-workers 
(2013a) published an extensive proteomic report on the early stage phosphorylation 
dynamics of acute DON-induced ribotoxicity in mice splenocytes, and found initialisation 
of MAPK and PI3K/AKT intracellular cascade pathways controlling intracellular signalling, 
cytoskeletal processes, apoptosis regulation and nucleus organisation.  The current work 
however focusses on late stage protein ontology characterisation after such cascading 
would have occurred and the effects of stalled ribosomal components, reduced protein 
synthesis and late stage apoptosis and cellular senescence is instead a possibility.   
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6.5.3 Metabolism and protein enrichment 
Whilst the assay endpoints in the current study focus on tangible decreases in cell vitality 
or increases in DNA instability, it is worth considering how the metabolic status of the cell 
could be affected by DON-induced ribotoxicity.  A reduction in phase I activation enzymes 
would augment reduced metabolism of RET to its deleterious nucleophilic pyrrole form, 
resulting in less DNA damage.  Likewise, a reduction in phase II excretion would yield an 
increased RET potential. 
Chronic low levels of DON in mice have been linked to a reduced xenobiotic metabolising 
capacity in terms of glutathione conjugation of trichothecenes, yet P450 enzymes were 
unaffected (Gouze et al., 2006).  T-2 toxin, another potent Fusarium MT which also shares 
the same protein synthesis inhibitory toxicity mechanism as DON, did not affect drug 
metabolism in Rabbit livers in vivo when exposed through the dietary route (Guerre et al., 
2000).  T-2 did conversely increase the activity of phase I and II enzymes in piglets 
administered sub-cutaneously (Dong et al., 2008), significantly for 24 h and less so for the 
following 48 h, but the levels were reduced again at 48 h.  Xenobiotic enzymes found with 
western blotting to be upregulated included: CYP1A2, CYP2E1, CYP3A4, glutathione-s-
transferase and GST M1-1 (as was found with DON in the proteomic analysis).  It would 
therefore appear DON exposure would not likely reduce the amount of RET being 
metabolically activated, but it would reduce the potential for excretion of the DNA-
reactive pyrrole intermediate by the glutathione-s-transferase route as glutathione levels 
are depleted (Fu et al., 2002).  Since both toxins were exposed concurrently it can be 
assumed that such a depletion relationship is not as pivotal, since both compounds are 
exposed to the same initial cellular glutathione concentration (assuming equal passage 
through the cell membrane).  When the concentration of one toxin is increased 10-fold 
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and the other remains at the same concentration it could be hypothesised that there 
would be less detoxification potential proportionally, thus increasing the concentration of 
DON may yield more pyrrole adducts indirectly (Yan and Huxtable, 1995).  It can be added 
that equal competition for binding sites is reliant on DON or RET having a similar affinity 
for the enzyme involved.  Strange and Hayes (2000) noted that there is a large degree of 
redundancy in regards to substrate detoxification in microsomal and cytosolic glutathione 
families.  A similar amount of metabolic redundancy can be found with the cytosolic 
hydrolysis of carboxyfluorescein-diacetate in the CFDA assay.  This metabolism can be 
accomplished by a multitude of proteases, lipases and esterases within the cell, and the 
degree of de-acetylation is a proxy for cellular vitality (Kessel et al., 1994).  DON at the 
lowest tested concentration (0.1 µM) was found to decrease cellular proliferation (as 
measured by the protein, cell count and MTT assays), yet was found to increase the 
hydrolysis of CFDA, especially if combined with RET or MMC.  One hypothesis is that as 
the cells divide at a reduced rate due to ribotoxic stress / DNA lesions, the cells have more 
time and resources to up-regulate the proteins needed for maintaining homeostasis, 
including enzymes required for CFDA metabolism.  Though there are fewer cells, 
providing apoptosis has not been induced, they are individually more metabolically active.  
This phenomenon could be associated with the arresting of the cell cycle in G2 phase as 
discussed earlier, i. e. the cells have more facility for metabolism of CFDA due to the 
presence of post-mitosis daughter cell levels of enzymes in pre-mitosis single cells.   
Interestingly, the esterase activity could also be linked to the susceptibility of the cell to 
RET exposure.  Two main routes to PA metabolism are present in the liver.  Cytochrome 
P450 produces the crosslinking pyrrole form whilst a metabolism of the RET with 
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esterases produces a low toxicity molecule which can be more easily excreted (Prakash et 
al., 1999b).  In rats with depleted esterase activity it has been shown that a larger 
proportion of the toxic pyrrole was produced than the non-toxic necines and necic acids 
(Mattocks, 1981).  The metabolic status of the HepG2 cell line dictates which metabolites 
and hence which effects may be induced and whether these could be modulated by co-
exposure with DON is still unknown.  
6.5.4 Critical evaluation of interactive toxicity strategy and use of HepG2 as 
surrogate model for mammalian RET/DON toxicity  
This study is in effect a pilot as there is very little in the literature evaluating the 
interactive toxicity of a crosslinking agent and protein synthesis inhibitor.  Whilst this may 
be perceived as a gap in scientific knowledge ripe for further assessment, the results 
presented in this chapter highlight the reason for such a research opening!  Toxicological 
analysis of mixture data is highly intricate and convoluted that demands a large degree of 
scoping to tease out relevant interactive relationships worth pursuing further.  Only then 
can a robust interactive strategy be undertaken.  The evaluation of multi-MT toxicological 
interactions has been undertaken with different methodologies with some focussing on 
mathematical models derived from isobologram techniques (Alassane-Kpembi et al., 2013) 
whilst others adopt a more direct statistical comparison approach (Lei et al., 2013).  The 
problem exists when both antagonistic and synergistic toxicity is present concurrently 
over a dose-response curve.  The current results, in regards to cytotoxicity, indicate RET 
to be antagonistic at low doses and only synergistic/additive at 100 µM.  DON has a more 
linear dose response and is the principle cytotoxic component recorded when in 
combination with RET.  The use of a wider range of concentrations and time course 
sampling strategies would greatly benefit this study, especially when trying to pin-point 
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the threshold interactive dose when cellular proliferation is reduced.  With so many 
facets of cellular toxicity that could be targeted with RET / DON exposure it can get overly 
complex, although scoping for key mechanisms is an important part of toxicological 
investigation.  It is perhaps more effective to focus on just cellular proliferation as a single 
endpoint, since it is a shared effect of both toxins and nests together the latent effects of 
geno- and cytotoxicity.  Such an approach was utilised by Alassane-Kpembi and co-
workers (2013) who used lysosomal integrity as the sole endpoint when considering 
binary and ternary trichothecene exposures, and therefore could generate more robust 
indices of interaction but without the mechanistic evaluation. 
In terms of the proteomic characterisation, it must be considered that the HepG2 cell-line 
is derived from a human liver tumour and as such, the degree to which the results can be 
extrapolated to in vivo scenario needs to be carefully considered.  Some workers have 
noted that HepG2 cells do not have the full phase I and II enzyme complement for toxin 
metabolism compared with primary hepatocytes which are more efficient at bio-
activation of pro-mutagens (Wilkening et al., 2003).  Others have described HepG2 cells 
as having one of the better metabolic competencies for an established cell line (Roe et al., 
1993, Kevekordes et al., 2001).  This negates the use of rat liver S9 fraction, which actually 
yields inferior metabolic activation of PAs to primary hepatocytes in any case (Müller et 
al., 1992).  This can be further improved by utilising 3D culturing techniques (such as 
spheroid culture), to restore native liver-like metabolic activity (Xu et al., 2003).  In 
addition, HepG2 cells were shown to have similar glucuronidation activity to freshly 
isolated human hepatocytes (Grant et al., 1988), and thus have a mechanism for DON and 
RET excretion in vitro (He et al., 2010b), which non-liver cell lines lack (UDP-
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glucuronosyltransferase was found enriched in the DON, RET and binary exposure in the 
current study).   
Extrapolation of the in vitro toxicological results collated in the current study to an 
assessment of human and production animal risk is not possible without additional in vivo 
experiments.  In vitro data does not account for differential rates of uptake during a 
dietary exposure (due to intestinal integrity and gut flora, (Akbari et al., 2014)) or the 
inter-individual variation in metabolism (due to body size, hepatic blood flow, liver weight 
and reserve capacity, age, sex and genetics, (Rostami-Hodjegan and Tucker, 2007)).  
However, the genotoxicological and cytological information gathered in vitro could help 
design a robust and efficient in vivo experiment in relation to which parameters to focus 
on.  It would be interesting to obtain acute and chronic toxicokinetic data of both toxins 
individually and together, for DON has been shown to effect gut wall morphology and 
intestinal membrane functionality enabling increased uptake of xenobiotics (viz. RET) in 
mice (Akbari et al., 2014) and chickens (Osselaere et al., 2013).  Since DON exerts toxicity 
in both liver and intestines, it would be again difficult to distinguish the exact mode of 
interactive toxicity with RET.  Measuring bulk reductions in animal growth rate and 
increases in liver malignancies and histopathological lesions would confirm whether a 
pertinent problem exists with co-exposure of DON with RET, and whether the cell cycle 
and genotoxicity effects observed in vitro were actually valid biomarkers of effect.  It 
would be interesting to determine if chronic exposure to DON predisposes the liver to 
increased uptake, metabolism and damage by RET as this would be a first for any DON-
interaction study. 
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6.5.5 Concluding remarks 
Whilst cellular exposure to RET results in predominantly DNA and protein crosslinks that 
hinder cellular proliferation (Li et al., 2013), DON yields a cytotoxic response based on 
ribotoxicity (Pan et al., 2013b), ROS production and apoptosis, with DNA damage induced 
indirectly (Bony et al., 2006).  The toxicological interaction between these two 
hepatotoxins is highly complex with the exact mechanisms remaining unclear, perhaps 
due to each toxin individually targeting multiple sites within the cell, differential effects 
on the cell cycle and multiple metabolic effects (Carpenter et al., 1998).  Further work is 
required using a single assay for simplicity, but with multiple time-points and a focus on 
toxins exposed over longer time scales at chronic concentrations.  In the greater scheme 
of toxicological burden associated with natural toxins, the use of models to predict 
toxicity profiles derived from mixtures of compounds would be useful for legislators 
working to improve food/feed safety.  However, the results highlighted in the current 
investigation suggest mechanistically that interactive toxicity is not a simple task of 
additive impact, but often a combination of a mixture of additive, synergistic and 
antagonistic responses over a range of dose combinations.  This is supported by results 
collected by Mckean and co-workers (2006) working with binary AFB1 and Fumonisin B1 
toxicity in HepG2 cells which suggests combinational toxicity follows a bi-phasic pattern, 
with chronic doses often antagonistic and acute doses yielding additivity.  Collation of 
structural indicators of toxicity and known toxicological mechanisms, tissue specificity and 
cellular targets is paramount when evaluating toxicity risk associated with co-exposed 
toxins.  The health implications of multiple feed and food-borne toxin exposures should 
not be under estimated or ignored.         
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7 General discussion: DON toxicity and biological remediation 
strategies, a perspective. 
 
This study explores many facets of DON research; from DON-contaminated spikelets to 
liver cell proteomics.  It has been shown that DON is extremely potent in terms of toxicity, 
resistant to the effects of pH in fermented feeds and is unaffected by the presence of LAB 
isolated from birds or commercially available LAB silage additives.  However, there is an 
exciting suggestion that this robust molecule could be removed from contaminated CG by 
resident phyllosphere LAB under specific ensiling conditions.   
The original research question fielded in the initial stages of this investigation was 
whether LAB from liquid feed, commercial fermented feed inoculants or LAB from wild 
birds could play a role in DON removal in liquid media.  It was swiftly noticed that this was 
not to be.  Knowing when to pursue an anomalous result further and when to change tack 
and develop new hypotheses is well illustrated in the current thesis.  It was initially 
envisaged that a LAB would be able to degrade DON and its degradation products could 
be identified and tested for toxicity in an in vitro cellular experiment (fortuitously this was 
exactly what was possible with the equally as toxic, yet more labile patulin (Appendix 
10.2).  The scheme of events with the current DON investigation was too reliant on a 
positive result, hence the change of tack to CG feeds, a novel area in regards to MT 
research.  While published studies on CG are few in number (11 articles from 1950 to 
present in Web of Science when using “crimped grain” as keywords (WoK, 2015)), the 
application itself has a multitude of agricultural benefits such as: shorter cropping cycles, 
higher nutritional value and on-farm feed traceability.   
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Following the sourcing of freshly harvested CG for a spike and recovery experiment, 3 
silos from 30 were found to have a significant reduction in DON, and all 3 were heat 
treated to reduce the microbial community prior to addition of DON.  At the time of the 
first CG experiment there was only a short window between collecting the CG and 
ensiling.  CG has a relatively limited functional lifespan as once crimped, it can rapidly 
deteriorate through oxidation and hydrolysis to lose its realistic feed properties.  With the 
benefit of hindsight the mechanism of heat treatment would have been further 
characterised at this point, for it is unclear whether thermal inactivation of resident 
inocula or modifications to the CG matrix (i. e. anaerobicity, nutrient availability, water 
activity) were chiefly responsible for the shift in microbial assemblage and whether this 
augmented a biological reduction in DON, or conversely the heat treatment produced a 
matrix change which physically or chemically interacted with DON directly. 
Whilst there was a drop in DON recovery with the heat treated grain, without definitive 
evidence of metabolism, such as the identification of novel peaks in the HPLC-UV analysis, 
the detoxification mechanism remains unknown.  It is possible that a “dilute and shoot” 
LC-MS/MS approach would be more fruitful in determining if any specific DON 
metabolites were present at all using the selected-ion monitoring (SIM) approach without 
the requirement for immunoaffinity clean-up, and hence without the structural bias of 
DON-specific antibodies or effect of pH (Malachová et al., 2014).  The SIM approach was 
extremely successful with identifying the PAT metabolites in the attached hydroascladiol 
paper (Hawar et al., 2013), although it helps if the parent molecule and MS fragments 
M/Z are already known or mathematically derived.  Unfortunately, the decrease in DON 
in vitro with W. cibaria and H. alvei did not translate to an adequate decrease under silo 
224 
 
conditions with naturally contaminated grain.  Should more work be undertaken with 
these bacteria it is important to heed the recommendations by Jard et al. (2011) in order 
decide if they are viable degradation agents.  The biotransformation must be swift and 
the bacteria should be able to undertake the reaction under a range of oxygen, nutrient, 
water activity and pH conditions.  The biotransformation products need to be assessed 
for toxicity in vivo.  The bacteria need to be non-pathogenic and must not express 
antibiotic resistance.  A further beneficial trait would be the LAB possessing the enzymatic 
capacity for hydrolysis of D3G to DON in order effect a more thorough DON removal in 
the grain.  Berthiller et al. (2011) found L. plantarum could hydrolyse 62% of D3G in 8 h at 
37 °C in liquid media compared with other LAB which were negative for this property.  
Although the primary function would be to degrade DON, it would be worth testing the 
LAB as a potential BCA in the field or as a silage additive in isolation using the mould 
spore inhibition assay and by measuring solid state fermentation parameters further.  W. 
cibaria has already shown a reasonable ability to produce acetic and lactic acids, although 
whether it can compete with homolactic Lactobacilli in naturally colonised grain is 
currently unknown, although W. cibaria has been found to dominate maize silage under 
certain conditions (Pang et al., 2011).  The additional ability to degrade PAs, such as RET, 
within the silo would also reduce the toxicity burden of co-occurring silage toxins in cattle 
TMR.  This would be well received by the dairy industry considering the accumulative PA 
liver toxicity (Craig et al., 1991) and carryover of PAs into milk (Hoogenboom et al., 2011).  
Incidentally, the research on PA detoxification in silage is rather limited, notwithstanding 
one article by Candrian and co-workers (1984), who recorded a significant metabolism of 
PAs with grass silage compared with hay.  
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Decreasing DON or PA levels in silage would mean little if the resulting feed was inferior 
nutritionally, unpalatable and reduced animal productivity.  It must equally be considered 
that the nutritional components of the feed including; antioxidants, micronutrients, and 
probiotic LAB, may impart a protective role against DON in their own right.  Furthermore, 
if the mechanism of DON reduction in silage was through binding, it would be worthless if 
the bond was insufficiently strong to pass through the GI tract intact and would be 
considered “masking” the actual toxicity of the feed.  The same could be said for 
biotransformation where the end-products may be equally toxic, but may escape 
detection by IAC-RP-HPLC due to structural chemical changes.  
There is little doubt that reducing the amount of toxigenic Fusarium sp. in a crop to begin 
with is a better overall strategy than removing the MT’s postharvest.   However, climatic 
anomalies (Magan et al., 2011) and an imminent EU restriction on azole fungicides 
(European-Commision, 2011) may nullify any previously Fusarium-limiting farming 
practices, such as those discussed previously by Edwards (2004).  Some growing seasons 
yield an unusually high DON contamination, such as in the USA in 1993 when over $2 
billion was lost on the value of wheat and barley due to DON levels, on top of the yield 
losses caused by FHB itself (McMullen et al., 1997).  Had the grain been salvaged with a 
biological agent in a fermented feed context, then it is possible that the financial loss 
could have been lessened.  Another avenue of interest would involve applying a BCA in 
the field as a prophylactic additive to outcompete and inhibit Fusarium growth and ideally 
degrade DON immediately following production therefore preventing accumulation in the 
grain.  The use of BCAs rather than fungicides is a major development area, especially in 
organic farming (European-Commision, 2014).  An added benefit would be that should 
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the grain be ensiled, then the BCA at a sufficiently high seeding density could continue to 
reduce DON within the silo.  This would be the ideal situation with W. cibaria, as it was 
isolated from the phyllosphere of barley initially and would benefit from a higher seeding 
density to shape the initial community assemblage and effect DON removal, on the 
proviso that results under laboratory conditions can be transferred effectively into the 
field conditions.   
The banning of azole fungicides, whilst reducing the burden of manmade xenobiotics in 
food and feed may indirectly increase the amount of MT entering the food/feed chains.  
There can be no question as to the potency of many of the trichothecenes MTs and this 
should be weighed up against the toxicological risk of existing fungicides to the producer 
and consumer.  It is also worth mentioning  that in addition to fungicides, there is a EC-led 
decrease in the number plant protection products available for controlling toxigenic weed 
species in arable crops and pasture (e.g. Atrazine (European-Commision, 2011)), with a 
speculated knock-on effect being an increase in the amount of PAs such as RET entering 
the feed chain.  This process of balancing up the overall human and environmental 
toxicological burden of food and feed in terms of manmade and natural co-contaminants 
is a current research direction for eminent ecotoxicological scientists such as Dana Kolpin 
(Kolpin et al., 2010) and is a research question currently being investigated in our 
laboratory using a zebrafish embryo development assay.  This field can be aligned with a 
growing public awareness of climate change, heavy metal burden, persistent organic 
pollutants, endocrine disruptors, soil loss, food miles, food safety and food security.  A 
holistic view of these areas of human impact against a growing agricultural need is 
required, especially when considering the human population is predicted to surpass 9.6 
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billion by 2050 (UN, 2013).    Every aspect of agriculture will be scrutinised for nutritive 
losses, including CG feeds; therefore more research is required in this area. 
In harmony with a growing interest in the risk from grain-borne MT toxicity is the 
increased research into the effects of MT mixtures (Tatay et al., 2014, Ruiz et al., 2011a, 
Ruiz et al., 2011b, Prosperini et al., 2014).  It has always been appreciated that MT’s 
seldom appear individually within a commodity.  Trichothecene MTs such as DON, 
3AcDON, ZEA and T2-toxin co-occur in grain leading to co-exposure in the consumer 
(Ibáñez-Vea et al., 2012).  Furthermore, grain can be contaminated with a range of 
MT/phytotoxins which are equally as hazardous as trichothecenes, yet little attention has 
been made to determine whether the co-exposure of the omnipresent DON with non-
trichothecenes yields notable synergistic toxicity.  The co-exposure of AFB1 (A. flavus, 
cancer initiator) with Fumonisin B2 (F. verticillioides, cancer promoter), both found to co-
occur in maize and intrinsically linked to increased incidences of hepatic tumorigenesis in 
rats, humans and rainbow trout (Gelderblom et al., 2002b) may be noted as the driver for 
many MT interaction studies, yet it must also be appreciated that Hepatitis C can also 
synergistically interact with AFB1 to increase the likelihood of liver cancer (Kew, 2003).  
Whether DON plays a similar role as a cancer promoter has not yet been explored, 
although it is ubiquitous enough in a wide range of commodities to warrant further 
studies.  However, the results in vitro presented here do not entertain this possibility of 
such a relationship with RET, a less potent carcinogen than AFB1 .   
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Table 7.1.  The systems approach to counteracting MT contamination as introduced at the 8
th
 World 
Mycotoxin Forum (WMF, 2014).  The research areas which are related to the current study are highlighted 
with an asterisk. 
Contributory factors / 
preventative agricultural 
methods 
Research led MT 
prevention 
strategies 
 MT analysis  
Storage/processing 
methods 
Food safety and 
food security 
Weather conditions* Breeding Sampling* Storage* 
Human health 
risks* 
Climate change Genomics Analysis* Processing* 
Animal health 
risks* 
Land use Varieties Metabolomics 
Safe 
decontamination* 
Food and feed 
safety* 
Crop management* Bio-control*  Transport Food security* 
Good agricultural 
practice* 
   Regulations 
 
Whilst a lot of research has been undertaken, the toxicological and financial effects of 
DON continue to occur.  The challenge remains to exclude DON from food and feed, yet 
there is unlikely to be a one size fits all remedy any time soon.  Any significant reduction 
in DON impact is more likely to due to an integrated response based on the systems 
approach encompassing HACCP (hazard analysis and critical control points) and endorsed 
by the FAO and later updated at the World Mycotoxin Forum, 2014, in Table 8.1 (WMF, 
2014, FAO, 2001).  This study is aligned to many of the research areas outlined and whilst 
scoping in nature, the information gathered is hopefully a springboard for further work on 
DON remediation in fermented feeds. 
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9 Appendix 
10.1 Additional figures and tables 
Table 10.1. Enrichment of protein groups compared with the control for HepG2 cells exposed to 10 µM 
DON, RET or both for 48 h.  Each protein group is shown with the PEP value which is the significance 
probability of the identification ranging from <0.001 as a minimum to zero (absolute identification).  The 
minimum percentage increase to be considered enrichment was 4-fold (400%) or above.  Functionality of 
each protein is grouped as previously and labelled as follows: PS (protein synthesis); Tr (translational 
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elongation), Apop (apoptosis); Mem (membrane); ResOS (response to organic substance) and CCR (cell 
cycle regulation). 
PEP Gene Name                DON 
Percentage of 
control ion 
intensity 
4.71E-17 catenin (cadherin-associated protein), delta 1 (Mem) 5673.9 
0 
histone cluster 1, H2ag; histone cluster 1, H2ah; histone cluster 1, H2ai; 
histone cluster 1, H2ak; histone cluster 1, H2al; histone cluster 1, H2am 
3988 
3.27E-16 H2A histone family, member V 2521.9 
1.03E-30 programmed cell death 11 (Mem) 1390.2 
0`.000128 solute carrier family 30 (zinc transporter), member 7 (Mem) 1321.7 
3.07E-12 
ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit 
(Mem, CCR) 
1288.4 
4.30E-105 cytochrome b5 type B (outer mitochondrial membrane) (Mem) 1221 
1.30E-65 
VAMP (vesicle-associated membrane protein)-associated protein A, 
33kDa (Mem) 
1207.2 
7.70E-162 H2A histone family, member X (CCR, DNA damage repair) 1194.2 
2.30E-23 ribosomal protein L34 (PS, Tr) 1188.7 
1.45E-15 hippocalcin like 4 1174.5 
 
]1.40E-11 
small nuclear ribonucleoprotein polypeptides B and B1 1121.7 
0 tubulin, beta 4 1059.6 
3.51E-42 ribosomal protein L23 pseudogene 6; ribosomal protein L23 (PS, Tr) 1025 
7.80E-41 
ribosomal protein S10; ribosomal protein S10 pseudogene 4; ribosomal 
protein S10 pseudogene 11 13 (PS, Tr) 
1010.8 
2.66E-71 
chromosome 10 open reading frame 58; chromosome 10 open reading 
frame 57 (Mem) 
1000.5 
1.19E-17 ribosomal RNA processing 12 homolog (S. cerevisiae) (PS, Tr, Mem) 994.2 
3.32E-39 heterogeneous nuclear ribonucleoprotein A0 991.6 
1.84E-26 
ribosomal protein L26 pseudogene 33; ribosomal protein L26; ribosomal 
protein L26 pseudogene 16; ribosomal protein L26 pseudogene 19; 
ribosomal protein L26 pseudogene 6 (PS, Tr) 
987.7 
7.87E-18 transmembrane emp24 domain trafficking protein 2 (Mem) 985 
2.76E-12 asparaginyl-tRNA synthetase (PS, CCR) 970 
3.30E-148 RAB14, member RAS oncogene family (Mem) 960.7 
2.10E-120 microsomal glutathione S-transferase 1 (ResOS, Mem) 943.1 
3.68E-08 U2 small nuclear RNA auxiliary factor 2 941.6 
3.99E-17 ribosomal protein L18a pseudogene 6; ribosomal protein L18a (PS, Tr) 939.3 
2.20E-17 C-type lectin domain family 16, member A 938.8 
0 heterogeneous nuclear ribonucleoprotein A3 934.9 
8.96E-10 RAN binding protein 2 882.1 
1.82E-06 SEC11 homolog A (S. cerevisiae) (Mem) 868.4 
1.33E-68 splicing factor, arginine/serine-rich 9 866.7 
9.48E-05 
NADH dehydrogenase (ubiquinone) 1, subcomplex unknown, 2, 14.5kDa 
(Mem) 
856.2 
2.19E-28 polyribonucleotide nucleotidyltransferase 1 825.3 
1.89E-36 cytochrome c oxidase subunit IV isoform 1 (Mem) 819.3 
7.43E-12 chromosome 7 open reading frame 50 819 
1.40E-134 RAB2A, member RAS oncogene family (Mem) 803.6 
1.39E-26 ADP-ribosylation factor 4 787.4 
3.00E-117 
ATP synthase, H+ transporting, mitochondrial F0 complex, subunit B1 
(Mem, CCR) 
770 
1.01E-06 RecQ protein-like (DNA helicase Q1-like) (CCR, DNA damage repair) 769.5 
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9.05E-62 
ribosomal protein, large, P2 pseudogene 3; ribosomal protein, large, P2 
(PS, Tr) 
768.2 
4.92E-11 ilvB (bacterial acetolactate synthase)-like (Mem) 729.5 
3.53E-18 hepatoma-derived growth factor (high-mobility group protein 1-like) 729.5 
1.88E-07 ADP-ribosylation factor-like 8B (Mem) 727.2 
1.58E-14 ENSG00000174886 727.1 
1.60E-148 phosphatidylethanolamine binding protein 1 (ROS, Mem, CCR) 700.6 
1.07E-37 GCN1 general control of amino-acid synthesis 1-like 1 (yeast) 699 
2.29E-42 cytochrome b5 type A (microsomal) (Mem) 675.4 
0 serpin peptidase inhibitor, clade B (ovalbumin), member 12 674 
7.73E-67 ribosomal protein S9; ribosomal protein S9 pseudogene 4 (PS, Tr) 669.8 
1.85E-26 adipose differentiation-related protein (ResOS, Mem) 658.9 
3.86E-55 
ribosomal protein S6 pseudogene 25; ribosomal protein S6; ribosomal 
protein S6 pseudogene 1 (PS, Tr, Apop) 
658.2 
4.50E-64 S100 calcium binding protein P 654 
0.000505 splicing factor 3b, subunit 4, 49kDa 639.9 
1.37E-28 
high-mobility group box 1; high-mobility group box 1-like 10 (Apop, DNA 
damage repair) 
633.7 
3.11E-40 thioredoxin-related transmembrane protein 2 (Mem) 624.8 
1.42E-14 BCS1-like (yeast) (Mem, CCR) 621.3 
1.80E-147 
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation 
protein, zeta polypeptide (Tr,  Apop) 
612.8 
5.52E-41 chromosome 9 open reading frame 114 605.6 
6.83E-06 scribbled homolog (Drosophila) (Apop, Mem) 600.9 
2.16E-34 SERPINE1 mRNA binding protein 1 595 
1.12E-11 RAN binding protein 6 590.1 
9.66E-47 
eukaryotic translation initiation factor 2, subunit 2 beta, 38kDa (PS, Tr, 
CCR) 
587.6 
2.78E-46 echinoderm microtubule associated protein like 4 (CCR) 585.7 
8.10E-283 signal recognition particle receptor, B subunit (Mem) 579.8 
7.06E-06 laminin, alpha 5 560.7 
2.60E-125 complement component 1, q subcomponent binding protein 559.1 
7.58E-16 mitochondrial ribosomal protein L37 558.3 
5.11E-08 methionyl-tRNA synthetase (PS, CCR) 557.7 
1.12E-30 ENSG00000215472 554.1 
5.54E-95 
sulfotransferase family, cytosolic, 1A, phenol-preferring, member 4; 
sulfotransferase family, cytosolic, 1A, phenol-preferring, member 3 
552.2 
1.44E-25 gamma-glutamyl cyclotransferase (Apop) 546.5 
6.08E-12 isocitrate dehydrogenase 3 (NAD+) alpha 542.8 
2.80E-249 
glyceraldehyde-3-phosphate dehydrogenase-like 6; hypothetical protein 
LOC100133042; glyceraldehyde-3-phosphate dehydrogenase (Mem) 
542.1 
8.76E-11 Fas associated factor family member 2 529.9 
9.16E-30 tetratricopeptide repeat domain 35 514.6 
8.36E-25 
ribosomal protein S15a pseudogene 17; ribosomal protein S15a 
pseudogene 19; (PS, Tr) 
507.8 
2.01E-12 
CTAGE family, member 5 pseudogene; CTAGE family member; CTAGE 
family, member 4; CTAGE family, member 5 (Mem) 
506.4 
7.40E-130 ribosomal protein L9; ribosomal protein L9 pseudogene 25 (PS, Tr) 497.5 
1.00E-115 RAB1A, member RAS oncogene family (Mem, CCR) 495.9 
1.92E-52 
ribosomal protein S16 pseudogene 1; ribosomal protein S16 pseudogene 
10; ribosomal protein S16 (PS, Tr) 
494.7 
0.000776 LIM homeobox transcription factor 1, beta 489.7 
1.33E-82 
VAMP (vesicle-associated membrane protein)-associated protein B and C 
(ResOS, Mem) 
487.2 
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1.76E-13 Mov10, Moloney leukemia virus 10, homolog (mouse) (Mem) 485.1 
2.24E-55 
ribosomal protein S13 pseudogene 8; ribosomal protein S13; ribosomal 
protein S13 pseudogene 2(PS, Tr) 
483.6 
1.33E-52 RAB11B, member RAS oncogene family (Mem) 478.2 
1.25E-11 isovaleryl Coenzyme A dehydrogenase (CCR) 477.8 
8.37E-20 CSE1 chromosome segregation 1-like (yeast) (Apop) 472.5 
0.000761 proteasome (prosome, macropain) subunit, alpha type, 4 (CCR) 469.4 
2.52E-17 ribosomal protein L15 pseudogene 22;  468.5 
4.86E-11 
eukaryotic translation initiation factor 2-alpha kinase 2 (PS, ResOS, CCR, 
Apop) 
467.6 
5.39E-06 SAR1 homolog B (S. cerevisiae) (Mem) 467.6 
4.94E-27 NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 12 (Mem) 466.3 
1.05E-08 ribosomal protein L27 (PS, Tr) 463.6 
3.09E-40 glutamine-fructose-6-phosphate transaminase 1 462.2 
1.05E-33 aspartyl-tRNA synthetase (PS, CCR) 461.3 
3.05E-05 NADH dehydrogenase (ubiquinone) 1 beta subcomplex, 3, 12kDa (Mem) 449.2 
2.93E-10 zinc finger RNA binding protein 448.4 
2.64E-55 
proliferation-associated 2G4, 38kDa; proliferation-associated 2G4 
pseudogene 4 (CCR) 
445.6 
7.65E-35 talin 1   (Mem) 444.4 
2.88E-12 LEM domain containing 2 (Mem) 443.7 
4.50E-240 
solute carrier family 25 (mitochondrial carrier; adenine nucleotide 
translocator), member 6 (Mem, Apop) 
441.3 
7.06E-05 chromobox homolog 1 (HP1 beta homolog Drosophila ) 434.9 
4.75E-30 Thioredoxin 433.9 
1.80E-37 
ribosomal protein L21 pseudogene 134; ribosomal protein L21 
pseudogene 80; ribosomal protein protein L21 (PS, Tr) 
430.8 
1.48E-18 proteasome (prosome, macropain) subunit, beta type, 1 (CCR) 428.6 
1.10E-10 inositol 1,4,5-triphosphate receptor, type 3  (Mem) 427.2 
1.50E-178 ER lipid raft associated 1 (Mem) 427.1 
1.89E-41 
ribosomal protein L13a pseudogene 7; ribosomal protein L13a 
pseudogene 5; ribosomal protein L13a pseudogene 16; ribosomal protein 
L13a; ribosomal protein L13a pseudogene 18 (PS, Tr) 
426.6 
2.99E-22 v-ral simian leukemia viral oncogene homolog A (ras related) (Mem) 423.9 
2.96E-08 RAN, member RAS oncogene family (Tr, CCR) 423.8 
2.63E-14 retinol dehydrogenase 11 (all-trans/9-cis/11-cis) (Mem) 418.5 
5.30E-122 eukaryotic translation initiation factor 3, subunit L(PS) 413.3 
9.36E-44 phosphoenolpyruvate carboxykinase 2 (mitochondrial) 412.5 
4.13E-51 eukaryotic translation initiation factor 2, subunit 1 alpha, 35kDa (PS) 411.8 
7.20E-102 prolactin regulatory element binding (Mem) 411.8 
1.82E-06 emopamil binding protein (sterol isomerase) (Mem) 411.6 
1.56E-26 RAP1B, member of RAS oncogene family (Mem) 409.1 
7.96E-07 NADH-ubiquinone oxidoreductase chain 5 (Mem) 408.9 
1.32E-40 ribosomal protein S25 pseudogene 8; ribosomal protein S25 (PS, Tr) 407.5 
 Gene Name                 RET 
Percentage of 
control ion 
intensity 
0 
histone cluster 1, H2ag; histone cluster 1, H2ah; histone cluster 1, H2ai; 
histone cluster 1, H2ak; histone cluster 1, H2al; histone cluster 1, H2am 
4813.246 
1.19E-17 ribosomal RNA processing 12 homolog (S. cerevisiae) (Mem) 956.2 
1.02E-12 ATP citrate lyase 824.9 
1.03E-30 programmed cell death 11 (Apop) 692.1 
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1.34E-07 nucleolar complex associated 3 homolog (S. cerevisiae) 672.4 
1.37E-28 
high-mobility group box 1; high-mobility group box 1-like 10 (Apop, DNA 
damage repair) 
650 
2.34E-08 sel-1 suppressor of lin-12-like (C. elegans) (Mem) 647.3 
3.09E-14 procollagen-lysine, 2-oxoglutarate 5-dioxygenase 2 (Mem) 600 
7.06E-06 laminin, alpha 5 534.7 
4.71E-17 catenin (cadherin-associated protein), delta 1 (Mem) 524.4 
6.45E-43 pentatricopeptide repeat domain 1 455.6 
5.69E-05 
growth arrest and DNA-damage-inducible, gamma interacting protein 1 
(PS, CCR) 
418.6 
1.82E-06 emopamil binding protein (sterol isomerase) (Mem) 417.8 
PEP  Gene Name             DON/RET 
Percentage of 
control ion 
intensity 
1.07E-26 uridine phosphorylase 2 14920.8 
2.75E-08 
lectin, galactoside-binding, soluble, 7; lectin, galactoside-binding, soluble, 
7B 
1676.3 
5.67E-58 KIAA0020 1412.3 
0.012821 spermatogenesis associated 18 homolog (rat) 1393.9 
6.83E-06 scribbled homolog (Drosophila) 682.2 
4.75E-30 Thioredoxin 663.6 
9.81E-53 
tyrosine 3-monooxygenase/tryptophan 5-monooxygenase activation 
protein, gamma polypeptide 
648.9 
1.47E-43 enhancer of rudimentary homolog (Drosophila) 558.7 
0 
signal recognition particle 14kDa (homologous Alu RNA binding protein) 
pseudogene 1; signal recognition particle 14kDa (homologous Alu RNA 
binding protein) 
515.4 
5.74E-09 polymerase (RNA) I polypeptide C, 30kDa 515.1 
3.09E-40 glutamine-fructose-6-phosphate transaminase 1 489.0 
1.51E-65 glutathione reductase 478.0 
0 ribosomal protein L9; ribosomal protein L9 pseudogene 25 450.5 
7.80E-41 
ribosomal protein S10; ribosomal protein S10 pseudogene 4; ribosomal 
protein S10 pseudogene 11; ribosomal protein S10 pseudogene 22; 
ribosomal protein S10 pseudogene 7; ribosomal protein S10 pseudogene 
13 
443.0 
5.96E-23 chaperonin containing TCP1, subunit 5 (epsilon) 424.5 
1.98E-43 chaperonin containing TCP1, subunit 7 (eta) 421.8 
2.16E-06 COX4 neighbor 419.7 
1.18E-08 
proteasome (prosome, macropain) 26S subunit, ATPase, 1; similar to 
protease (prosome, macropain) 26S subunit, ATPase 1 
413.0 
 
 
 
Table 10.2. Reduced expression of protein groups compared with the control for HepG2 cells exposed to 
10 µM DON, RET or both for 48 h.  Each protein group is shown with the PEP value which is the 
significance probability of the identification ranging from <0.001 as a minimum to zero (absolute 
identification).  Only a 4-fold reduction (25% of control or less) was considered significant and is 
presented.  Functionality of each protein is grouped as previously and labelled as follows: PS (protein 
synthesis); Tr (translational elongation), Apop (apoptosis); Mem (membrane); ResOS (response to organic 
substance) and CCR (cell cycle regulation).   
PEP  Gene name                                    DON 
Percentage of control 
ion intensity 
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0 protein disulfide isomerase family A, member 6 24.9 
2.49E-07 similar to ferritin, light polypeptide; ferritin, light polypeptide 24.7 
3.19E-06 dihydrolipoamide branched chain transacylase E2 24.6 
8.20E-144 
translocase of outer mitochondrial membrane 7 homolog (yeast) 
(Mem) 
24.5 
1.35E-07 Ly1 antibody reactive homolog (mouse) 24.1 
3.32E-27 alcohol dehydrogenase 4 (class II), pi polypeptide 23.9 
7.96E-30 eukaryotic translation elongation factor 1 epsilon 1 23.8 
1.40E-21 phosphate cytidylyltransferase 1, choline, alpha (Mem) 23.3 
6.84E-10 acyl-Coenzyme A oxidase 2, branched chain 23.1 
7.42E-07 dipeptidase 1 (renal) (Mem) 23 
5.80E-45 acyl-Coenzyme A oxidase 1, palmitoyl 22.5 
8.17E-05 serpin peptidase inhibitor, clade B (ovalbumin), member 1 22.3 
3.06E-84 endoplasmic reticulum protein 29 22 
0.000167 hypothetical LOC100130009; high mobility group AT-hook 1 21.4 
1.18E-05 cathepsin B 21.3 
8.10E-135 hydroxysteroid dehydrogenase like 2 21.3 
4.61E-32 secretory carrier membrane protein 2 (Mem) 21.1 
8.00E-208 vesicle amine transport protein 1 homolog (T. californica) 20.2 
7.74E-05 N-myc downstream regulated 1 (Mem) 20.2 
1.70E-14 transcription elongation factor A (SII), 3 20 
5.99E-79 
heat shock 27kDa protein-like 2 pseudogene; heat shock 27kDa protein 
1 
19.4 
1.66E-06 myelin protein zero-like 1 19.1 
2.80E-126 serine hydroxymethyltransferase 2 (mitochondrial) 18.9 
3.74E-06 protein O-fucosyltransferase 1 18.6 
3.19E-13 carboxypeptidase D (Mem) 18.6 
2.01E-07 glycosyltransferase 25 domain containing 1 18.3 
9.70E-138 hypothetical LOC100129500; apolipoprotein E 17.6 
0 histone cluster 1, H1c 17.3 
3.90E-138 annexin A7 17 
5.30E-290 mercaptopyruvate sulfurtransferase 17 
4.59E-15 catechol-O-methyltransferase (Mem) 16.8 
6.82E-15 
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 2, 8kDa 
(Mem) 
16.5 
9.75E-09 HtrA serine peptidase 2 (Mem, Apop) 15.6 
9.64E-12 
 
mitochondrial ribosomal protein L39 15.3 
4.72E-07 arsA arsenite transporter, ATP-binding, homolog 1 (bacterial) 14.6 
3.20E-07 arylsulfatase E (chondrodysplasia punctata 1) 14 
3.25E-12 FUN14 domain containing 2 13.6 
3.34E-08 lectin, galactoside-binding, soluble, 3 binding protein 13.4 
9.84E-05 sialidase 1 (lysosomal sialidase) (Mem) 12.8 
6.12E-61 farnesyl-diphosphate farnesyltransferase 1 (Mem) 12.7 
5.56E-38 PDZ and LIM domain 1 12.5 
1.96E-27 tropomyosin 4 11.5 
1.03E-07 transcription factor B1, mitochondrial 11.2 
2.59E-26 poly(rC) binding protein 2 10.6 
0.000853 
translocase of outer mitochondrial membrane 6 homolog (yeast) 
(Mem) 
9.6 
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2.42E-13 carbonic anhydrase I 9.4 
5.93E-07 cytochrome P450, family 4, subfamily F, polypeptide 2 9 
2.57E-32 chromosome 11 open reading frame 59 (Mem) 8.8 
1.78E-05 
ribosomal protein S29 pseudogene 11; ribosomal protein S29 
pseudogene 16; (PS) 
8.6 
2.49E-22 
small nuclear ribonucleoprotein polypeptide E-like 1; small nuclear 
ribonucleoprotein polypeptide E; similar to hCG23490 
8.1 
1.77E-11 ribosomal protein L28 3.2 
PEP  Gene Name                         RET 
Percentage 
of control 
ion intensity 
0.001759 ADAM metallopeptidase domain 10 24.9 
1.78E-05 ribosomal protein S29 pseudogene 11;  24.7 
2.51E-16 KRR1, small subunit (SSU) processome component, homolog (yeast) 24.2 
3.01E-79 protein kinase C substrate 80K-H 23.6 
3.03E-12 general transcription factor II, i; general transcription factor II, i, pseudogene 22.5 
1.66E-06 myelin protein zero-like 1 21.8 
2.68E-06 adenine phosphoribosyltransferase 21.7 
3.68E-08 U2 small nuclear RNA auxiliary factor 2 20.9 
0.00E+00 small nuclear ribonucleoprotein D3 polypeptide 18kDa 17.0 
0.000197 peptide deformylase (mitochondrial); component of oligomeric golgi complex 8 16.0 
7.96E-30 eukaryotic translation elongation factor 1 epsilon 1 15.5 
0.002203 vacuolar protein sorting 8 homolog (S. cerevisiae) 14.6 
5.43E-13 calmodulin-like 5 13.6 
7.42E-07 dipeptidase 1 (renal) (Mem) 10.7 
2.42E-13 carbonic anhydrase I 10.4 
0.005129 programmed cell death 6 interacting protein 7.9 
1.77E-11 ribosomal protein L28 5.3 
0.021621 phospholipase C, eta 1 4.9 
2.38E-17 proline rich 4 (lacrimal) 3.2 
0 lactate dehydrogenase A 0.1 
PEP  Gene Name                         DON/RET 
Percentage 
of control 
ion 
intensity 
1.85E-16 methylenetetrahydrofolate dehydrogenase (NADP+ dependent) 1-like 25.0 
2.28E-21 mago-nashi homolog, proliferation-associated (Drosophila) 24.7 
1.4E-42 mitochondrial ribosomal protein S27 24.5 
3.01E-79 protein kinase C substrate 80K-H 24.4 
3.07E-12 ATP synthase, H+ transporting, mitochondrial F1 complex, delta subunit 24.3 
5.6E-18 solute carrier family 16, member 3 (monocarboxylic acid transporter 4) 23.9 
5.59E-13 transmembrane protein 70 23.8 
6.02E-52 pyruvate carboxylase 23.7 
2.31E-06 solute carrier family 2 (facilitated glucose transporter), member 2 23.7 
1.6E-158 catenin (cadherin-associated protein), beta 1, 88kDa 23.5 
2.85E-09 S100 calcium binding protein A16 23.2 
2.1E-13 tripartite motif-containing 28 22.7 
7.27E-68 poly(A) binding protein, nuclear 1 22.5 
2.32E-24 acylglycerol kinase 22.5 
5.42E-43 fibrinogen alpha chain 22.4 
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1.13E-05 P450 (cytochrome) oxidoreductase 22.0 
8.8E-290 
non-metastatic cells 1, protein (NM23A) expressed in; NME1-NME2 readthrough 
transcript; non-metastatic cells 2, protein (NM23B) expressed in 
21.8 
1.94E-08 cadherin 1, type 1, E-cadherin (epithelial) 21.0 
0.002974 calcium activated nucleotidase 1 20.5 
0.00189 syndecan 2 19.7 
2.91E-53 topoisomerase (DNA) I 19.7 
2.68E-06 adenine phosphoribosyltransferase 18.9 
6.5E-113 myosin, heavy chain 9, non-muscle 18.7 
9.72E-22 protein kinase, interferon-inducible double stranded RNA dependent activator 18.6 
2.43E-73 adenylate kinase 3 18.4 
2.61E-48 AHNAK nucleoprotein 18.2 
1.43E-43 HEAT repeat containing 1 18.2 
0 histone cluster 1, H2bo 18.1 
1.62E-27 peroxiredoxin 4 18.1 
5.9E-110 sterol carrier protein 2 18.1 
4.17E-82 IQ motif containing GTPase activating protein 2 18.0 
8.78E-18 nucleophosmin/nucleoplasmin, 3 18.0 
0 histone cluster 1, H2bd 17.9 
0.002826 lysocardiolipin acyltransferase 1 17.7 
0.000172 zinc finger CCCH-type containing 15 17.2 
0.001759 ADAM metallopeptidase domain 10 17.1 
0 heat shock protein 90kDa beta (Grp94), member 1 17.0 
7.96E-07 NADH-ubiquinone oxidoreductase chain 5 16.9 
1.94E-42 glycoprotein, synaptic 2 16.9 
1.01E-07 squamous cell carcinoma antigen recognized by T cells 16.6 
4.8E-155 myosin IB 16.2 
6.34E-40 tropomyosin 3 16.1 
3.03E-12 general transcription factor II, i; general transcription factor II, i, pseudogene 16.1 
1.01E-33 KH domain containing, RNA binding, signal transduction associated 1 15.3 
6.28E-73 staphylococcal nuclease and tudor domain containing 1 14.6 
3.09E-25 Nicastrin 14.1 
3.3E-112 UDP-glucose ceramide glucosyltransferase-like 1 13.8 
3.97E-06 spectrin repeat containing, nuclear envelope 2 13.3 
1.3E-103 methionine adenosyltransferase II, alpha 13.0 
9.73E-13 RNA binding motif (RNP1, RRM) protein 3 12.9 
0.000197 peptide deformylase (mitochondrial); component of oligomeric golgi complex 8 12.4 
4.03E-39 inter-alpha (globulin) inhibitor H2 12.4 
6.87E-20 high mobility group AT-hook 2 12.3 
3.07E-14 coatomer protein complex, subunit gamma 12.2 
1.7E-19 solute carrier family 2 (facilitated glucose transporter), member 3 12.0 
9.36E-36 glucosidase, alpha; neutral AB 11.9 
1E-122 ribosomal protein S4, Y-linked 1 11.5 
6.61E-46 
similar to Bcl-2-associated transcription factor 1 (Btf); BCL2-associated 
transcription factor 1 
11.3 
0 glycyl-tRNA synthetase 10.7 
6.7E-283 heterogeneous nuclear ribonucleoprotein U-like 2 10.6 
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5E-104 thyroid hormone receptor associated protein 3 10.1 
5.43E-13 calmodulin-like 5 9.2 
0 histone cluster 2, H2be 8.9 
1.02E-54 ATP-binding cassette, sub-family C (CFTR/MRP), member 2 8.4 
4.86E-08 major vault protein 8.1 
5.2E-52 hypoxia up-regulated 1 7.7 
2.36E-08 cytochrome P450, family 27, subfamily A, polypeptide 1 5.8 
0 fibronectin 1 4.9 
0.021621 phospholipase C, eta 1 4.6 
6.1E-122 alanyl (membrane) aminopeptidase 2.7 
2.38E-17 proline rich 4 (lacrimal) 2.0 
6.5E-174 actin, beta-like 2 1.5 
0 lactate dehydrogenase A 0.1 
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